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ABSTRACT 
 
Glial cell line-derived neurotrophic factor (GDNF) is a growth factor promoting 
survival, proliferation and differentiation of neural crest cells. Neural crest cells play an 
important role within mesenchymal tissues during dental pulp and calvarial bone 
development. GDNF also has a role within non-neuronal tissues and is expressed during 
dental development. GDNF null mutations prevent the formation of the mineralised 
hard tissues of the tooth. The hypothesis for this study was that GDNF affects 
mesenchymal dental pulp cells (DPC), promoting the regenerative responses of 
mineralised tissues. This study utilised cell culture models to investigate the direct 
effects of GDNF on the proliferation and differentiation of dental pulp cells, bone 
marrow mesenchymal stromal/stem cells (BMSC) and calvarial osteoblasts. This 
research demonstrated that these culture models expressed GDNF and its receptors 
GFRα1 and RET.  GDNF was shown to directly stimulate DPC and osteoblast-like cell 
proliferation and differentiation. Moreover, GDNF was cytoprotective when DPCs were 
cultured under conditions reflecting aspects of inflammation, which may occur during 
repair. These conditions included supplementation with the pro-inflammatory cytokine 
TNFα and culture under serum-starved conditions. It is proposed that GDNF may play 
an important regulatory role in dental pulp homeostasis and bone metabolism.  
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CHAPTER 1 INTRODUCTION 
 
Factors regulating the development of mineralised tissues may also be involved 
in the subsequent repair and regeneration of the tissue. The primary focus of this 
research was to investigate the possible roles of Glial Cell line-Derived Neurotrophic 
Factor (GDNF) in the regulation of non-neuronal cells that form mineralised tissues, by 
using odontoblast-like and osteoblast-like cell culture models.  
1 GDNF and Neurotrophic Growth Factors (NTGF) 
GDNF was first discovered in the medium of the B49 glial cell line and was 
identified as a survival factor for dopamine secreting neurons (Lin et al.  1993). It is 
secreted as a pro-form that is cleaved to give the mature growth factor, which is a 
dimeric protein of approximately 33-45 kDa (Lin et al.  1994; Green 2002). GDNF 
belongs to the cysteine knot growth factor super-family and the locations of most 
cysteine residues within GDNF are homologous to those within the TGF-β2 
(transforming growth factor-beta2) structure (Chen et al.  2000). The TGF-β family of 
proteins along with other major classes of proteins such as BMPs (bone morphogenic 
proteins) are considered to be members of the NTFG family. The GFLs (glial family 
ligands) consists of GDNF, Neurterin, Artemin and Persephin and are regarded as a part 
of the larger NTGF family which also includes the neurotrophins; Nerve Growth Factor 
(NGF) and Brain Derived Neurotrophic Factor (BDNF), Neurotrophin 3 (NT-3) and 
Neurotrophins 4/5, (NT-4/5) (Levy et al.  2005; Freund-Michel and Fossard 2008; 
Sariola and Saarma 2003). GFLs and NTGFs are known survival factors for neurones 
(Airaksinen and Saarma, 2002; Hirano et al.  2000; Bromberg and Wang 2009) and 
includes groups such as the neurokines (e.g. IL-6) which can function during early 
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repair and development (Nibali et al.  2012; Heinrich et al.  2003). Family members 
such as IL-6 are also known to mediate oral pathologies and diseases of bone and joints 
(Nibali et al.  2012; Nishimoto and Kishimoto 2006; Kishimoto 2010).  
Neurotrophins have been shown to stimulate the proliferation of numerous cell 
types in culture, including neurones, liver and muscle cells (Kitomitsu 2000; Brodie and 
Sampson 1987). However, in certain cases in vitro actions are not always replicated in 
vivo, for instance, in vitro NGF stimulates the proliferation of muscle cells whereas in 
vivo within damaged muscle, it appears not to have the same effect (Brodie and 
Sampson 1987; Menetrey 2000). NGF affects cell survival and apoptosis via binding to 
p75NTR and TrKA receptors (Schor 2005; Bredesen et al.  2005; Mizuno 2007).  
1.1.1 GDNF receptors and signalling 
GDNF dimers elicit intracellular signalling by binding to the GDNF family 
receptors alpha (GFRα1) (glycosyl phosphostidylinositol (GPI) linked subunits) and 
RET (Rearranged during Transfection) (Figure 1). RET dimerises, forming the core of 
the complex with outer GFRα1 dimers (Airaksinen and Saarma 2002; Sariola and 
Saarma 2003; Naughton et al.  2006). RET is a tyrosine kinase receptor (RTK) and can 
also be classified as a dependence receptor that is able to initiate opposing signalling 
cascades, i.e. either survival or apoptosis (Goldschneider and Mehlen 2010; Bredesen et 
al.  2005; Mehlen 2005; Del Rio et al.  2007). RET binding is common to all GFL’s 
however, these molecules bind more selectively to the GFRα receptor isoforms (Figure 
1).  
 
3 
 
LIGANDS                   Receptors     Interaction      Receptors          LIGANDS 
GDNF 
 
                                   
NGF 
NTN 
 
                           
BDNF 
 
ART 
 
   
 
                             
NT-3 
  
 
PSP 
 
                                                            
NT-4/5 
 
KEY 
Most specific binding 
Non-specific binding  
Figure 1 Receptor interactions between neurotrophins (NT) and glial family 
ligands (GFL). GDNF = glial cell-line derived factor; NTN = neurturin; 
ART=Artemin; PSP=Persephin; NGF = nerve growth factor; BDNF= (brain derived 
neurotrophic factor); NT-3= (Neurotrophin 3); NT-4/5= (Neurotrophins 4/5). 
GDNF binding to RET and GFRα1 modulate cell survival, apoptosis, 
proliferation and differentiation via activated intracellular signalling cascades (Figure 
1.1). GDNF activation of RET dimers, results in autophosphorylation of the RET 
receptors (Jing et al.  1996; Sariola and Saarma 2003; Manié et al.  2001) and leads to 
activation of Ras, PLC-y (PKC), Ras/MAPK, JNK and PI3/AKT intracellular signalling 
cascades (Airaksinen and Saarma 2002; Coulpier et al.  2002; Manié et al.  2001) 
(Figure 1.1) (Airaksinen and Saarma 2002; Airaksinen et al.  1999).  
Gfrα2 
Gfrα1 
Gfrα3 
RET 
P75NTR 
Gfrα4 
 
 
TrKA 
TrKB 
TrKC 
4 
 
 
 
Figure 1.1 Intracellular signalling pathways activated by Gfrα/RET 
phosphorylation (adapted from Prazeres et al.  2011). Abbreviations; PI3-kinase, 
phosphoinositide 3-kinase; PDK, pyruvate dehydrogenase kinase; HIF1α, hypoxic 
inducible factor; VEGF, vascular endothelial growth factor; AKT, acutely transforming 
retrovirus AKT8 in rodent T cell lymphoma or protein kinase B; mTOR, mammalian 
target of rapamycin; STAT, signal transducer and activator of transcription; SH3, Src 
homology 3; GRB2 =; SOS, son of sevenless; RAS, rat sarcoma protein; RAF, v-raf-1 
murine leukemia viral oncogene homolog 1; ERK, extracellular signal-regulated kinase; 
PLC-y, phospholipase C-gamma; JNK, c-Jun, N-terminal kinase; TCF-4, T-cell factor 
4 (also known as TCF7L2). 
 
Cell membrane 
RPI-1 
Extracellular receptor 
portion 
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Interestingly the GFRα1 receptor may also be present as a soluble isoform and 
can subsequently activate signalling in a paracrine manner (Airaksinen and Saarma 
2002; Sariola and Saarma 2003). This type of signalling involving soluble GFRα1 with 
RET may sustain GDNF effects (Manié et al.  2001). Furthermore, the GDNF-GFRα1-
RET complex may bind in a cell-to-cell manner, whereby one cell may express RET and 
the other GFRα1 (Sprinzak et al.  2010). Poteryaev et al. (1999) found that GDNF and 
Gfrα1 binding could occur independently of RET binding resulting in activation of 
cAMP, MAPK and PLC-y intracellular signals. Later it was also determined that GDNF 
signalling through GFRα1 without RET activates Src, a tyrosine kinase receptor (Brown 
and Cooper 1996) and GDNF also activated Met, the Hepatocyte growth factor (HGF) 
receptor, present on tumour cells (Sariola and Saarma 1999; Gao and Vande Woude 
2005). Popsueva  et al.  (2003) indicated that direct Met and GDNF interactions did not 
however occur within the kidney and therefore these findings suggest that RET-
independent actions of GDNF may be cell-type or tissue specific. NCAM (neural cell 
adhesion molecule) is also a GPI linked receptor that may act as a GDNF co-receptor 
mediating the mitogenic effects of GDNF within Sertoli cells (neural crest derived cells) 
of the testes independently of RET (Yang and Han 2010). NCAM is expressed within 
the developing dental pulp, however, unlike RET-GDNF-GFRα1 complexes, GDNF and 
NCAM expression were not found to be overlapping during tooth development (Obara 
et al.  2002) (see Table 1.2 and Figure 1.4). NCAM is expressed by differentiated 
osteoblasts of human cranial bones (Marie et al.  2002) and during long bone 
development, although NCAM expression appears more prominent during cartilage 
formation compared with osteoblast formation (Hall and Miyake 1995).  GDNF 
signalling may also be dependent on cells being in contact with the extracellular matrix 
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(ECM), i.e. requiring cell surface-associated heparan sulphate glycosaminoglycans 
(Lindfors 2006; Sariola and Saarma 2003). RET protein structure contains cadherin-like 
and fibronectin binding motifs that are also observed within other adhesion molecules 
indicating that RET may couple the cytoskeleton to the ECM (Kuma et al.  1993; 
Anders et al.  2001; Gumbiner et al.  2005).   
Interestingly GFRα receptors are much more widely expressed in the nervous 
system compared with RET receptors (Trupp et al.  1997). Okragly and Haak-Frendscho 
(1997) reported on levels of GDNF expression within the organs of postnatal mice, 
finding that higher concentrations are found within the brain compared to the kidney and 
other organs. The importance of the role of the GDNF receptor complex in neuronal and 
non-neuronal tissue development is highlighted by observation of the phenotypes which 
occur as a result of genetic mutations in GDNF and its receptors (Table 1). 
Gene Phenotype Reference 
RET  Null mutation results in death at birth or 
shortly after. Lack of neural crest derived 
neuronal innervation of gut. Kidneys fail to 
fully develop or may be absent. 
Schuchardt et al. 
(1994) 
GFRα1 Null mutations die 24 hours after birth. 
Reduction in neurons of the colon. No 
kidneys develop. 
Enomoto et al. (1998); 
Garcès et al.  (2000) 
G     GDNF Mutations cause megacolon (or 
Hirschsprung's disease in humans).  Null 
mutations die at birth or shortly afterwards. 
Lack of neural crest derived neuronal 
innervation of gut.  Dentine and enamel of 
the teeth fail to develop. 
Pichel et al. (1996) 
De Vicente et al. 
(2002) 
 
Table 1. Disease/dysfunction resulting from gene mutations in GDNF and its 
associated receptors in mice [adapted from Airaksinen et al. (1999) and Schor et al. 
(2005)]. 
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1.1.2 GDNF, cell proliferation, survival and apoptosis   
GDNF acts as a pro-survival factor for a large number of cell types and is able to 
exert mitogenic and differentiation effects (Weisenhofer et al.  2000; Ng et al.  2009; 
Peterson et al.  2004; Toshifumi et al.  2005; Baldassarre et al.  2002 Meng et al.  2000; 
Park et al.  2005; Wu et al.  2005 Insua et al.  2003; Hofmann et al.  2005; Mwizerwa et 
al.  2011). Changes in cell cycle phases are linked with differentiation (Ohnuma et al.  
2001; Buttitta and Edgar 2007) and studies have identified certain points within the cell 
cycle that can be modulated by GDNF signalling, in particular G1 entry and G1/S phase 
via p27
kip1
 and cyclin A regulation (He et al.  2008; Vitagliano et al.  2004; Baldassarre 
et al.  2002).  
Apoptosis plays an important role during tissue development, differentiation, 
maintenance and repair as it allows excess or damaged cells to be safely removed 
(Elmore 2007). For instance, during neuronal development excess cells are generated in 
response to neurotrophins and those not receiving growth factor stimulation 
subsequently apoptose (Yuan and Yankner 2000). Apoptosis and survival are controlled 
by a balance between activators (pro-apoptotic proteins) and inhibitors (anti-apoptotic 
proteins). Activation of the apoptotic process involves caspases-3, -6 and -7 and these 
are termed effector or executioner caspases and are responsible for initiating both the 
degradation of DNA and the end stages of apoptotic cascades (Nicholson 1999; Elmore 
2007). Two major pathways of apoptosis are discerned and include the intrinsic or 
mitochondrial pathway, whereby activators of apoptosis are released from the 
mitochondria, and the extrinsic pathway, where apoptosis is induced following receptor 
binding (Ashe and Berry 2003; Elmore 2007). Both processes ultimately result in DNA 
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and cytoskeletal degradation, nuclear fragmentation and the formation of apoptotic 
bodies (Elmore 2007) (see Figure 1.2). 
The extrinsic pathways leading to apoptosis can be influenced by growth factors 
(see Figure 1.2, pg 9). GDNF and other growth factors can function as pro-survival 
factors influencing the expression of anti-apoptotic factors such as Bcl family members 
(Ghribi et al.  2001; Pugazhenthi et al.  2000). However, the intracellular domain of 
RET has a caspase-3 cleavage site, which in the absence of GDNF signalling may be 
cleaved to initiate apoptotic cascades (Bordeaux et al.  2000). GDNF signalling via RET 
activates the AKT/P13 and Ras pathways that regulate cyclin D and stimulates cell cycle 
progression, also GDNF stimulation suppresses BAD activity and up-regulates IAPs 
(inhibitors of apoptosis) (see Figure 1.2) (Neff et al.  2002; Drosten et al.  2004; 
Airaksinen and Saarma 2002). Similarly to the RET receptor, the TNFα receptor 
(p75
NTR 
low affinity nerve growth factor receptor or CD271) can also supply both 
positive and negative signals for survival determined by the activation of transcription 
factor NFĸB that subsequently regulates apoptosis in response to TNFα (Wullaert et al.  
2007; Liu et al.  1996).  
1.2 Tissue development and GDNF function 
Apoptosis occurs during cell differentiation within the developing calvarial 
bones in order to prevent premature closure of the adjoined skull bones and this process 
of cranial osteoblasts is proposed to be regulated by FGF-2 (beta-fibroblast growth 
factor) and BMP-2 (Marie et al.  2002). Similarly, a wave of apoptosis has been 
reported during tooth development that coincides with the differentiation of 
odontoblasts (cells that form mineralized tissue of the tooth (see section 1.2.1 and 1.2.4) 
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(Mitsiadis et al.  2008)  although the growth factors regulating this process have not 
been reported. Organ development is often subject to reciprocal interactions, involving 
epithelial tissue transmitting inductive signals (growth factors) and a mesenchymal 
tissue being competent to respond to the signal by returning an inductive signal (Gurdon 
1992; Thesleff et al.  1995; Zhang et al.  2005). In line with these reports, abnormal 
GDNF expression and hence signalling between epithelial and mesenchymal tissues 
within the developing lung has been linked with decreased levels of apoptosis and 
subsequent 
 
Figure 1.2 Schematic diagram detailing the signalling pathways involved 
during apoptosis that may be regulated by growth factors such as GDNF (from 
Johnstone et al. 2002). Component molecules in red inhibit apoptosis while those in 
green promote apoptosis. Abbreviations used: FADD, Fas-Associated protein with 
Death Domain; Apaf-1, apoptotic peptidase activating factor 1; Bid, BCL-2 Interacting 
Domain; Smac, diablo homolog ; HtRA2, HtrA serine peptidase 2; Bax, BCL2-
associated X protein; Bak, BCL2-antagonist/killer 1; Bad, Bcl-2-associated death 
promoter; Bcl-xL/Bcl-2 associated death promoter; PTEN, phosphatase and tensin 
homolog; PP2A, protein phosphatase 2A activator, regulatory; BH3, Bcl-2 Homology 
(BH) domain 3; ATM, ataxia telangiectasia mutatedChk2, CHK2 checkpoint homolog 
(S. pombe); MDM2, Mdm2 p53 binding protein homolog (mouse); p19
ARF 
, p19 
alternative reading frame, casp, caspase; cyt, cytochrome. 
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malformation of the organ structure (Fromont-Hankard et al.  2002). Epithelial- 
mesenchymal signalling is a prominent process during tooth development and data 
indicates that GDNF may play a role in such reciprocal interactions (Vainio and Lin 
2002; Fromont-Hankard et al.  2002; Airaksinen 1999; Nosrat et al.  2002; Lukko et al.  
1997; Nosrat et al.  1998; Fried et al.  2000).   
Organ and tissue development reportedly occurs due to the actions of 
morphogens (growth factors) forming concentration gradients that specify cell fates 
within the embryo (Gierer and Meinhardt 1972; Green 2002). Notably GDNF as well as 
FGF, TGFs and activin (a NTGF) have been identified as morphogens involved in tissue 
development (Armelin 1973; Todaro et al.  1981; Vale et al.  1986; Slack et al.  1987; 
Smith et al.  1990; Green and Smith 1990; Green 2002). These growth factors 
subsequently influence a range of transcription factors such as HOX (Homeobox) genes, 
PAX (Paired box genes) and SOX [SRY (sex determining region Y)-box genes] gene 
families, specifying cell fates.  Interestingly GDNF regulates SOX10 transcription 
within neural crest cells (NCC), and SOX10 with PAX3 also regulate the transcription 
of RET (Lang et al.  2000, 2003; Linnarsson et al.  2001; Wu et al.  2008).  
During early embryogenesis NCC are generated from ectodermal tissue of the 
mid- and hind-brain neural folds (Lumsden 1986, 1988; Ruch et al.  1995). These 
pluripotent NCC migrate from the ectoderm throughout the embryo to specific sites 
where they proliferate and differentiate to form structures within organs and tissues, e.g. 
odontoblasts of the dentine-pulp complex of the tooth (Gilbert 2000; Nanci 2003; 
Gronthos and Brahim 2002). Embryonic NCC develop into the adult cranial and sensory 
neurones (including nocioceptors) (Nanci 2003), sympathetic neurones and 
parasympathetic neurones (White and Anderson 1999), the periodontal ligament, 
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alveolar bone, the adrenal medulla, neurones of the gut (Kruger et al. 2002) cranio-
facial bones, the skull (Nanci 2003), Schwann cells (Stemple 1992; Kaltschmidt et al. 
2012), glia (Henion et al. 2000), spinal ganglia (Lefcort and George 2007), carotid body 
and aorta (mechanosensors) of the heart (Izal-Azcárate 2008, Gilbert 2000) (Figure 1.3). 
This ability of ectodermally derived cells to migrate, inhabit and function as 
mesenchymal cell types is unique to these pluripotent NCC.  
GDNF affects developing NCC derived tissues, influencing cellular 
proliferation, migration and differentiation throughout the embryo (Britsch et al.  2001; 
Young et al.  2001; Natarajan et al.  2002; Mwizerwa et al.  2011). GDNF is also 
expressed in postnatal neural crest derived tissues including the dermis (Motohashi 
2006; Oshima et al.  2010), carotid body of the heart (Izal-Azcárate 2008; Shakhova and 
Sommer 2010; Miwa et al.  2010; Leitner et al.  2005), the Sertoli cells of the testes 
(Sariola and Immonen 2008), the inner ear (Stöver et al.  2001; Nam et al. 2000; 
Fransson et al.  2010; Minoux and Rijli 2010) and retinal cells of the eye (Hauck et al.  
2006; Grocott et al.  2011). It is now proposed here that GDNF may influence NCC 
derived dental pulp and bone cell differentiation. 
1.2.1 Tooth development  
The pathway whereby NCC form odontoblasts begins with cranial NCC 
migration from the cranial region of the embryo into the mesenchymal tissue of the 
branchial arches. The first branchial arch (Figure 1.3, pg 12) develops into the jaw and 
after cranial NCC migration into the branchial arch, the adjacent epithelium thickens 
and invaginates into the NCC containing condensing mesenchyme (consisting of 
aggregates of mesenchymal cells) to form a dental placode (Figure 1.4, pg 14). This 
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developing tooth subsequently proceeds through a series of developmental stages 
termed bud, cap, bell and crown (see Figure 1.4, pg14). 
During the bell stage the condensing mesenchyme develops into the dental 
papillae and the epithelium forms the dental or enamel organ (Figure 1.4, pg 14) 
simultaneously re-iterative signals (of growth factors) occur throughout the different 
stages of tooth development, beginning with initial stimulation from the oral epithelium 
to the cranial NCC derived mesenchyme (Thesleff and Tummer 2009). The growth 
factor signalling involved reportedly includes BMPs, FGF, Wnt (wingless-type MMTV 
integration site family) and Shh (sonic hedgehog) (Thesleff and Tummers 2009).  
 
 
 
 
A.     B.             
Figure 1.3 (A) The gross anatomy of the developing human embryo showing the 
position of the four branchial arches at the head end of the embryo. Red arrows 
indicate branchial arch positions. (B) Section through the branchial (pharyngeal 
arch). The red line indicates the saggital plane from where the cross section is derived. 
The branchial arches are shown in sagittal plane as regions of the ectoderm, mesoderm 
and endoderm. There would appear a mirror image of this structure on the right hand 
side of the existing image if the whole cross section was shown, from 
http://rad.usuhs.edu/medpix. 
Branchial arches 
1  2  3  4 
A Branchial 
arch 
Point of 
contact 
between 
ecto-and 
endoderm 
layers 
(Homma ) al 
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(Outermost epithelia) 
Mesoderm (layer) of 
Cranial NCC 
Endoderm layer 
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Migration and recombination studies have demonstrated that odontoblasts 
develop from the NCC derived mesenchyme of the dental papilla and only form 
following interaction between cranial NCC and branchial arch epithelium (Lumsden 
1988; Thesleff et al.  1995; Zhang et al.  2005). The importance of correct control of 
cranial NCC migration is highlighted in Di George syndrome where cranial NCC 
migration is disrupted, subsequently branchial arch structures do not develop normally 
and tooth development is therefore abnormal (da Silva Dalben et al.  2008). 
Interestingly mutations in VEGF (vascular endothelial growth factor) cause the 
phenotypic changes seen in Di George patients (Campbell 2003). Notably Tufro et al. 
(2007) reported that VEGF activates RET and induces GDNF up-regulation, indicating 
an interesting interrelationship between these molecules that may affect craniofacial 
development. Furthermore, inhibition of GDNF-RET signalling may repress tooth 
formation (Klein et al.  2006; Taketomi et al.  2005). Studies have previously shown 
that GDNF mediates the differentiation of NCC during the development of several other 
organ systems (Vainio and Lin 2002; Sariola and Saarma 2003).  
Odontoblasts differentiate from the cells of the dental papillae and begin 
producing pre-dentine (unmineralised collagenous ECM of dentine) during the late bell 
stage. Differentiating dental papilla/pre-odontoblasts also produce proteins such as 
fibronectin and collagen type III that are associated with the forming basement 
membrane positioned between the dental papilla and the inner epithelial (IDE) (Smith 
and Lesot 2001; Tzaifas and Kondados 2010; Ruch et al. 1982). Thesleff et al. (1978) 
reported that both mesenchymal dental papilla cells and IDE cells are needed to produce 
the basement membrane and this interaction initiated odontoblast differentiation. 
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Figure 1.4 Stages of rodent tooth development (adapted from Thesleff and Tummers 
2009; Lumsden 1988). E=embryonic murine day; ODE= Outer dental epithelium; 
IDE= inner dental epithelium; DP =dental papilla; ERM= epithelial cell rests of 
Malassez; HRM= Hertwig's epithelial root sheath. 
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The basement membrane proteins fibronectin and decorin have previously been 
shown to support and signal odontoblast polarisation and differentiation (Ruch et al.  
1995; Ruch 1998) however more importantly growth factor signalling is considered 
crucial to this process. In particular, IGF, FGFs (a and b), TGF-βs (-1, -2, -3) and BMP 
(-2, -4, -6) have been identified as putative factors involved. Other growth factors that 
may regulate odontoblastic differentiation include NGF, PDGF (platelet derived growth 
factor) (Yokose et al.  2004), HGF (Ye et al.  2006), Gdf11 (growth/differentiation 
factor 11) (Nakashima et al.  2002) and ADM (adrenomedullin) (Musson et al.  2010).  
1.2.2 Primary, secondary and tertiary dentinogenesis 
Dentine is located beneath the tooth enamel (Frank 1999) (Figure 1.7 pg 31) and 
is initially synthesized during development in a process termed primary dentinogenesis. 
Following tooth eruption dentine is continually formed at the periphery of the dental 
pulp throughout the life of the tooth (Linde 1989) and this process is termed secondary 
dentinogenesis (Linde 1989; Sloan and Smith 2007). If the dentine becomes damaged 
after eruption further dentine may be produced as a replacement in a process referred to 
as tertiary dentinogenesis (Smith and Lesot 2001; Smith 2001; Tziafas et al.  2000).  
Odontoblasts have processes which are the first point of contact between the 
peripheral dentine and dental pulp. Cellular processes from an odontoblasts extend 
within the dentine tubules along with neighbouring nerve fibres potentially up to the 
dentine border with the enamel (Frank 1999; Karjalainen and Le Bell 1987; Moss et al.  
2005). Consequently, physiological changes within the dentine/enamel are detected by 
the odontoblast and nerve processes (Chaussain-Miller et al.  2006; Smith et al.  2001; 
Smith 2001; Karjalainens and Le Bell 1987) and may stimulate tertiary dentinogenesis. 
16 
 
Physiological changes in the biofilm affect the dentine and enamel. Teeth develop a 
naturally occurring coating of bacteria termed a biofilm which can become excessively 
populated by acid producing bacteria, such as Streptococcus mutans, that subsequently 
cause tooth mineral dissolution releasing the components of the dentine/enamel 
structure (Marsh 2006; Verstraeten et al.  2008). As this dental caries progresses the 
odontoblast may also come into direct contact with the bacteria or its components. 
Odontoblasts have been shown to express toll-like receptors (TLR) that bind bacterial 
surface proteins and these interactions may initiate an immune and inflammatory 
response within the dental pulp, which may also contribute to tertiary dentinogenesis 
depending on the severity of the infection (Cooper et al.  2010; Berkovitz 2002; Jones 
and Boyde 1977; Hirao et al.  2009; Botero et al.  2006; Horst et al.  2009; Durand et al.  
2006).  
Dentine production by existing odontoblasts is termed reactionary 
dentinogenesis and is a form of tertiary dentinogenesis. Severe disease/trauma may 
result in odontoblast apoptosis or necrosis (Mitsiadis et al.  2008), however 
neighbouring post-mitotic terminally differentiated odontoblasts cannot divide to 
produce new daughter cells to repopulate and repair the injury site (Berkovitz 2002; 
Moss et al.  2005). Generation of new odontoblast-like cells, differentiating from 
mesenchymal dental pulp stem/progenitor cells may occur under appropriate conditions 
(see section 1.3.1) and dentine produced during this form of tertiary dentinogenesis is 
termed reparative dentinogenesis (Smith and Lesot 2001; Sloan and Smith 2007; Shiomi 
2000). 
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1.2.3 Intramembranous and endochondral bone development               
         Long/limbs bones are formed by endochondral ossification whereby cartilage is 
formed initially and subsequently replaced by bone produced by osteoblasts. Osteoblasts 
are differentiated from the mesenchyme surrounding the cartilaginous tissue. However, 
the flat bone of the cranium develops primarily by intramembranous ossification, 
whereby osteoblasts directly differentiate from cranial NCC-derived condensed 
mesenchyme (Figure 1.5, pg 20). Unlike tooth and craniofacial bones, the limb bud 
mesenchyme is not derived from cranial NCC (LeLièvre and Douarin 1975; Noden, 
1988; Chai et al.  2000; Jiang et al.  2002; Couly et al.  1992, 1993; Lumsden et al.  
1986). In particular, the frontal area of the cranium forms from cranial NCC and the 
posterior region from mesoderm (Opperman et al.  1993, 1996; 2000; Couly et al.  1992, 
1993; Santagati and Rijli 2003). Thus, due to the differences in cellular origins, the 
fundamental developmental processes as well as behaviour of osteoblasts within cranial 
and long bones may be different (Ornitz and Marie 2002; Depew et al.  1999) (Mao et 
al.  2006). Indeed Moore et al. (2002) noted that fibroblast growth factor -2 (FGF-2) 
implanted into the developing skull had no detectable effect yet when it was implanted 
into the developing limb it initiated growth of this structure. Furthermore, null mutation 
of the BMP receptor type 1B gene resulted in defects in limb bones but not cranial bone 
formation (Lian et al. 2006) underscoring physiological differences between 
endochondral and intramembranous ossification. Van der Bos et al. (2008) also reported 
differences in levels of collagen, osteopontin and osteonectin within the ECM 
composition of each bone type. 
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Little is known about the role of GDNF in bone development and osteoblast 
differentiation. It is postulated here that GDNF may be involved in cranial bone 
formation through a direct action on NCC. During intramembraneous ossification 
mesenchymal cells condense, then differentiate into osteoprogenitors and osteoblasts 
directly (Hall and Miyake 1992) (Figure 1.5). Osteoprogenitors and pre-osteoblasts 
secret extracellular matrix (ECM) components (e.g., collagen III, hyaloronan, collagen 
type I) that may be stimulated by growth factors such as TGF-β and these ECM 
molecules may play a role in inducing further osteoblast differentiation (Lian and Stein 
2003, 2004, 2006). Furthermore, autocrine secretion of BMP-2, BMP-4, and BMP-7 by 
differentiated calvarial osteoblasts may have further effects stimulating cyto-
differentiation, increasing the transcription of bone constituents including osteocalcin 
(OCN) and bone sialoprotein (BSP) transcripts (Xiao et al.  2002; van der horst et al.  
2002). 
The role of GDNF in long bone formation is also unclear. During long bone 
formation, the proliferation and differentiation of osteoblasts is due to a series of 
interactions between chondrocytes and a pre-osteoblast mesenchymal region (called the 
perichondrium) (Vortkamp et al.  1998) secreting growth factors such as BMP-2, -4, and 
-7 (Yamaguchi et al.  2000; Vortkamp et al.  1998), FGF-7, -8, -17 and -18 (Ornitz and 
Marie 2002; Ducy et al.  1997; Yamaguchi et al.  2000). Later osteoblasts differentiate 
from the mesenchyme (the perichondrium) surrounding the chondrocytes. GDNF 
mRNA has been detected in mesenchymal tissues surrounding the forming cartilage in 
femur limb buds at embryonic day 14.5 (Hellmich et al.  1996). Furthermore GDNF was 
secreted by chondrocytes stimulated with TNFα (Kashani et al.  2010). Interestingly, 
HOX11 null mice have no detectable expression of GDNF or the GDNF transcription 
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factor six2 (Wellik et al.  2002; Brodbeck et al.  2004). HOX11 functions together with 
HOX10 (Myers 2008) and HOX9 to regulate digit formation in forelimbs (Xu and 
Wellik 2011; Goff and Tabin 1997) and HOX11 mutant mice have spine and limb joint 
abnormalities (Small and Potter 1993; Davis et al.  1995). This data suggests that 
HOX11 is involved in transcription of GDNF during endochondral ossification.  
1.2.4 Dentine and bone extracellular matrix   
 The mineralised matrix of dentine and bone consists of hydroxyapatite crystals 
[Ca5(OH)(PO4)3] that are embedded in a collagenous ECM. The ECM affects the 
position, orientation, size and growth of the crystal hydroxyapatite in these hard tissues 
(Boskey 1991). Bone and dentine also contain non-collagenous proteins, including 
phosphoproteins, dentine matrix protein-1 (DMP-1), dentine sialoprotein (DSP), dentine 
phosphoprotein (DPP), bone sialoprotein (BSP), osteonectin (ON), osteocalcin (OCN), 
osteopontin (OPN) and proteins from serum (such as growth factors and albumin) 
(Smith et al.  2011; Hao et al.  2009; Huang et al.  2008). The acidic non-collagenous 
phosphoproteins of dentine and bone are suggested to be the sites of nucleation for 
hydroxyapatite formation on the ECM due to their capacity to bind to collagen and 
calcium ions (Fujisawa and Kuboki 1991; Houlle et al.  1997; Saito et al.  1997; Boskey 
1991; He et al.  2003).  
The enzyme alkaline phosphatase (ALP) has been suggested to play an important 
role in the ECM mineralisation process (Beertsen and van den Bos 1989). It was 
hypothesized that ALP is involved in the generation of inorganic phosphate ions 
necessary for matrix mineralisation whilst inhibiting factors that reduce inorganic 
portions of the ECM (Beertsen and van der Bos 1992; Damek-Poprawa et al. 2006). 
20 
 
 
Figure 1.5 Diagrammatic comparison of human endochondral bone formation (A) 
and intramembraneous ossification (B), from Orntiz and Marie (2002). Note the limb 
bud and mesenchymal condensations initiation of bone development differs, 
osteoprogenitors (pink) are formed directly from mesenchyme (clear) during 
intramembranous ossification, these differentiate to osteoblasts (yellow) that later reside 
on the inner lining surface of the bone facing the bone marrow cavity or in the 
outermost  periosteum lining of the bone surface (B), compared to (A) endochondral 
ossification where chondrocytes (light blue) form directly from mesenchyme (clear). 
 
Notably, bone ALP (tissue non-specific ALP or TNSALP) is used as a biochemical and 
clinical marker for osteoblast activity and total serum ALP is used for biochemical 
diagnosis of bone diseases (Singer and Eyre 2008; Karjalainens and Le Bell 1987). 
Recently, mutations in human TNSALP genes and TNSALP null rats have been shown 
to produce hypophosphatasia a bone disease characterized predominantly by decreased 
skeletal mineralization (Whyte 2010), indicating ALP is required for the mineralisation 
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of bone.  In vitro ALP has also been used as an early, albeit nonspecific, marker for 
osteogenic cell differentiation and has been suggested to reflect in vitro mineralization. 
During osteoblast differentiation, confluent osteoblast cultures are able to form 
multilayers which coincide with a decrease in cell proliferation whilst the expression 
levels of ALP increase; notably as the ECM matures during mineralised nodule 
formation ALP levels subsequently decrease (Bellows et al.  1991; Porter et al.  2003; 
Golub and Boesze-Battaglia 2007). In vitro mineralisation can be stimulated by the 
presence of osteogenic supplements, β-glycerophosphate (β-gp), dexamethasone (DEX) 
and ascorbic acid (AA or Vitamin C). β-gp is necessary for the formation of mineralised 
collagenous matrix (Fratzl-Zelman N et al.  1998), supplying ―active‖ phosphate for the 
mineralisation of the collagenous ECM and is also a substrate for ALP (Fratzl-Zelman et 
al.  1998). Collagen synthesis is dependent on the presence of AA (Murad et al.  1983; 
Fratzl-Zelman et al.  1998) and DEX is a pleiotropic synthetic steroid that is used as an 
inducer of osteogenic differentiation in vitro and also increases ALP expression (Boskey 
and Roy et al.  2008; Alliot-Licht et al.  2005; Cheng et al.  1994, 1996).  
The ―master‖ gene regulators of transcription during osteoblast differentiation 
are regarded as Osterix and Cbfα1/RUNX2 (Ducy et al.  1997). The processes involved 
in the regulation of odontoblast differentiation are however less well understood, but, 
similar transcriptional controls as to those in osteoblasts may be involved in regulating 
this process (Narayanan et al.  2001; Hao et al.  2005; Qin et al.  2001, 2004, 2007). 
Interestingly the DSPP (dentin sialophosphoprotein) promoter has putative binding sites 
for Cbfα1 (Chen et al.  2005) and this gene encodes two proteins DSP and DPP, both of 
which have been associated with odontoblast differentiation and dentinogenesis (Shi 
2001).  
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1.3 GDNF and repair of mineralised tissue 
Serum proteins such as albumin, PDGF, TGF-β, bFGF, IGFI and II and VEGF 
have been identified within the dentine ECM, sequestered there during dentinogenesis 
(Roberts-Clark and Smith 2000; Linde and Goldberg 1993; Finkleman et al. 1990; 
Kinoshita, 1979). Similarly, during bone development growth factors are also 
sequestered within the developing mineralised matrix and are involved in osteoclast-
osteoblast signalling and the regulation of bone remodelling (Hauschka et al.  1986). 
These signalling molecules may also be present in the soft extracellular 
stromal/mesenchymal matrix postnatally. Bone remodelling repairs small areas of 
damaged bone as a part of the normal homeostatic postnatal mechanism, controlling 
bone size, strength and density. However, research investigating postnatal repair 
processes of mineralised tissues has suggested larger repairs utilise mechanisms that 
mimic the developmental processes forming mineralized tissues (Robling et al.  2006; 
Ferguson et al.  1998, 1999; Vortkamp et al.  1998 Tsiridis and Giannoudis 2006; 
Silkstone et al.  2008; Smith and Lesot 2001; Simon et al.  2009, 2010). Several growth 
factors such as BMP-2, PDGF, VEGF and TGF-β involved in embryonic tooth 
development and bone development are already known to influence postnatal dental 
pulp physiology (Kinoshita 1979; Kato 1988; Lynch et al.  1999; Roberts-Clarke and 
smith 2000; Tziafas et al.  2000; Matsushita 2000; Haddad et al.  2003; Kurihara 2003, 
2007; Iohara et al. 2004; Sloan & Smith 2007; Scheven et al.  2009; Hauschka et al.  
1986 ).  
During injury/infection degradation of the mineralized ECM may liberate growth 
factors and other proteins previously sequestered there (Chaussain-Miller et al.  2006), 
where they may be bound to carrier molecules which maintain their stability, such as 
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heparin sulphate, decorin and biglycan (Berkovitz 2002; Karjalainens and Le Bell 1987; 
Smith et al.  2011; Buckwalter and Mankin 1988). The release from the ECM following 
disease may be key to signalling repair (Smith and Lesot 2001; Hing 2004), by evoking 
migration, proliferation, survival and differentiation of osteo/odontoblasts, progenitors 
and stem cells that can regenerate the mineralised tissue (Smith et al.  1990; 2001; 
Benezra et al.  1993; Farges et al.  2003; Grassinger et al.  2009). However, the 
existence of GDNF, NGF or other NTGFs among sequestered growth factors within 
dentine is as yet unreported.  
1.3.1 Mesenchymal stem/stromal cells (MSC)  
Mesenchymal stem cells (MSC) have been identified within various 
mesenchymal tissues including bone marrow, adipose and skin (Zuk et al.  2002), 
kidney (Huang et al.  2009), umbilical cord (Lu et al.  2006) and muscle (Jankowski et 
al.  2002). Neural crest stem cells within the mesenchyme such as the dental pulp may 
also be considered as mesenchymal stem cells often referred to as ―ecto-mesenchymal‖. 
The term stem cell is indicative of the self renewing or colony forming ability of cells 
along with pluri-/multi-potentiality. MSC may be recruited to sites of injury, migrating 
and differentiating to form tissue specific cells in situ (Koç et al.  2000; Crisan et al.  
2011; Wise and Ricardo 2012; Theise et al.  2000; Peterson et al.  1999; Barry and 
Murphy 2004). Distinct MSC populations can be obtained by FACS, however 
significant work still remains to identify definitive panels of markers for MSC isolation 
for all tissues (Gronthos et al.  2011; Battula et al.  2009; Kagami et al.  2011; Bühring 
et al.  2007, 2009). The role of mesenchymal stem cells in tissue repair and regeneration 
has generated a significant amount of interest over the last decade, in particular dental 
pulp stem cells (DPSC) have now been considered as a potential and promising source 
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for repair and regeneration of the tooth as well as other tissues (Sasaki et al.  2008; Nesti 
et al.  2011; Gandia et al.  2008; Arthur et al.  2009; Kerkis et al.  2006, 2008; Zhang et 
al.  2008). Although the precise identity and tissue localisation of DPSC are not fully 
known, DPSC share many similarities with bone marrow MSC [(BMSC) bone marrow 
mesenchymal stem/stromal cells] (Yan et al.  2011; Alge et al.  2010; Huang et al.  
2009). DPSC and BMSC are multipotent, able to differentiate along osteogenic, 
odontoblastic, adipogenic, neurogenic and chondrogenic lineages (Arthur et al.  2008; 
Egusa et al.  2005; Sanchez-Ramos et al.  2000; Tziafas and Kondonas 2010). Similarly 
to dentine regeneration, bone can regenerate during repair by osteoblast differentiation 
from MSC (Hing 2004; Yu et al.  2007; Batouli et al.  2003). Thus, DPSC and BMSC 
cultures may be used as model cultures pertaining to study of stem cells and the 
processes involved in cell differentiation and tissue repair (Aubin 1998, 1999; Frank et 
al.  2002; Zou et al.  2008; Wang et al.  2010b & c; Gronthos et al.  2002; Shi et al. 
2005; Miura et al.  2003, 2004; Couble et al.  2000; Woodbury et al.  2002; Egusa et al.  
2005).  
The ability of MSC to differentiate along different lineages is influenced by 
growth factors present within the injured/repairing tissue (Hermann et al.  2004; Barry 
and Murphy 2004; Banfi et al.  2000) and MSC themselves also secrete a range of 
growth factors that further influence the tissue repair and also act in an auto-/paracrine 
manner (Majumdar et al.  1998; Barry and Murphy 2004). Interestingly, DPSC and 
BMSC cultures produce a range of NTGFs including GDNF which prompted an 
emerging interest in the use of these cells for neurological disorders and nerve repair 
(Nosrat et al. 2001; Apel et al. 2009; Chop and Li 2002; Sasaki et al.  2008; Nesti et al.  
2011). In addition, GDNF has been reported to induce stem cell self-renewal and to be 
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cytoprotective for MSC of the kidney stimulating proliferation and migration (Shi et al.  
2008; Meng et al.  2000; Gonzalez et al.  2009). Therefore elucidation of the basic 
functions of GDNF that control mesenchymal cell differentiation has potential for  
broader beneficial applications. 
Furthermore, GDNF effects may be co-ordinated with other growth factors such 
as Wnts, TGF-βs, BMPs or mediators of inflammation, such as TNFα, neuropeptides 
and neurotrophins, that are up-regulated during mineralised tissue  repair (Golub and 
Boesze-Battaglia 2007; Liu et al.  2008; Rawadi et al.  2003). Blocking Wnt signalling 
abrogates ALP activity and results in abnormal tooth development (Qiang et al.  2008 
Golub and Boesze-Battaglia 2007; Liu et al.  2008). Interestingly, Wnt signals down-
regulate GDNF, inhibiting stem cell self renewal during spermatogenesis (Tanwar et al.  
2010) while Wnt11 deficiency decreases GDNF expression within the kidney (Chi et al.  
2004). TGF-3 has also been reported to be required for recruiting the GDNF receptor 
Gfr1 to the plasma membrane (Peterziel et al.  2007; Sariola and Saarma 2003) and 
TGF-βs are required for the trophic actions of GDNF in vitro and in vivo (Krieglstein et 
al.  2002; Schober et al.  1999). TGF-s are expressed in odontoblasts (Linde 1989, 
Tziafas et al. 2000) and dental pulp cells, and isoforms I and III increased odontoblast 
secretory activity, differentiation and repair in rat organ and cell culture models (Sloan 
et al. 2002; Sloan and Smith 1999; Tziafas et al.  1998; Nie et al.  2006). Moreover 
TGF-1 application within pulp capping experiments in vivo (Tziafas et al.  1998, 2001; 
2000; Smith 2001) along with the inhibition of reparative dentinogenesis caused by 
TGF-1 anti-sera application in ferrets (Smith et al.  1994) indicates TGF-1’s potential 
important role in promoting dental hard tissue formation. Conceivably, differentiation 
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and mineralization events which occur during bone and dental pulp repair may involve 
interactions between TGF-β and GDNF.  
 TNFα is a cytokine involved in immune and inflammatory responses at sites of 
disease and injury (Szlosarek and Balkwill 2003; Konisti et al. 2012). TNFα inhibits 
osteoblast terminal differentiation and has been found to be abundantly expressed in 
many diseases of bone, including rheumatoid arthritis (Boyce et al.  2005). Dental pulp 
cell TNFα expression is up-regulated by bacterial LPS (lipopolysaccharide) and LTA 
(Lipoteichoic acid) and within infected pulpal tissue (McLachlan et al 2004; Bletsa et al.  
2006; Keller et al.  2010). The role of TNFα in vivo during dental pulp inflammation 
may however have opposing effects on DPC behaviour due to its potential ability to 
promote repair processes at relatively low concentrations while inhibiting repair 
processes at high concentrations (Cooper et al.  2010, 2011; Okabe and Matsushima 
2006; Paula-silvia et al.  2009; Pezelj-Ribaric et al.  2002). Notably the GDNF promoter 
has a binding site for NFĸB which is a key transcription factor activated in response to 
TNFα signalling (Grimm et al.  1998) and GDNF expression in Sertoli cells is also 
known to be up-regulated by TNFα stimulation (Simon et al.  2007; Hofmann 2008). 
GDNF expression in the brain is also up-regulated during inflammation and repair; a 
finding similar to that reported for GDNF within other non-neuronal tissues (Eberling et 
al.  2009; Cheng et al.  2008; Katoh-Sembah et al.  2007; Nam et al.  2000; Tsui et al.  
2006) indicating that GDNF specifically functions during soft tissue injury, infection or 
repair. GDNF may therefore also influence hard mineralised tissue repair, directly or 
indirectly via interactions with prominent growth factors and cytokines that regulate 
these processes.  
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1.3.2 The role of the nervous system in mineralised tissue repair 
Several functions have been ascribed to the up-regulation of NTGF and 
neuropeptides (NP) released from the nervous system during injury/infection. Such 
functions include the further stimulation of the nervous and immune systems to remove 
infection, produce anti-inflammatory factors, modulate pain and perform neuronal repair 
(Toben et al.  2011; Xian and Zhou 2009; Paschalia et al.  2011; Lundy and Linden 
2004; Wang et al. 2003; Pezet and McMahon 2006; Lambrecht 2001). Highly 
innervated bone (See Figure 1.6, pg 28 for the localisation of nerves) contains numerous 
sympathetic nervous system fibres that have previously been suggested to regulate 
haemopoietic cell proliferation and mobilisation from within the bone (Afan et al.  
1997; Elmquist and Strewler 2005; Chen et al.  2002; Marenzana and Chenu 2008; Serre 
et al.  1999; Delgado et al.  2004).  However, more recently the innervation has been 
suggested to be involved in bone development (Elmquist and Strewler 2005). This 
newer more direct role of the sympathetic bone innervation and neuropeptides (NP) on 
bone formation and putatively on repair was initially demonstrated by adrenergic 
receptor activation, (Elefteriou 2005, Elefteriou et al.  2005; Elmquist and Strewler 
2005) is currently under investigation (Lundy and Linden 2004; Sato et al.  2007; Goto 
et al.  2007; Natsume et al.  2010). However NP are also secreted from non-neuronal 
tissues during tissue damage and infection and these molecules can stimulate growth of 
cells within mineralised tissues; for instance VIP (Vasoactive intestinal peptide), and 
CGRP (calcitonin gene related peptide) are secreted by DPC, furthermore CGRP and SP 
(substance P) were secreted by DPC in vitro after incubation with proteases from 
P.gingivalis (Tancharoen et al.  2005). Both CGRP and SP also increased dental pulp 
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Figure 1.6 Immunohistochemical localization of neurones and nerve markers in long bones of growing rats aged 15-25 days. (a) Metaphysis of 
neonatal rat femur. NF 200-positive nerve processes (arrows), showing local enlargements (arrow heads), are running along bone trabaeculae (t) and 
vessels (v). They are close to bone cells (Oc: osteoclast, Ob: osteoblast) and hematopoietic cells (H). Original magnification: X1000. (b) Deep 
metaphysis of neonatal rat femur at the level of the afferent vessel. Tyrosine hydroxylase is present in these nerve processes (arrows) showing local 
dilatations (arrow heads) in contact with hematopoietic cells (H). Oc: osteoclast. Original magnification: X1500. (c) Deep metaphysis of neonatal rat 
femur. MAP2-positive nerve processes showing dilatations (arrow heads) in contact with hematopoietic cells (H) and osteoclasts (Oc). Original 
magnification: X1000. (d) Diaphysis of 15-day-old rat tibia. NF200 is present in nerve endings (arrow heads) in contact with hematopoietic 
cells (H). Original magnification: x1000, from Serre et al.(1999). 
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proliferation in vitro (Bongenhielm et al. 1995) The NP, ADM (adrenomedullin) is also 
secreted by many cell types after LPS exposure and stimulates growth of odontoblast- 
like MDPC-23 cells (Zudaire et al. 2006; So et al. 1996; Musson et al.  2010).Therefore 
NP and NTGF released from non-neuronal cells of the dental pulp and bone may 
stimulate both indirect and direct repair of mineralised tissue by activating the immune 
and nervous systems as well as MSC.  
NGF is previously the only NTGF to be investigated regarding direct effects on 
bone repair and direct application was found to enhance bone regeneration when applied 
in a fracture model and stimulated the differentiation of osteoblastic cells (Wang et al. 
2006; Xian and Zhou 2009; Paschalia et al.  2011). NGF and its receptor, p75
NTR
, 
exhibit overlapping expression in polarising/differentiating odontoblasts during 
odontogenesis and dentinogenesis (see Table 1.2, pg 36) (Maas and Bei 1997; Mitsiadis 
et al.  1992, 1995; Fried 2000). Moreover, recent data also indicates that NGF may also 
be an important ligand involved in tissue inflammation and repair of the dentine-pulp 
complex (Woodnutt et al.  2000; Shiomi et al.  2000; O’Hara et al.  2009). Moreover, 
postnatally NGF was up-regulated on pulp fibroblasts and odontoblasts within injured 
teeth. Therefore similarly to a direct effect of NGF on osteoblasts, this molecule may 
conceivably have a more direct function during dental repair by stimulating odontoblast-
like cell differentiation (Arany et al.  2009; Kurihara et al. 2007).  
  1.3.3 The role of GDNF in mineralised tissue repair 
Sympathetic innervation has also been implicated in tooth development and 
repair (Fried et al.  2000; Hildebrand 1995). Indeed the dental pulp is highly innervated 
and contains sympathetic fibres of the trigeminal nerve that secrete NTGFs and 
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neuropeptides (Fried et al.  2001) (Figure 1.7, pg 31). Similarly to osteoblasts and 
BMSC within bone, the nerve fibres within pulp are closely associated with 
odontoblasts and can extend into the dentine (as described above) (Byers et al.  2003; 
Egan et al.  1996) (Figure 1.6, pg 28, 1.7, pg 31 and 1.7.1, pg 32) and for animals of 
lower evolutionary order such as polyphyodont teleost, (fish that continuously produce 
teeth) nerve fibres have also been implicated in regulating odontogenesis (Hildebrand et 
al.1995). Innervation of the tooth begins during the bud stage of development and this is 
also at approximately the same time point when the mesenchyme expresses odontogenic 
potential (Luukko et al.  1997). Due to this coordinated timing this has resulted in the 
suggestion of a role for nerves in the regulation of odontogenesis (Luukko et al.  1996;  
Hildebrand et al.1995). However, the location of GDNF and associated receptors 
appears independent of the presence of the local nerve supply (Hellmich et al.  1996; 
Luukko et al.  1996; Lukko et al.  1997), indicating that NTGF secretion within the 
dental papilla may not necessarily emanate from the trigeminal nerve and may originate 
from the non-neuronal DPC/MSC. Specifically, GDNF, GFRα1 and RET expression are 
overlapping within sub-odontoblast and odontoblastic regions during late bell stage and 
early postnatal days when the polarisation and differentiation of odontoblasts occurs 
(Table 1.2, pg 35) suggesting a role for GDNF during odontogenesis and 
dentinogenesis. Indeed NGF and GDNF have been suggested to direct the growth of the 
trigeminal nerve into the dental papilla at the bud stage, however a causative effect of 
GDNF or NGF has not been definitively demonstrated (Kvinnsland et al.  2004; Luukko 
et al.  2008; Lillesaar et al. 2003). Moreover, the retrograde transport of NGF and 
GDNF occurs away from the dental pulp into the main trigeminal nerve (Thoenen et al.  
1988; Kvinnsland et al.  2004).  
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(i)                                         (ii)                                                              (iii) 
Figure 1.7 Innervation of the head and neck region and teeth. (i) The trigeminal nerve is the sensory nerve to the face also called cranial 
nerve five (Cn V). It has three main, afferent branches from the face; known as Ophthalmic Va. Maxillary Vb and Mandibular Vc.The Vb and c 
innervates the teeth (ii) Schematic showing gross anatomy of the teeth and entry of the nerve fibres into the dental pulp via the root canals (iii) 
Trigeminal nerve density in peripheral pulp and dentine of adult rat molars is greatest near the tip of the pulp horn on one side (**) and is less 
dense on the other side (*). The asymmetric density decreases towards mid-crown, and the innervation is missing from the dentine at the floor of 
the crown. Nerve fibres were labelled by radioactive axonal transport and autoradiographic detection (modified from Byers and Kish, 1976; 
Byers, 1984). Bars = 100 nm. From Byers et al. (2003). 
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Figure 1.7.1 Demonstration of nerve fibres in (A) human teeth using immunohistochemical staining for p75
NTR
 and (B) rat teeth with 
immunohistochemical staining for Calbindin (CB). (A) The nerve fibres extend from the subodontoblastic nerve plexus (SN) towards the 
odontoblast layer (OB). Arrows indicate the immunopositive Schwann cells. Reproduced from Maeda (1996), Bar = 100 nm. (B) Thin CB- 
immunopositive nerve fibers penetrate into the predentin beyond the odontoblast cell layer (OB) (arrows) D: dentine. Bar = 100 nm, from 
Miyawaki et al. (1997).
B A 
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GDNF is therefore detected during tooth development (Nosrat et al.  1998, 2002; Lukko et al.  
1997; Fried et al.  2000) and up-regulated during repair in other tissues (Eberling et al.  2009; 
Cheng et al.  2008). GDNF up-regulation from DPC or MSC may promote repair by modulating 
nervous and immune systems and mineralised tissue responses. Neither GDNF nor other GFLs have 
been studied in respect to their direct effects on the functioning within non-neuronal physiology of 
mineralised tissues until recently (this study; Gale et al.  2011; 2012). Indirect evidence however 
demonstrates that GDNF is likely to be important during tooth development. Indeed GDNF null 
mice fail to form dentine and enamel, despite trigeminal nerve development being unaffected (De 
vincente et al.  2002). Interestingly, Waardenburgs syndrome (resulting from Pax3/SOX10 
mutations), has a cross over in definition and symptoms with Hirschsprung’s disease where ~50% 
of Hirschsprung cases have inactivating mutations of RET (Tassabehji et al.  1993; Wang et al.  
2010b; Yang et al. 2012; Bondurand et al.  2007; Pelet et al.  1998) and phenotypes of both diseases 
may present with  missing teeth and defects in craniofacial and limb bones (Eigelshoven et al.  
2009; Bandyopadhyay et al.  1999; Zelzer and Olson 2003; Pingault et al.1998; Parisi 2002).  These 
data suggest that GDNF-RET expression within the developing dental papilla may reflect the 
importance of this signalling complex in neural crest derived cells during odontogenesis, 
dentinogenesis, craniofacial and long bone development.  
MGIF (murine glial cell-derived neurotrophic factor inducible transcription factor) is 
homologous to TIEG (TGF-beta-inducible early-response gene) (Yajima et al.  1997; Subramaniam 
et al.  2005; Consales et al.  2007; Hefferan et al.  2000) and is implicated in osteoblast 
differentiation. Furthermore upstream of GDNF  intracellular signalling, the Lef-1 transcription 
factor, is reported to stimulate odontoblast and osteoblast differentiation (Yokose and Naka 2010; 
Hoeppner et al.  2011; Miletich and Sharpe 2003) which has a putative consensus site for binding to 
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the GDNF promoter (Tanwar et al.  2010). Taken together, these data further suggest that GDNF 
may play a role in osteoblast and odontoblast differentiation during development and repair.  
1.4. Aims of this study 
Hypothesis: GDNF affects non-neuronal/mesenchymal dental pulp cell (DPC) behaviour and 
may promote the regenerative responses in mineralised tissues. 
The aims of the study were to investigate the expression and action of GDNF within in vitro culture 
models of mesenchymal cells capable of forming mineralised tissues. For this purpose, DPC, BMSC 
and cranial osteoblast-like cells were used.   
Research objectives 
a) To identify suitable DPC culture models and compare with BMSC and osteoblast-like cultures to 
allow the study of GDNF action in vitro. 
b) To study cellular proliferation, differentiation and in vitro mineralisation in response to GDNF in 
vitro.  
c) To assess the effects of GDNF under conditions reflecting some aspects of the inflammation and 
infection processes that occur during disease and repair. 
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STAGES OF TOOTH DEVELOPMENT 
Transcript 
detected 
 
Bud stage Cap stage 
 
Bell stage Postnatal/neonatal Postnatal 
 
References 
GDNF Facial cartilages; 
Jaw mesenchyme 
Dental epithelium 
Jaw, mesenchyme, 
Dental papilla; Dental 
follicle; Dental 
epithelium 
Dental papilla;Pre-
odontoblasts 
Pre-odontoblasts, odontoblasts, 
Sub-odontoblastic mesenchyme; 
Sub-odontoblastic layer 
Odontoblast and 
Sub-odontoblast 
region 
(Nosrat et al.  2002; 
Luukko et al.  1997; 
Nosrat et al.  1998; 
Fried et al.  2000) 
RET Dental 
mesenchyme 
Dental papilla 
mesenchyme 
Dental papilla 
mesenchyme 
Sub-odontoblastic region and  
odontoblastic region  
Not reported or 
detected 
(Luukko et al.  1997; 
Nosrat et al.  1997) 
GFRα1 Not reported or 
detected 
Dental and outer 
epithelium  
 
Dental and outer 
epithelium;Pre-
odontoblasts and sub-
odontoblastic region  
Odontoblasts and Sub-
odontoblast region 
Pre-odontoblast region 
Not reported or 
detected 
(Luukko et al.  1997; 
Nosrat et al.  1997) 
Table 1.2 GDNF, RET, GFRα1, NGF and p75NTR transcripts detected within the developing tooth. The data cited above was based on different in vivo 
models; Luukko et al. (1997) and Nosrat et al. (1997) used murine, Nosrat et al. (2002) used human and  Hildebrand et al.  (1995), Byers et al. (1990), 
Mitsiadis et al.  (1992) used rat dental tissues. 
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STAGES OF TOOTH DEVELOPMENT 
Transcript 
detected 
 
Bud stage Cap stage 
 
Bell stage 
 
Postnatal/neonatal Postnatal 
 
References 
NGF Not reported or 
detected  
Dental follicle, 
outer epithelium 
Pre ameloblast, 
Pre odontoblasts 
Not reported or detected Not reported or 
detected 
(Hilldebrand et 
al.  1995; 
Mitsiadis et al.  
1992) 
P75
NTR
 Dental 
epithelium 
Enamel 
epithelium, 
Dental papilla 
(transient 
expression) 
Dental papilla 
(transient 
expression)/pre 
odontoblasts 
Sub odontoblastic Sub-
odontoblastic 
(Byers et al.  
1990; Hildebrand 
et al.  1995; 
Mitsiadis et al.  
1992) 
Table 1.2 continued GDNF, RET, GFRα1, NGF and p75NTR mRNA detection within the developing tooth. The data cited above was based on different 
in vivo models; Luukko et al. (1997) and Nosrat et al. (1997) used murine, Nosrat et al. (2002) used human and Hildebrand et al. (1995), Byers et al. (1990), 
Mitsiadis et al. (1992) used rat dental tissues. 
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CHAPTER 2 MATERIALS AND METHODS 
2.1 Cell isolation 
2.1.1 Culture of bone marrow stromal/stem cells (BMSC) 
Femurs of male Wistar rats (Charles River Laboratory, UK) aged 4-6 weeks old 
were dissected out and the muscle stripped from the bones using a scalpel, scissors and 
forceps. The femurs were then placed into universal tubes containing medium 
consisting of αMEM (Biosera) supplemented with 10 % FBS (Fetal Bovine Serum), 
penicillin (100 µg/ml), streptomycin (100 µg/ml) and (2.5 µg/ml Amphotericin B 
(Sigma-Aldrich). The femurs were sprayed with 70 % ethanol and the ends (epiphyses) 
were removed using a scalpel blade and were then flushed through with 10 ml medium 
using a needle (~22gauge) and 20 ml syringe (BD sciences). The bone marrow was 
collected into a 50 ml centrifuge tube (Falcon). Cells were collected by centrifugation 
(5804R, Eppendorf) at 800 rpm for 5 mins and pellets were re-suspended in 5 ml of 10 
% FBS supplemented αMEM medium. Cell suspensions were seeded into 75 cm2 flasks 
(Nunc) containing 10 % FBS supplemented αMEM (Biosera). 
2.1.2 Dental pulp extraction   
Incisors (upper and lower) were dissected from 4-6 week old male Wistar rats. The 
extracted teeth were briefly submerged in 70% ethanol for disinfection and then 
immediately placed into universal tubes containing 20% FBS / αMEM (Biosera) 
supplemented with penicillin (100 µg/ml) streptomycin (100 µg/ml) and (2.5 µg/ml) 
Amphotericin B (Sigma-Aldrich). Teeth were placed onto a glass slide within a petri 
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dish and the pulp removed from the tooth using forceps and a scalpel (Figure 2A). 
Medium was added to the pulp tissue to prevent it from becoming desiccated.  
2.1.3 Explant-derived dental pulp cells (DPC)  
Pulpal tissue was placed onto a sterile glass slide and chopped coarsely to ~ 
2mm
2
 pieces using a scalpel, prior to transfer to culture flasks containing 1 ml 20 % 
FBS supplemented αMEM (Figure 2B, pg 42). These explants were gently pressed onto 
the bottom of the flask using the flat side of the scalpel blade. Cells were incubated 
overnight in a humidified atmosphere at 37
o
C with 5 % CO2 and the following day a 
further 4 ml of 20 % FBS supplemented αMEM was added to the culture. Medium was 
changed every 3 days until cultures reached 80 - 90 % confluence. 
2.1.4 Enzymatically-derived DPC 
Extracted pulp was minced (see Figure 2A, pg 42) using a scalpel and then 
transferred to a 15 ml centrifuge tube (Falcon) containing 5 ml trypsin [2.5g/l of trypsin 
in 0.38g/l of EDTA (Invitrogen)] and digested for 30 mins at 37
o
C. Tissue samples were 
agitated every 5 mins using a 1 ml Gilson pipette tip to aid dissociation, then after 30 
mins, 5 ml 10 % FBS supplemented αMEM was added to halt the action of the trypsin. 
Subsequently the cell suspension was passed through a 70 µm filter (Millipore) and 
centrifuged for 5 min at 800 rpm. The supernatant was removed using vacuum 
aspiration and the cell pellet re-suspended in 1 ml of αMEM and seeded into a 25 cm2 
flask (Nunc). Cells were incubated overnight humidified at 37
o
C, 5% CO2 to enable 
attachment and the following day a further 4 ml of 20% FBS supplemented αMEM was 
added to the culture. Medium was changed every 3 days until cultures reached 80 – 90 
% confluence. 
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A 
 
B 
Figure 2 (A) Dental pulp was extracted from the tooth. (B) Dental pulp was minced 
using a scalpel blade prior to enzymatic digestion.  
 
Extracted 
dental 
pulp on 
glass slide 
Minced dental 
pulp 
Mineralised 
tooth with 
dental pulp 
removed 
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2.1.5 Cell lines culture 
A C6 glioma cell line of isolated rat glial cells derived from a chemically 
induced glial tumour by Benda et al.  (1968), a mouse MDPC-23 cell line isolated from 
fetal mouse dental papillae (Hanks et al.  1998) and the mouse osteoblast MC3T3-E1 
cell line established from neonatal calvarial bone of C57BL/6 mice (Wang et al.  1999) 
were established from cryopreserved stocks (original sources of cell lines were ATCC 
except MDPC-23 cells which were kindly donated by Jacques Nör’s Laboratory, 
University of Michigan, US). 
2.1.6 Cell culture 
Explant-derived and enzymatically-derived DPC were cultured as above (2.1.3 
and 2.1.4), MC3T3-E1 cells and BMSC were cultured using the same reagents except 
10% FBS (Biosera) was used. MDPC-23 and C6 glioma cells were cultured using 
DMEM (Biosera); 10% FBS, Penicillin (100 µ/ml) streptomycin (100 µg/ml), L-
glutamine (2 mM) (Sigma-Aldrich). All cells were cultured in either 25 cm
2
 (primary 
cells, passage 0-1) or 75 cm
2
 flasks (Falcon). Cells were detached upon reaching 80-90 
% confluence using trypsin/EDTA. Cell suspensions were transferred to tubes (Falcon) 
size 15 ml or 50 ml respectively, depending on flask size and centrifuged at 800 rpm for 
5 mins to pellet the cells. Supernatants were removed by using a vacuum pump and 
cells re-suspended in 1 ml of αMEM for counting or subculture. DPC and BMSC were 
expanded and used at passage 2-4 for subsequent experiments. 
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2.1.7 Cell counting  
A 100 µl sample of cell suspension was mixed with 100 µl Trypan blue (Sigma); the 
unstained viable cells were counted using a Neubauer haemocytometer slide under a 
variable relief contrast (VAREL) microscope (Zeiss Axiovert 25). A minimum of three 
counts per sample were obtained and average cell number was calculated. Cell 
suspensions were then diluted accordingly and seeded at densities and volumes 
presented in Table 2, pg 45- 46.  
2.1.8 Preparation of serum-free medium  
Bovine serum albumin (BSA) supports cell cultures by acting as a buffer, 
antioxidant and carrier for proteins, lipids and minerals (He and Carter 1992; Nicholson 
et al.  2000). BSA (fraction V, Sigma) was reconstituted with dH2O to a 1 % solution 
(w/v), then heat inactivated at 56
o
C for 30 mins. This solution was filter sterilised using 
a 0.2 µm filter (Millipore) and stored at -20 
o
C prior to use. Serum-free medium 
consisted of 0.1 % BSA in αMEM, penicillin (100 µg/ml) streptomycin (100 µg/ml) and 
Amphotericin B (2.5 µg/ml) (Sigma-Aldrich).  After seeding into an appropriate tissue 
culture vessel the cells were incubated in a humidified 5% CO2 incubator at 37
o
C. 
2.2 Preparation and storage of GDNF  
Human GDNF is highly homologous to mouse or rat GDNF (Wang et al. 1998). 
rh GDNF [recombinant human GDNF produced in E.coli (Amgen) ] was supplied at a 
concentration of 10 mg/ml and aliquots of 1 µg/ml in 0.1 % BSA/αMEM were stored at 
-80
o
C. On thawing GDNF was diluted with medium to the relevant concentrations used 
for the in vitro experiments. Before adding GDNF to the cultures the medium was 
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replaced with freshly prepared medium, containing either 10 % FBS or 0.1 % BSA 
supplemented αMEM (serum-free medium). Cells were then cultured for 48 hours, 
except for the mineralisation assays where cells were cultured for 4 days to obtain 
confluence before osteogenic conditions were applied. Cells were incubated in a 
humidified 5 % CO2 incubator at 37
o
C, for periods shown in Table 2, pg 45- 46.  
 
A 
 
B 
Figure 2.1 Phase-contrast images of (A) enzymatically-derived and (B) explant-
derived DPC. 
Explanted 
pulpal 
tissue 
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2.2.1Preparation and storage of tumour necrosis factor alpha (TNFα) 
Human, rat and mouse TNFα are highly homologous, the sequences display 80- 
89% homogeneity (Kwon et al. 1993; Marmenout  et al. 1985). rh TNFα [ produced in 
E.coli (Peprotech)] was centrifuged and reconstituted using 0.1 % BSA/αMEM. 1 µg/ml 
aliquots were stored at -80
oC. On thawing, TNFα was serially diluted using serum-free 
or serum supplemented medium with or without GDNF (100 ng/ml). The same protocol 
was used as for the GDNF experimental analysis (section 2.2; see Table 2, pg 45-46). 
2.2.2 Preparation and storage of nerve growth factor beta (NGF-β)  
Mouse, rat and human NGF are highly homologous (Hallböök et al. 1991; 
Ullrich et al. 1983). NGF has three subunits, alpha, beta and gamma (Baker et al.  
1974). It is the beta subunit that exerts the majority of the biological effects of NGF 
(Shooter 2001).  rh NGF-β [ produced in E.coli (Peprotech)] was reconstituted at 100 
µg/ml in 0.1 % BSA/αMEM and 1 µg/ml aliquots stored at -80oC. On thawing NGF was 
diluted in either serum-free or serum supplemented medium and the same protocol was 
used as for the GDNF experiments (section 2.2; see Table 2, pg 45-46). 
2.2.3 WST-1 viable cell number assay  
To determine the number of viable cells the WST-1 assay (Roche) was 
performed. This assay was originally developed by Ishiyama et al.  (1993) (see also 
Scheven et al.  2009). In accordance with the manufacturers guidelines 10 µl of WST-1 
reagent per 100 µl of medium was incubated with cell cultures for 60 mins at 37
o
C. In 
viable, metabolic active cells, WST-1 is converted to form a coloured soluble formazan 
dye by dehydrogenases. A universal plate reading spectrophotometer (ELx800, Biotek) 
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was used to quantify the amount of formazan dye formed at 450/630nm. The 630 nm 
wavelength was used as a reference wavelength, this represents background readings 
that was subtracted from the test spectrophotometry reading. The linear relationship 
between the formazan dye product and seeding density (up to 50,000 cells per well) 
under differing serum conditions was subsequently used to determined the number of 
viable cells under different experimental conditions.  
2.2.4 RET receptor inhibition (RPI-1) 
RPI-1 (1, 3-Dihydro-5, 6-dimethoxy-3-(4-hydroxyphenol) methylene)-2H-indol-
2-one) (Merck Chemicals Ltd) was used to inhibit RET. RPI-1 was reconstituted to 5 
mg/ml in DMSO, subsequently aliquots at 300 µM/0.2 % DMSO/ αMEM were stored at 
-20
o
C prior to use. The RPI-1 inhibitor was serially diluted in serum-free medium with 
or without GDNF (100 ng/ml) and incubated for a further 48 hours with cell cultures. 
2.2.5 GFRα1 receptor inhibitor (PI-PLC)  
PI-PLC hydrolyses the extracellular portion of the GFRα receptor (and other 
proteins that are GPI-linked glycosyl-phosphatidylinositol) from the membrane surface 
(Low 1989). Thus PI-PLC cleaves phosphatidylinositol and this removes the 
extracellular receptor protein and hence the binding site for GDNF. PI-PLC (Sigma) 
62.5 units/ml was stored at 2-8
o
C. Treatment of the cells was started 1 hour prior to 
addition of GDNF (to allow adequate time for cleavage of the receptor from the cell 
membrane). The medium was then removed and replaced with respective concentrations 
of PI-PLC (as above) in serum-free medium with or without GDNF (100 ng/ml) and 
incubated for a further 48 hours with cell cultures (see Table 2, pg 45- 46).  
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Table 2 Summary of experimental assays and conditions used. 
Assay Applied Experiment/Analysis Culture ware and seeding 
density used 
Duration/time 
point examined 
Detection method Additional reagents 
prepared 
WST-1 viable 
cell number 
Standard curve 
determination  
96 well plates; 5x10
3 
cells in 
200 µl per well 
30 mins, 24 and 48 
hours 
Spectrophotometry at 
450/630 nm 
0.1 % BSA  
WST-1 cell 
viability 
Comparison of serum 
conditions all cell types 
96 well plates; 5x10
3 
cells in 
200 µl per well  
48 hours, 3, 5 10 
days 
Spectrophotometry at 
450/630 nm 
0.1 % BSA 
WST-1 cell 
viability 
Effect of GDNF 
On all cell types 
96 well plates; 5x10
3 
cells in 
200 µl per well  
48 hours Spectrophotometry at 
450/630 nm 
GDNF 
0.1 % BSA 
WST-1 cell 
viability 
Effect of S.mutans on DPC  
and MC3T3-E1 cells 
96 well plates; 5x10
3 
cells in 
200 µl per well  
48 hours Spectrophotometry at 
450/630 nm 
S.mutans 
WST-1 cell 
viability 
Effect of TNFα on DPC and 
MC3T3-E1 cells 
96 well plates; 5x10
3 
cells in 
200 µl per well  
48 hours Spectrophotometry at 
450/630 nm 
TNFα; GDNF; 0.1 % 
BSA 
WST-1 cell 
viability 
Effect of NGF on DPC 96 well plates; 5x10
3 
cells in 
200 µl per well  
48 hours Spectrophotometry at 
450/630 nm 
NGF; 0.1 % BSA 
WST-1 cell 
viability 
 
 
 
Inhibition of RET and 
cleavage of GFRα receptors 
96 well plates; 5x10
3 
cells in 
200 µl per well  
48 hours Spectrophotometry at 
450/630 nm 
PI-PLC; GDNF; 0.1 % 
BSA; RPI-1 
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Assay Experiment Seeding density Duration/time 
point 
Detection Additional reagents 
prepared 
ALP ALP levels for all cell types 96 well plates; 5x10
3 
cells in 200 
µl/ well 
48 hours Spectrophotometry at 
405/630 nm 
Buffer for pNPP tablets 
BrdU Proliferation assay for DPC and 
MC3T3-E1 cells 
12 well plates; 5x10
4  
cells in 
1ml/well 
24 and 48 hours Light microscopy. Cell 
counts calculated using 
image J cell counter add 
in. 
Buffers; fixative; 
antibodies; GDNF 
Live dead Number of live and dead cells 
determined 
12 well plates; 5x10
4  
cells in 
1ml/well 
24 and 48 hours Fluorescent 
microscopy. Cell counts 
BrdU; Acridine orange; 0.1 
%BSA; ethanol fixative 
Caspase-3/-7 Levels of apoptosis determined 
for DPC 
96 well plates; 5x10
3 
cells in 200 
µl/well 
48 hours Luminometer 0.1 % BSA.  
LDH Levels of lactate 
dehydrogenases (LDH)  
determined the levels of cell 
death for all cell types 
96 well plates; 5x10
3 
cells in 100 
µl/ well 
48 hours Spectrophotometry at 
490/630 nm 
0.1 % BSA. Kit preparation 
 
Mineralisation Levels of calcified ECM for 
MDPC-23, DPC and MC3T3-
E1 cells 
48 well plates; 2.5x10
4
 cells at 
200 µl/well. 35mm dishes; 5X10
4
 
7, 24 and 48 days Spectrophotometry 
450/630 nm 
Alizarin Red 2 % solution. 
Ammonium hydroxide; 0.1 
% BSA 
Table 2 continued. Summary of experimental assays and conditions used. 
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2.2.6 BrdU (5-Bromo-2’-deoxy-uridine) assay 
Cells were cultured within multiwell plates (see Table 2, pg 45- 46) and after 24 
hours medium was replaced with serum-free or serum supplemented medium with or 
without GDNF (100 ng/ml). After a further 24 or 48 hours the BrdU assay was 
performed using the 5-Bromo-2’-deoxy-uridine labelling and detection kit II (Roche) 
according to the manufacturer’s guidelines. Cells were grown in 12-well tissue culture 
plates, incubated with the DNA-intercalating BrdU for 60 mins. The cells were then 
fixed and fractured to later allow antibody access to the BrdU labelled DNA. The 
fixation procedure included fixing cells with 70 % ethanol for 20 mins at room 
temperature and followed by fixation using 50 mM glycine/70 % ethanol at pH 2.0 for 
20 mins. Finally cells were fractured by incubating at - 20
o
C for 20 mins. The DNA 
labelled 5-Bromo-2’-deoxy-uridine was detected using antibodies and visualised by 
ALP conjugated secondary antibody reacted with BCIP (5-bromo-4-chloro-3-indolyl 
phosphate, toluidinium in dimethylformamide).  Mayer’s haematoxylin was used as a 
counterstain and a variable relief contrast Zeiss Axiovert 25 microscope was used to 
observe BrdU labelled nuclei that appeared brown/black. BrdU stained and non-stained 
nuclei were counted in at least nine fields of view for each test condition. 
2.2.7 Live and dead assay  
Cultures were washed with 500 µl PBS and then ethidium bromide (EthBr) and 
flurochrome acridine orange (AO) were added (4 µM in PBS) for 5 mins. Dead cell 
controls were fixed cells using 70 % ethanol/PBS and all fixed (dead) cells appeared 
orange. EthBr crosses damaged cell membranes and intercalates with DNA and emits 
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fluorescent light appearing orange. AO binds to nuclear DNA and all live cells take up 
the AO stain across the cell membrane and nuclei appear green however dead cells with 
ruptured/leaky membranes take up EthBr and over stain the green AO to appear orange. 
Cells were visualised and counted using a Nikon Eclipse fluorescent microscope with 
480-520 nm filter (530 nm max emission for AO and 590 nm for EthBr). For each 
experiment three wells were counted per test condition and within each well three fields 
of view were counted and numbers of live/dead cells were recorded.  
2.2.8 Lactate Dehydrogenase (LDH) assay 
The LDH Cytotoxicity Detection Kit (Roche) was utilised according to the 
manufacturer’s instructions. After 48 hours samples of cultured cells were exposed to 
the supplied lysis buffer for 20 mins to act as a positive control. 100 µl of supernatant 
was removed and incubated with the manufacturers’ catalyst and dye reaction mixture 
for 30 mins at room temperature (RT). After 30 mins the stop reaction mixture was 
added at 25 µl per well and samples were placed on an orbital plate shaker for 20 
seconds. The LDH levels released from damaged cell membranes were then quantified 
using a multiwell plate reading spectrophotometer (ELx800Biotech) at a wavelength of 
490/630 nm.  
2.2.9 Caspase Glo 3/7 assay  
After 24 hours culture in white walled multiwell plates (Microlite; 7567 
Thermoscientific) the medium was replaced and serum-free, serum supplemented and 
serum-free medium containing GDNF (100 ng/ml) was added to the cultures for a 
further 48 hours. The Caspase Glo 3/7 assay (Promega) was performed according to the 
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manufacturer’s instructions. Caspases cleave the caspase specific DEVD amino acid 
sequence within the supplied luminogenic substrate to form a substrate for the luciferase 
enzyme that is luminescent following cleavage. Luminescence from the reaction was 
measured by taking continuous readings (0-120 mins) using a multiwell plate 
luminometer (LB96v Bethold Technologies) and data from the time point of maximum 
peak emission used for analysis. Plates were incubated within the luminometer at 22
o
C. 
2.3 Streptococcus mutans (S.mutans)  analysis 
Heat inactivated S.mutans [(Streptococcus mutans Clarke 1924 AL) original 
source from the ATCC No. 25175] were stored at -80
o
C at 7.55 x 10
9
/ml prior to use. 
On thawing the bacterial suspension was diluted to 5x10
6
 S.mutans/ml and further 
serially diluted to obtain a ratio of 1000, 100, 10 and 1 S.mutans per DPC or MC3T3-E1 
cell. DPC or MC3T3-E1 cell cultures were seeded at 5x10
3
 per well prior to addition of 
bacteria in serum supplemented medium with or without 100ng/ml GDNF. After 
incubation for 48 hours the WST-1 assay was performed to quantify viable cells using a 
plate reader (ELx800 Biotek). 
2.3.1 Mineralisation assay  
Cells were seeded into 35 mm dishes under standard culture conditions and 
medium. After 4 days medium was changed to include osteogenic supplements which 
consisted of 10
-7 
M dexamethasone (DEX) 50 µg/ml, L-ascorbic acid, 10 mM β- 
glycerophosphate (Sigma) (Jaiswal et al.  1997). This osteogenic  medium with or 
without 100 ng/ml GDNF was freshly prepared prior to use and changed every other 
day for the duration of the experiments for up to 28 days.  
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For serum-free mineralisation assays the cells were first seeded into 48 well 
plates under standard serum conditions for 24 hours. After 24 hours the medium was 
changed to serum-free medium containing 0.1 % BSA, osteogenic supplements with or 
without GDNF as described above. L- glutamine is essential for the survival and growth 
of fibroblasts under low serum conditions (Eagle et al.  1955) therefore an additional, 
2mM L-glutamine was added to the osteogenic medium. After 4 weeks culture under 
serum-free osteogenic conditions cultures were stained with Trypan blue to assess the 
levels of viable cells under the experimental conditions. Culture medium was aspirated 
and 50 µl Trypan blue: 50 µl PBS was added to each well and viewed immediately. The 
staining was visualised using an inverted microscope (Zeiss Axiovert 25).              
    
Figure 2.2 Trypan blue staining of DPC in (A) serum-free cultures and (B) serum 
supplemented cultures after 4 weeks culture with osteogenic supplements. Red 
arrow shows dead cell identified with Trypan blue staining and blue arrows indicate live 
cells. 
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Alizarin red stain (ARS) forms salts with calcium, replacing the anions in 
calcium (Puchtler et al.  1969). The pH of the ARS stain was adjusted to pH 4.1 using 
ammonium hydroxide. ARS was made freshly to ensure pH 4.1 was maintained due to 
the solubility of calcium deposits at pH 4.5-5 (Puchtler et al.  1969). Cultures were 
washed with 200 µl PBS per well, then fixed with 10 % formalin for 10 mins. Formalin 
was aspirated. 200 µl of 2 % ARS was added to the cultures at room temperature (RT) 
and agitated on an orbital plate shaker for 20 mins. The unincorporated ARS was 
aspirated and the cells were washed gently with PBS, then with dH2O for 5 mins. The 
dH2O was drained by inverting the plate/dish. 
For the post staining of 35 mm dishes and 48-well plates, 800 µl and 400 µl of 
acetic acid (10 %) was added, respectively and incubated for 30 mins RT on an orbital 
plate shaker. Dishes and wells were scraped and contents placed into centrifuge tubes. 
Tubes were mixed using a vortex for 30 seconds, heated at 85
o
C for 10 minutes and 
after 5 mins cooling on ice, centrifuged at 1500 rpm for 15 minutes. Then 150 µl (for 
dishes) or 100 µl (per well) of 10 % ammonium hydroxide was added to each sample to 
neutralise the acid and 150 µl from each sample was added to multiwell plates in 
triplicate. The concentration of ARS staining per eluted sample was determined against 
a standard curve using a plate reader at 405/630nm (ELx800, Biotek).  
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Figure 2.3  Linear standard curve for ARS. Results expressed as average absorbance 
unit ( n=2). 
 
2.3.2 Alkaline phosphatase (ALP) assay  
Cells were rinsed using 100 µl PBS per well of multiwell plates (see Table 2.0), 
then lysed using 0.1 % triton X100. pNPP (p-Nitrophenyl Phosphate) tablets were 
added to DEA buffer to make 1 mg/ml pNPP and incubated at RT for 10 mins. The 
DEA buffer contains Mg
2+
 and Zn
2+
 ions enabling optimum activity of alkaline 
phosphatase. The DEA buffer stock at 10X concentration consisted of 500 mg MgCl2, 
400 mls dH2O and 48.5 ml diethanolamine, pH was adjusted to pH 9.8 using 
concentrated NaOH or HCl. pNPP is hydrolysed by ALP to the yellow coloured p-
nitrophenol and its levels were determined using a multiwell plate reader  at 405/630 
nm.  
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2.4 Reverse transcriptase polymerase chain reaction (RT-PCR) analysis  
Gene expression was investigated using semi-quantitative RT-PCR (sqRT-PCR) 
analysis. RNA isolation was performed using the RNeasy mini-kit (Qiagen) with DNase 
treatment according to the manufacturer’s instructions. Dissected tissue samples were 
initially disrupted using an Ultraturrax homogeniser (Netzgerat T8.01 aboratiechnik) 
within 700 µl of lysis buffer (10 µl β-Mercaptoethanol per 1ml buffer RLT). 700 µl 
lysis buffer was added per confluent (80 - 90 %) cultures in 75 cm
2
 flasks followed by 
vigorous pipetting to detach and disperse the cells. After ~ 5 mins 70 % ethanol was 
added to all samples and two aliquots per sample of the total volume (1400 µl) pipetted 
into RNeasy mini- column sequentially (the total column volume per aliquot does not 
exceed 700 µl) and centrifuged for 15 seconds at 10,000 rpm. The flow through was 
discarded after each centrifugation. All centrifugation steps were performed using an 
Eppendorf 5415 D centrifuge (Eppendorf, UK). Contaminating DNA was removed by 
performing the DNase digestion steps; 350 µl RW1 manufacturers buffer was added per 
column, centrifuged at 10,000 rpm for 15 secs and flow through discarded. 15 µl DNase 
I (inhibitor) and 60 µl RDD manufacturer’s buffer was added per column and incubated 
at RT for 15 mins. Next 350 µl RW1 buffer added to each column and centrifuged at 
10,000 rpm for 15 secs, then flow through was discarded. Subsequently, 500 µl RPE 
buffer was added to each column within a new collecting tube and centrifuged at 10,000 
rpm for 15 secs, then flow through was discarded. This step was repeated except 
centrifugation took place for 2 mins then columns were placed into new collecting tubes 
and centrifuged for a further 1 min at full speed. The RNA was eluted by placing the 
column into an Eppendorf and adding 30 µl RNase free water. RNA was collected by 
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centrifugation for 1 min and the collected RNA placed onto ice whilst purity and 
quantity were assessed. Purity and quality of the RNA was determined by measuring 
absorbance values at 260 nm (A260) and 280 nm (A280) using a Biophotometer 
(Eppendorf, UK) and by visualisation on agarose gels (see section 2.4.1, pg 55). An 
absorbance ratio of between 1.8 to 2.1 and distinct double bands (18S and 28S) of RNA 
observed on gels signified high purity and quality of the isolated RNA.  RNA was 
stored at - 80
o
C prior to use. 
 RNA was reversed transcribed using the Omniscript Reverse Transcription kit 
(Qiagen) according to the manufacturer’s instructions. 50 ng - 1 µg RNA was incubated 
with 2 µl sterile molecular grade water (Merck) at 65
o
C
 
for 5 min to denature RNA 
secondary structure and quenched on ice prior to use. A master mix containing 1X RT 
buffer, 0.5 mM dNTPS, 1 µM Oligo-dT primer, 0.5 u/µl RNase inhibitor, 0.2 u/µl 
omniscript reverse transcriptase were combined and added to the RNA solution making 
a total volume of 20 µl per sample. This reaction mix was incubated in a Mastercycler 
gradient thermal cycler (Eppendorf, UK) for 60 mins at 37
o
C and then 95
o
C for 5 mins. 
 YM-30 Microcon centrifugal filter devices (Millipore) were used to purify and 
concentrate resultant cDNA.  20 µl of cDNA in solution was added to 500 µl in 
molecular biology grade water, transferred to YM-30 microcon assemblies and 
centrifuged (Centrifuge 5415D, Eppendorf) for 6.5 minutes at 10,000 rpm (Centrifuge 
5415D, Eppendorf). The eluate was discarded and this process was repeated until 
approximately 30 μl cDNA in solution remained on the surface membrane of the filter. 
The microcon centrifugal filter device was inverted in an Eppendorf tube and 
centrifuged at 1000 rpm (Centrifuge 5415D, Eppendorf) for 3 mins to collect the cDNA. 
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The purity and concentration of the cDNA were analysed by determining absorbance 
readings at 260 nm and gel electrophoresis (see section 2.4.1). cDNA was stored at -
20
o
C prior to use.  
 50 ng of the cDNA, primers (25 mM) (see Table 1.0) and 
REDTaq®ReadyMix™ PCR Mix (with MgCl2) were gently combined and transferred 
to a Mastercycler gradient thermal cycler (Eppendorf, UK) and amplified using repeated 
cycles. Reactions were amplified following an initial denaturation step of 5 min at 94 
°C, a typical amplification cycle consisted of denaturing 94 °C for 20s, annealing 
(temperatures shown in Table 2.1, pg 58) for 20 s and extension at 68 °C for 20 s ending 
with a 10 min extension at 72 °C. Following the designated number of cycles (Table 
2.1), 6 μl of the reaction mix was removed. Primers (Table 2.1, pg 58) were designed 
from NCBI mRNA sequences Primer-3 Primer design software 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi). The PCR products were 
analysed by agarose gel electrophoresis (see below section 2.4.1). 
2.4.1 Agarose gel electrophoresis and image analysis  
Non-denaturing agarose gels (1 % w/v for RNA and 1.5 % w/v for PCR) were 
generated from lyophilised agarose powder (Helena Biosciences, UK) dissolved in 1X 
Tris acetate EDTA (TAE) buffer, pH ~8.3, (Helena Biosciences UK). Mixtures were 
heated in a microwave (Samsung, TDS) and the solution was poured into gel casting 
trays. Ethidium bromide 50 µg/ml (Sigma) or 1X SYBR gold (Molecular probes) 
nucleic acid stains along with combs were added to enable nucleic acid visualisation 
and to form sample-loading wells prior to gel solidification at room-temperature. 
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Samples of 6 µl per well were added and separated by gel electrophoresis  at 50-100V 
in agarose gels submerged under 1x TAE (Tris-Acetate EDTA) running buffer with the 
Hyperladder IV (Bioline, UK) as a nucleic acid standard.  
 Images of RNA and PCR products were visualised by UV illumination and 
captured using a G:BOX system with the gene tools software (Syngene) used to perform 
the densitometric analysis. Density values were normalised to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) housekeeping gene (Robbins and McKinney 1992) 
control value by dividing target gene sample volume density by respective GAPDH 
volume density.   
2.5 Immunocytochemistry   
Cells were seeded onto multispot slides (Hendley) at a density of 1.5 x10
4
 
Glioma cells, 2 x10
4
 DPC, 2 x10
4
 MC3T3-E1 cells, or 2.5 x10
4 
BMSC and incubated 
for 24 hours in standard serum conditions. Cells were then gently washed with warm 
(37
o
C) PBS/1% BSA, fixed with cold acetone at - 20
o
C for 5 mins, followed by 
quenching of endogenous peroxidase using 3 % H2O2/PBS for 30 minutes. After 
washing with PBS/1 % BSA, the slides were ―blocked‖ with 20 % goat serum/1 % 
BSA/PBS for 1 hour to prevent non-specific antibody binding. Primary antibodies 
against Gfrα1 (sc10716, polyclonal rabbit; SantaCruz) or against RET (sc167, 
polyclonal rabbit; Santa Cruz) at 2 µg/ml/1 % BSA/PBS and controls of normal rabbit 
serum (Sigma) 14 µg/ml/1 % BSA/PBS or 1 % BSA/PBS were added and incubated for 
1 hour at RT. The substitution of 1 % BSA/PBS in place of primary antibody was used 
to determine the specificity of the secondary antibody (shown in Figure 2.4 pg 59). 
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Biotinylated secondary antibody (link) was added at 1/200 dilution in 1 % PBS/BSA 
and incubated for 1 hour at RT. Next streptavidin-HRP (label) was added 1/200 dilution 
and incubated for 30 minutes at RT. The SuperSensitive™ Link-Label IHC Detection 
System (Biogenex LP000-UL) was used to detect and visualise the antibody labelling. 
DAB solution (0.01g 3,3-diaminobenzidine tetrahydrochloride plus 25 µl H2O2 in 20 
mls PBS) was added until a golden brown colour developed, subsequently, the slides 
were counterstained with Mayers haematoxylin for 5-15 mins.  Cells were then 
dehydrated through sequential steps in 100 %, 95 % then 70 % alcohol and placed into 
xylene and mounted using XAM (BDH Laboratory). Stained cells were examined under 
a variable relief contrast (VAREL) microscope (Zeiss Axiovert 25)  
2.6    Statistical analysis  
Statistical and data analyses were performed using Microsoft Excel and Minitab 
(version 15 and 16). Statistical analyses comparing groups were undertaken using the 
Student’s t test and in the case of more than two groups regression/ANOVA with 
Tukeys posthoc test. A P-value of < 0.05 was considered to be significant.         
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Gene  Primer sequence (F-forward; R-
reverse) 5’     3’ 
Tm Accession no. Product Cycle 
No. 
GAPDH F-CCCATCACCATCTTCCAGGAGC;R-
CCAGTGAGCTTCCCGTTCAGC 
60 NM_017008 473bp 
 
21-27 
GDNF F-GAGGAATCGGCAGGCTGCAGCTG; 
R-GATACATCCACATCGTTTAGCGG 
60 NM_019139  
 
364bp 33-38 
rRET F-TCAGGCATTTTGCAGCTATG; 
R-TGCAAAGGATGTGAAAGCAG 
62.5  
 
NM_001110099.1 393bp 35-45 
Gfrα1 F-AATGCAATTCAAGCCTTTGG; 
R-TGTGTGCTACCCGACACATT 
60  
 
NM_012959.1 218bp 33-43 
P75
NTR
(NGFR) 
 
F-CAAAGGACGGATTTCCTGAG; 
R-AGCTCCTGGGGAGGAAAATA 
60  
 
NM_012610 323bp 37 
 
CD105 F-TTCAGCTTTCTCCTCCGTGT; 
R-TGTGGTTGGTACTGCTGCTC 
60 NM_001010968 325bp 41-45 
CD44 F-TGGGTTTACCCAGCTGAATC; 
R-CTTGCGAAAGCATCAACAAA 
60 NM_012924.2 392bp 
33-37 
PCNA F-TTGGAATCCCAGAACAGGAG; 
R-CGATCTTGGGAGCCAAATAA 
60 NM_022381.2 390bp 30-33  
p27kip1 F-ACGGTTCCCCGAATGCTGGC; 
R-CCCCCACCCAAGTTGCTTCTCT 
60 NM_031762.3 483bp 30-42 
IL-6 F-TGTGCAATGGCAATTCTGAT; 
R-GAGCATTGGAAGTTGGGGTA 
60 NM_012589 312bp 33 
TNFα F-TCCGGCGGTGTCTGTGCCT; 
R- CGGGGCAGCCTTGTCCCTTG 
60 NM_012675 369bp 35 
BSP F-ATGGAGATGGCGATAGTTCG; 
R-TCCACTTCTGCTTCTTCGTTC 
60 NM_012587.2 
307bp 34-35 
Cfbα1 F-GCCGGGAATGATGAGAACTA; 
R-GGACCGTCCACTGTCACTTT 
60 NM_053470.2 
200bp 35 
Table 2.1 Details of primers and assay conditions for PCR analysis. Tm indicates 
annealing temperature 
o
C, rRET, rat RET primer sequences. 
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Figure 2.4 Secondary antibody controls for immunocytochemical staining: 1 % 
BSA/PBS was substituted for primary antibody. (A) Explant derived DPC (B) C6 
glioma cells (C) BMSC (D) MC3T3-E1 cells.  
 
 
A 
C 
B 
D 
60 
 
CHAPTER 3 RESULTS 
Characterisation and analysis of culture models 
 
3 Characterisation of cell cultures  
  The primary aim of this study was to investigate the affect of GDNF on DPC 
behaviour.  For this purpose, different cell models were used; (i) explant-derived and 
(ii) enzymatically-derived models of DPC were compared to (iii) BMSC along with (iv) 
osteoblast-like MC3T3-E1 cells. The viability of these cell types following exposure to 
different culture conditions along with the transcriptional profile and expression of 
GDNF receptors, RET and GFRα1 were assessed.   
 
3.1 DPC, BMSC and MC3T3-E1 growth curve analysis under varying culture 
conditions  
 Two in vitro DPC culture approaches were established and compared, these 
were explant-derived (Couble et al.  2000) and enzymatically-derived culture (Gronthos 
et al.  2000, 2002).  DPC were cultured in plastic multiwell plates using 10 %, 20 % 
serum, or serum-free conditions at various cell seeding densities and analysed using the 
WST-1 assay to determine the number of viable cells.  Standard curves obtained 
using the WST-1 assay demonstrated a linear relationship between seeding density and 
the absorbance of the reduced WST-1 product for both DPC culture models, BMSC and 
MC3T3-E1 cells (Figures 3 and 3.1). 
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Figure 3 Correlation between number of cells seeded and WST-1 formazan 
product absorbance. Standard curve for A) explant-derived DPC and B) 
enzymatically-derived DPC in serum-free (SF), 10 % FBS and 20 % FBS serum 
supplemented conditions. R
2
 values indicates a linear relationship between seeding 
density and WST-1 product absorbance (Mean ± SD; n=3).    
 
R2 =0.9443 R2 =0.9622 R2 =0.9469 
R2 =0.8744 R2 =0.8096 R2 =08464 
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Figure 3.1 Correlation between the number of cells seeded and WST-1 formazan 
product absorbance. Standard curves for BMSC and MC3T3-E1 cells. Cells were 
seeded at a range of densities in 10 % serum supplemented medium. R
2
 values indicates 
a linear relationship between seeding density and WST-1 product absorbance (n=3, 
Mean ± SD). 
 
 
3.1.1 Comparison of growth curves for explant-derived and enzymatically-derived 
DPC under serum supplemented conditions after 48 hours 
 Cells were cultured in 10 % serum supplemented medium for 48 hours to 
determine whether changes in cell number remained within a range detectable by the 
WST-1 assay at the 48 hour time point. A relationship between seeding density and 
absorbance was apparent at 48 hours of culture (Figure 3.1.1). For future experiments an 
optimal seeding density of 5000 cells per well (observed at 3.69x just below mid-point 
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on the line graph) was selected to allow decreases and increases in cell number after 48 
hours to be within a measureable range for the assay.  
 
 
Figure 3.1.1 Number of viable explant and enzymatically derived DPC determined 
after 48 hours culture in 10% serum supplemented medium. Explant (A) and 
enzymatically (B) derived DPC increasing seeding densities increased viable cell 
number at 48 hours. Line equations for explant derived DPC and enzmatically derived 
DPC were y=-0.2339x
2
+2.1315x+0.0037 and y=-0.1538x
2
+1.6631x-0.0046 
respectively. (Explant derived DPC and enzymatically derived DPC number were 
determined using the formulae from Figure1;  y=0.0141x and y = 0.0263x, 
respectively).(n=3, Mean ± SD)( ANOVA  = 0.0001 all groups were significantly 
different to zero cells seeded). 
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3.1.2   DPC, BMSC and MC3T3-E1 cell viability under serum-free and serum 
supplemented conditions  
 
To characterise this culture model further, the viability of explant-derived DPC 
were analysed under serum-free culture conditions. Serum is ill-defined, although major 
protein constituents are known; batches can differ in various bioactive components, 
including growth factors, which contribute to the survival and expansion of cell cultures 
(Zolotarjova et al.  2008; Gstraunthaler 2003). Notably, serum supplementation of 
media can mask or modify cellular responses during experiments designed to assess the 
effects of growth factors (Chase et al.  2010; Wagner & Ho 2007). To establish cell 
culture conditions for the culture models under which the effect of GDNF could later be 
analysed, the culture of DPC under serum-free conditions was compared to DPC 
cultured in 10 % serum supplemented medium at both 24 and 48 hours (Figure 3.1.2). 
Based on the reliability of the explant-derived cultures in terms of numbers of cells 
obtained per isolation, consistency of cellular morphology, technique reproducibility 
and technical speed, the further studies described below utilised this approach.    
 Serum-free DPC cultures exhibited significantly reduced numbers of viable DPC 
compared to 10 % serum cultures (Figure 3.1.2). DPC number did not increase over 
time from 24 to 48 hours indicating absence of cell growth under serum-free conditions 
(Figure 3.1.2).  
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Figure 3.1.2 Effect of serum-free culture on explant derived DPC at 24 and 48 
hours culture. Serum-free (SF) culture for 48 hours significantly decreased the number 
of viable explant derived DPC compared to 10 % serum supplemented (10 %) culture 
throughout a range of seeding densities (n=3, Mean ± SD;2-way ANOVA * p= 0.003 
signifcantly different groups; 
…
p= 0.0001 significantly different to respective zero cells 
seeded). 
   
 
BMSC and MC3T3-E1 osteoblast-like cells are well characterised models used 
for multipotent mesenchymal and osteoblastic cell differentiation, respectively 
(Harichandan and Bühring 2011, Jones and McGonagle 2008; Beck et al.  2001; Raouf 
and Seth 2000). While the full repertoire and exact integrated regulatory processes 
which underpin mineralised tissue formation are not yet completely understood the 
transcriptional control and intracellular mechanisms of osteoblast differentiation and 
hence bone formation during development and repair are generally better described 
within the literature compared with DPC differentiation and dentine formation (Aubin 
and Heersche 2000; Karsenty 2008; Robling et al.  2006; Komori 2005; Simon et al.  
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2009; Smith and Lesot 2001; Mitisiadis and Rahiotis 2004; Thelstaf 2006; Lin and 
Rosenburg 2011).  
 BMSC and MC3T3-E1 cultures were therefore used to investigate if differential 
responses occur between BMSC, MC3T3-E1 cells and DPC when exposed to the same 
culture conditions. The effect of serum-free medium on viable BMSC and MC3T3-E1 
numbers at 24 and 48 hours was evaluated (Figure 3.1.3). The number of viable BMSC 
and MC3T3-E1 cells did not significantly increase over time following culture in 
serum-free conditions. This data was comparable to that obtained for the DPC cultures 
(Figure 3.1.2).  Indeed a minimal decrease in viable cell DPC and MC3T3-E1 cell 
number was apparent after 48 hours under serum-free conditions, although no decrease 
in BMSC numbers was evident.  
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A  
             
B  
Figure 3.1.3.Effect of serum-free culture conditions on BMSC and MC3T3-E1 cell 
growth.  Number of viable A) BMSC and B) MC-3T3-E1 (BMSC (n=3), MC3T3-E1 
(n=2) Mean ± SD; 2- way ANOVA . * p = 0.001 significant difference from respective 
control (zero cells seeded) ; … p = 0.001 significant difference between groups at 24 
and 48 hours.  
  
To further investigate whether serum-free conditions would support long-term 
differentiation and mineralisation of cultures, the effect of extended culture periods  was 
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also analysed. BMSC cultures were not included in this analysis due to the lack of 
reduction in viable cell numbers observed at 48 hours compared to 24 hours. 
Conversely in serum-free culture at seeding densities of  3125 to 12500 cells per well 
BMSC number increased after 48 hours compared to 24 hour culture (Figure 3.1.3A). 
Therefore it was on this premise that BMSC could be supported in long term serum-free 
culture.  
 During longer-term cultures (up to 10 days), the number of viable DPC and 
MC3T3-E1 cells in serum-free conditions decreased significantly at day 5 (Figure 
3.1.4). DPC numbers remained significantly decreased at day 10 compared to day 3. 
However at day 10 the decrease in number of  viable explant-derived and MC3T3-E1 
cells under serum-free conditions was minimal at 16.92 % and 14.43 % respectively.  
              
Figure 3.1.4 Effect of serum-free culture on the number of viable explant-derived 
DPC and MC3T3-E1 cells after 3, 5 and 10 days. Viable MC3T3-E1 cell numbers 
were signifcantly decreased at Day 5 and viable DPC numbers significantly decreased at 
Day 5 and 10. Results are expressed as percentage controls (day 3 value). (n = 6, mean 
± SD; TTest 
…
p= 0.000 and *p= 0.05, resepectively).  
* 
… 
* 
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3.2 Relative gene expression profiles in DPC, BMSC and MC3T3-E1 cultures 
 
3.2.1 GDNF, GFRα1 and RET receptor gene expression within a glial cell line. 
  To enable the culture models to be screened to detect GDNF and GDNF 
receptor (GFRα1 and RET) gene expression, RT-PCR conditions were established using 
RNA from rat C6 glioma cell line, which is reported to express both receptors 
(Wiesenhofer et al.  2000; Wan and Too 2010). Transcripts for GDNF and its associated 
receptors, RET and GFRα1, were detected in accordance with this literature (Figure 
3.2). 
 
A                                                    B 
Figure 3.2 A) sq-RT-PCR analysis of C6 glioma cell line relative gene expression 
for the GDNF receptors, RET and GFRα1 and GDNF as analysed by sq-RT-PCR. 
GAPDH was used as an amplification control. (B) Representative gel electrophoresis 
image of transcripts detected (n=3, Mean ± SD). 
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3.2.2 Relative gene expression of GDNF, Gfrα1 and RET in DPC cultures  
 
 Explant-derived and enzymatically-derived DPC culture models were analysed 
for the gene expression of GDNF receptors, RET and GFRα1, along with GDNF. The 
culture models were additionally analysed for the presence of mesenchymal stem cell 
(MSC) marker transcripts, p75
NTR
 (CD271), CD44 and CD105 (Endoglin) (Pittenger et 
al.  1992, 2008; Jones and McGonagle 2008; Bϋhring et al. 2007; Moscatelli et al.  
2009) (Figure 3.2.1).   
 Both DPC models expressed the MSC markers, p75
NTR
, CD105 and CD44 
(Huang et al.  2009; Strys et al.  2011; Bianco et al.  2001), indicating the mesenchymal 
nature of these cultures. GDNF receptor gene expression was evident in both DPC 
culture models and in vivo dental pulp and brain tissue. Gene expression levels of 
GFRα1 and RET receptor suggested that these receptors may be relatively higher in 
explant-derived DPC compared with enzymatically derived DPC (Figure 3.2.1).  
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A       B 
Figure 3.2.1 sq-RT-PCR analysis of explant-derived and enzymatically-derived 
DPC cultures. A) Relative gene expressions of DPC and B) representative 
electrophoresis gel images.  Brain tissue RNA extracts were used as controls. GAPDH 
was used as an amplification control;* p<0.05. (n=4, Mean ± SEM (except CD105 and 
CD44 n=2)). 
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 These data indicated that the GDNF receptors are expressed in vivo within pulpal tissue 
and in vitro in DPC, indicating that both DPC culture models may provide suitable 
model systems for the analysis of the effects of GDNF.   
3.2.3 Relative gene expression of GDNF, GFRα1 and RET in BMSC and MC3T3-
E1 cell cultures  
In vitro cultures of BMSC and the MC3T3-E1 cell line were also investigated 
for transcript expression of GDNF and its receptors RET and GFRα1, along with that of 
mesenchymal cell markers.  Both GDNF and GFRα1 transcripts along with 
mesenchymal cell markers were detected within BMSC and MC3T3-E1 cells (Figures 
3.2.2 and 3.2.3). Gene expression within BMSC and the MC3T3-E1 cell line indicates 
that these models are also potentially responsive to GDNF. 
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A                           B 
Figure 3.2.2 sq-RT-PCR analysis of BMSC relative gene expression for GDNF, 
RET & GFRα1 receptors along with mesenchymal cell markers A) Graphical 
representation of relative gene expression levels in BMSC and B) representative 
electrophoresis gel images of transcripts detected for each gene amplified. GAPDH was 
used as an amplification control. (n=4, Mean ±SE).  
 
3.3 Immunocytochemical analysis of GDNF receptor expression  
 
 To substantiate the RT-PCR results and determine the protein expression and 
localisation of RET and GFRα1, immunocytochemical (ICC) staining was performed 
using the C6 glioma cell line as control and in explant-derived DPC, BMSC and 
 CD105 
 GFRα1 
            
 GDNF 
          RET 
      p75
NTR
  
          
CD44 
GAPDH 
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A               B 
Figure 3.2.3 sq-RT-PCR analysis of MC3T3-E1 gene expression for GDNF, and 
RET & GFRα1 receptors along with mesenchymal cell markers. A) Relative gene 
expressions of MC3T3-E1 and B) representative electrophoresis gel image. GAPDH 
was used as an amplification control (n=3 except for CD44 where n =2; Mean ±SE). 
MC3T3-E1 cell cultures (Figures 3.3-3.3.3).  Similar uniform distribution of 
cytoplasmic staining was visible for the GDNF receptors, RET and GFRα1, within 
DPC, BMSC and MC3T3-E1 cell cultures. GFRα1 receptor staining of BMSC and 
MC3T3-E1 cells displayed distinct darkly staining areas within the cytoplasm at levels 
much elevated above background as seen compared to the control.  Specifically, where 
staining that appeared to be localised towards the nucleus and may therefore possibly 
indicate that the receptors aybe stored within the endoplasmic reticulum within DPC 
and MC3T3-E1 cells (Figures 3.3 and 3.3.3).  
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Figure 3.3 C6 Glioma cell cultures stained for the GDNF receptors GFRα1 and 
RET cultured in 10 % FBS supplemented medium on multispot glass slides. Non-
specific/negative staining controls used were normal rabbit serum substituted for 
primary antibody. The biotinylated secondary antibody was used at 1/200 (column (A)) 
and higher magnification images are shown in column (B). DAB and Mayer’s 
haematoxylin were used for visualisation of antibody binding and as a counterstain, 
respectively. Scale bars represent for (A) 100 µm and for (B) 50 µm. 
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Figure 3.3.1 DPC cultures stained for the GDNF receptors GFRα1 and RET in 10 
% FBS supplemented medium on multispot glass slides. Non-specific/negative 
staining controls used were normal rabbit serum substituted for primary antibody. The 
biotinylated secondary antibody was used at 1/200 (column (A)) and higher 
magnification images are shown in column (B). DAB and Mayer’s haematoxylin were 
used for visualisation of antibody binding and as a counterstain, respectively.  Scale 
bars represent (A) 100 µm and for (B) 50 µm.       
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Figure 3.3.2 BMSC cultures stained for the GDNF receptors RET and GFRα1 in 
10%FBS supplemented medium on multispot glass slides. Non specific/negative 
staining controls used were normal rabbit serum substituted for primary antibody. The 
biotinylated secondary antibody was used at 1/200 (column (A)) and higher 
magnification images are shown in column (B). DAB and Mayer’s haematoxylin were 
used for visualisation of antibody binding and as a counterstain, respectively. Scale bars 
represent (A) 100 µm and for (B) 50 µm. Arrows depict increased intensity of staining 
specific to the receptors within cytoplasm compared to weak diffuse non-specific 
controls (normal rabbit serum).        
    
78 
 
 
Figure 3.3.3 MC3T3-E1 cell cultures stained for the GDNF receptors RET and 
GFRα1 in 10% FBS supplemented medium on multispot glass slides. Non-
specific/negative staining controls were normal rabbit serum substituted for primary 
antibody. The biotinylated secondary antibody was used at 1/200 (column (A)) and 
higher magnification images are shown in column (B). DAB and Mayer’s haematoxylin 
were used for visualisation of antibody binding and as a counterstain, respectively. 
Scale bars represent (A) 100 µm and for (B) 50 µm. Arrows depict increased intensity 
of staining specific to the receptors within cytoplasm compared to weak diffuse non-
specific controls (normal rabbit serum).     
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CHAPTER 4 RESULTS 
GDNF effects on DPC, MC3T3-E1 and BMSC survival and proliferation 
 
 
4 GDNF effects on viable cell numbers  
 
Standard cell cultures contain serum or additional components and growth 
factors to support cell viability and growth, whilst serum or growth factor deprivation 
often results in apoptosis and senescence. Chapter 3 demonstrated that serum-free 
culture decreased DPC and MC3T3-E1 viable cell numbers indicating growth 
arrest/increased cell death occurred under these conditions. To study cellular 
proliferation, cultures in growth arrest are commonly used to detect a response to 
exogenously applied growth factors. In this study, the direct cellular effect of GDNF 
was investigated in both serum-free and serum-supplemented cultures.  
Changes in viable DPC, BMSC and MC3T3-E1 cell numbers in response to GDNF 
were measured under serum-free and serum supplemented conditions using the WST-1 
assay. Glioma cell cultures express GNDF receptors and have been reported to be 
responsive to GDNF (Ng et al.  2009). Glioma cells were used as a positive control and 
GDNF significantly increased the numbers of viable C6 glioma cells under serum-free 
culture (Figure 4).  
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Figure 4 GDNF effect on C6 glioma cell numbers as assessed by WST-1 under 
serum-free culture conditions after 48 hour culture. Results are expressed as 
percentage control (0 ng/ml unsupplemented cultures) (n=3, Mean ± SD; *p< 0.005 
versus control).  
 
 The addition of GDNF to serum-free DPC and MC3T3-E1 cell cultures also 
significantly increased the number of viable cells. Linear regression analysis of 
individual experiments for (i) DPC resulted in p < 0.000- 0.007 with R
2  
values up to 
0.49 and (ii) for MC3T3-E1  p>0.000 with R
2
 values up to 0.54. No effect of GDNF 
was apparent in serum supplemented DPC cultures (Figures 4.1).  Interestingly, the 
number of viable BMSC did not change significantly in response to GDNF addition in 
serum-free cultures. However a decrease in viable BMSC and MC3T3-E1 cell numbers 
in serum supplemented conditions was evident at 100 ng/ml GDNF (Figure 4.1.1 and 
4.1.2). 
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Figure 4.1 GDNF effect on viable DPC number as assessed by WST-1 under 
serum-free and 10 % serum supplemented culture conditions. Results are expressed 
as percentage controls (0 ng/ml GDNF unsupplemented cultures) (n=4, Mean ± SEM; 
*p= 0.0003 versus control). 
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Figure 4.1.1 GDNF effect on viable MC3T3-E1 cell number under serum-free 
and 10% serum supplemented culture conditions as assessed by WST-1. Results 
are expressed as percentage of controls (n=4, Mean ± SEM; *p= 0.0003 versus control 
(0 ng/ml GDNF unsupplemented cultures). 
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Figure 4.1.2 GDNF effect on viable BMSC number under serum-free and serum 
supplemented culture conditions as assessed by WST-1   Results are expressed as 
percentage of controls (0 ng/ml GDNF unsupplemented cultures) (n=4, Mean± 
SEM).  
 
4.1 GDNF effects on cell proliferation and cell viability 
To further investigate whether the increase in viable cell numbers was due to increased 
proliferation or increased survival, the BrdU assay, and the live/dead assays were 
applied.   
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4.1.1 Effect of GDNF on DPC and MC3T3-E1 cell proliferation 
 A BrdU incorporation assay was performed under serum-free and serum 
supplemented conditions for DPC and MC3T3-E1 cells in response to GDNF (100 
ng/ml) (Figures 4.2 to 4.2.2). In serum-free media proliferative rates were decreased for 
MC3T3-E1 cell cultures compared to cultures containing serum as demonstrated by a 
significantly reduced BrdU labelling index (Figures 4.2.2). 
 At 48 hours, GDNF significantly increased the number of labelled nuclei in 
serum-free DPC and MC3T3-E1 cell cultures [BrdU labelled DPC nuclei increased 
from 4.5 to 9.9 % and BrdU labelled MC3T3-E1 nuclei from 1.3 to 3 % (Figures 4.2 
and 4.2.2]). At 24 hours the numbers of BrdU labelled DPC nuclei under serum-free 
conditions with GDNF was similarly increased compared to serum-free conditions 
(from 4.5% to 12.2%  BrdU labelled DPC nuclei ) (Figures 4.2 ). 
  Conversely GDNF significantly decreased the number of BrdU labelled DPC 
nuclei at 24 hours and MC3T3-E1 BrdU labelled nuclei at 48 hours within serum 
supplemented conditions (for DPC, BrdU labelled nuclei decreased from 23.8 % to 5.68 
%  and for MC3T3-E1 cells, BrdU labelled nuclei decreased from 8.9 % to 5%) 
(Figures 4.2.1 and 4.2.2). These data indicate that GDNF increased DPC and MC3T3-
E1 cell proliferation in serum-free cultures whilst decreasing mitosis in serum 
supplemented cultures, albeit at differing time points. BMSC cultures were not included 
in this investigation because results from the WST-1 assay detected no significant 
difference in viable cell numbers following the addition of GDNF in serum or serum-
free cultures at 48 hours (see Figure 4.1.2).      
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A 
      B   
Figure 4.2 BrdU labelling of DPC at 24 and 48 hours under serum-free conditions. 
A. Labelled number of DPC nuclei under serum-free conditions with and without 
GDNF addition recorded using Image J software  at 24 and 48 h. Results are percentage 
labelled /total nuclei for each condition (labelling index)(B. Representative microscope 
images of stained DPC cultures: BrdU labelled nuclei are shown appearing black and 
haematoxylin counterstained  nuclei appearing grey. (n=3, Mean ± SEM; *p ≤ 0.05 
versus 0 ng/ml GDNF unsupplemented control, scale bars represent 50 µm). 
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A 
          
Figure 4.2.1 BrdU labelling analysis of DPC at 24 and 48 hours under serum 
supplemented (10 % FBS) conditions. A. Labelled number of DPC nuclei under 
serum supplemented conditions with and without GDNF addition recorded using Image 
J software  at 24 and 48 h. Results are percentage labelled/total nuclei (labelling index) 
for each condition. B. Representative images of stained DPC: BrdU labelled nuclei are 
shown appearing black and haematoxylin counterstained nuclei appearing grey. (n=3, 
Mean ± SEM; ***p ≤ 0.005 versus 0 ng/ml GDNF unsupplemented control, scale bars 
represent 50 µm). 
B 
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A 
     
Figure 4.2.2 BrDU labelling analysis of MC3T3-E1 cultures at 48 hours under 
serum-free and serum supplemented (10 %FBS) conditions. A. Labelled number of 
MC3T3-E1 nuclei under serum-free and serum supplemented conditions with and 
without GDNF addition recorded using Image J software at 48 h.  Results are 
percentage labelled /total labelled nuclei (labelling index) for each condition B. 
Representative images of labelled MC3T3-E1 cells: BrdU labelled nuclei are shown 
appearing black and haematoxylin counterstained nuclei appearing grey. (n=2, Mean ± 
SEM; T-test;*p ≤ 0.05, ***p<0.005 versus 0 ng/ml GDNF unsupplemented control, 
scale bars represent 50 µm). 
B 
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4.2 Effect of GDNF on DPC, BMSC and MC3T3-E1 cell survival 
  
 The live/dead assay was used to assess cell survival in terms of the number of 
dead and live cells under serum-free and serum supplemented conditions. A range of 
GDNF concentrations were applied under serum-free conditions while 100 ng/ml 
GDNF was applied only for serum supplemented conditions. At both 24 and 48 hours 
the numbers of dead DPC, BMSC and MC3T3-E1cells under serum-free conditions  
without GDNF addition were all significantly increased compared to serum 
supplemented cultures (Figures 4.3- 4.3.5). GDNF significantly decreased the 
percentage of dead DPC, MC3T3-E1 cells and BMSC under serum-free cultures (albeit 
at differing concentrations and time points) (Figures 4.3.1; 4.3.3-4.3.5). DPC death was 
significantly decreased at 48 hours at both 10 and 100 ng/ml GDNF supplementation 
whereas MC3T3-E1 cell death was significantly decreased at 48 hours in response to 1 
ng/ml GDNF (Figures 4.3.1;-4.3.3). GDNF at 10 ng/ml also significantly decreased 
BMSC death under serum-free conditions (Figures 4.3.4 and 4.3.5). 
 Under serum supplemented conditions there were no significant changes in dead 
cell numbers with GDNF supplementation, although BMSC consistently demonstrated 
reduced levels of cell death at 24 and 48 hours in response to GDNF (Figures 4.3.4 - 
4.3.5).  
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A 
 
B 
Figure 4.3 Live and dead analysis of DPC under serum-free and serum 
supplemented conditions at 24 hours. A) The percentage of dead DPC within each 
condition (Serum-free with 0, 1, 10 or 100 ng/ml GDNF and serum supplemented with 
0 or 100 ng/ml GDNF). B) Representative images of live and dead staining; arrows 
show non-viable cells. Results are expressed as percentage; dead/total DPC. (n=3-7, 
Mean ± SEM; 
…
p = 0.0001 versus 100 ng/ml GDNF under serum-free conditions).  
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A  
              
B 
Figure 4.3.1 DPC under serum-free and serum supplemented conditions at 48 
hours. A) The percentage of dead DPC within each condition (Serum-free with  0, 1,10 
or 100 ng/ml GDNF and serum supplemented with 0 or 100 ng/ml GDNF). B) 
Representative images of live and dead staining, arrows show non viable cells. Results 
are expressed percentage; dead/total DPC (n=3-7, Mean ± SEM; *p =0.0001 versus 
serum supplemented (0 ng/ml GDNF unsupplemented); 
Δ 
p = 0.0001 versus serum-free 
control (0 ng/ml GDNF unsupplemented). 
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A  
          
B 
Figure 4.3.2 MC3T3-E1 cells under serum-free and serum supplemented 
conditions at 24 hours. A) The percentage of dead MC3T3-E1 cells within each 
condition (Serum-free with  0, 1,10 or 100 ng/ml GDNF and serum supplemented with 
0 or 100 ng/ml GDNF). B) Representative images of live and dead staining, arrows 
show non viable cells. Results are expressed as percentage; dead/total MC3T3-E1 (n=3-
7, Mean ± SEM; *p =0.0001 versus serum supplemented (0 ng/ml GDNF 
unsupplemented). 
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A 
           
 B 
Figure 4.3.3 MC3T3-E1 cells under serum-free and serum supplemented 
conditions at 48 hours. A) The percentage of dead MC3T3-E1 cells within each 
condition (Serum-free with  0, 1, 10 or 100 ng/ml GDNF and serum supplemented with 
0 or 100 ng/ml GDNF ). B) Representative images of live and dead staining, arrows 
show non viable cells. Results are expressed as percentage; dead/total MC3T3-E1. 
(n=3-7, Mean ± SEM; *p =0.0001 versus serum supplemented (0 ng/ml GDNF 
unsupplemented); 
Δ 
p = versus serum-free control (0 ng/ml GDNF unsupplemented)). 
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A    
         
B 
Figure 4.3.4 BMSC under serum-free and serum supplemented conditions at 24 
hours. A) The percentage of dead BMSC within each condition (Serum-free with  
0,1,10 or 100ng/ml GDNF and serum supplemented with 0 or 100 ng/ml GDNF).  B) 
Representative images of live and dead staining, arrows show non viable cells. Results 
are percentage; dead/total BMSC. (n=3-7, Mean ± SEM; *p =0.0001 versus serum 
supplemented (0 ng/ml GDNF unsupplemented);  Δp versus serum-free control (0 ng/ml 
GDNF unsupplemented). 
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A 
   
B 
Figure 4.3.5 BMSC under serum-free and serum supplemented medium at 48 
hours. A) The percentage of dead BMSC within each condition (Serum-free with  
0,1,10 or 100 ng/ml GDNF and serum supplemented with 0 or 100 ng/ml GDNF 
supplementation). B) Representative images of live and dead staining, arrows show non 
viable cells. Results are expressed as percentage; dead/total BMSC. (n=3-7, Mean ± 
SEM, *p =0.0001 versus serum supplemented (0 ng/ml GDNF unsupplemented); 
Δ 
p 
versus serum-free control (0 ng/ml GDNF unsupplemented). 
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4.2.1 Effect of GDNF on cellular apoptosis and necrosis  
 
 To support the live/dead data and detect necrosis and apoptosis within the 
cultures further biochemical cell death assays were performed under serum-free 
conditions.  The LDH (lactate dehydrogenase) cytotoxicity assay determined the overall 
levels of cell death from necrosis and/or apoptosis (Xin et al.  2001). At 48 hours 
GDNF addition decreased LDH levels for MC3T3-E1 cells compared to (no GDNF) 
control or the LDH measurement taken at 24hours. LDH levels for DPC were also 
reduced at 48 hours compared to 24 hours. However no significant differences to the 
(no GDNF) control cultures were evident for MC3T3-E1 cells, DPC or BMSC (Figure 
4.4).  
  
Figure 4.4 Effect of GDNF (100 ng/ml) on LDH levels in supernatants of DPC, 
MC3T3-E1 and BMSC cultures at 24 and 48 hours under serum-free conditions. 
Control contained no GDNF. Results are expressed as percentage control (0 ng/ml 
GDNF unsupplemented (Mean ± SEM, n=3). 
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 At 48 hours the activities of caspases-3/-7 as a marker for apoptosis were 
investigated within DPC cultures. The activities were significantly increased under 
serum-free compared to serum supplemented cultures. Moreover, caspase-3/7 levels 
were significantly reduced on GDNF addition compared to control serum-free cultures 
containing no GDNF (Figure 4.5). These caspase levels were significantly reduced to 
levels comparable to that of serum supplemented cultures (1130 RLU and 1065 RLU, 
respectively) indicating that apoptosis was reduced by GDNF supplementation. 
        
 
Figure 4.5 Caspase 3/7 activities within serum-free DPC cultures. Caspase levels 
were significantly reduced after 48 hours culture under serum supplemented conditions 
and GDNF (100 ng/ml) supplemented serum-free conditions compared to serum-free 
control (0 ng/ml GDNF unsupplemented). Results are shown as relative light units 
(RLU) (n=3, Mean ± SEM; T-test *p<0.05). 
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4.3 The effect of attenuating GDNF signalling on DPC and MC3T3-E1 cell viability  
  
 GDNF reportedly binds GFRα1, and can then form dimers with the RET 
receptors to induce intracellular signalling. (Sariola and Saarma 2003; Kawamoto et al.  
2004; Bespalov and Saarma 2007; Airaksinen 1999). To confirm that GDNF action was 
direct signalling via its main receptors RET and GFRα1 was reduced using RPI-1 and 
PI-PLC inhibitors, respectively (Iwase et al.  2005; Cao et al.  2006; Cuccuru et al.  
2004; Lanzi et al.  2000, 2003; Mologni et al.  2005).  
4.3.1 Inhibition of GFRα1 (GPI- linked receptor) 
  
PI-PLC hydrolyses GPI-membrane anchors thus cleaving the GFRα1 binding sites from 
the membrane. After 48 hours culture with PI-PLC the number of viable cells was 
assessed using the WST-1 assay. PI-PLC significantly reduced the number of viable 
DPC and MC3T3-E1 cells under serum-free GDNF supplemented conditions at all 
concentrations of PI-PLC (from 114 % to 76 % at 0.4 units PI-PLC for DPC and from 
144 % to 93 % at 0.2 units PI-PLC for MC3T3-E1 cells), whilst it had no significant 
effect at any concentration in control serum-free cultures (Figure 4.6 A and B). The 
number of viable GDNF–stimulated DPC and MC3T3-E1 cells was decreased by the 
PI-PLC to levels comparable to those of controls at all concentrations of PI-PLC tested. 
This data indicated that PI-PLC abrogated GDNF activity on DPC and MC3T3-E1 cells 
(Figure 4.16A and B) suggesting that binding to GFRα1 was needed for GDNF effects 
on DPC and MC3T3-E1 cells.          
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B 
Figure 4.6 PI-PLC effect on A) GDNF-stimulated DPC and B) GDNF-stimulated 
MC3T3-E1 cells at 48 hours under serum-free conditions. GDNF was added to 
cultures at 100 ng/ml. Results are expressed as percentage controls (n=6, Mean ± SD; 
*p =0.0001 versus serum-free + GDNF control; 
…
p=0.01 versus serum-free control (0 
ng/ml GDNF unsupplemented).  
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4.3.2 The effect of inhibition of RET receptor DPC and MC3T3-E1 cell viability 
  
 RPI-1 competitively inhibits RET receptors by binding at an active site of the 
receptor and thereby blocking auto-phosphorylation and subsequent activation of 
intracellular signalling pathways (Figure 1.1, pg 4) (Mologni et al.  2005, 2006; 
Kawamoto et al.  2004). In serum-free controls, high RPI-1 concentrations (>30 µM) 
significantly decreased viable DPC numbers compared to the control cultures indicating 
RPI-1 was toxic at these concentrations. Such toxicity has previously been recorded for 
this compound (> 30 µM) (Lanzi et al.  2000). At 30-60 µM the RET inhibitor had a 
similar cytotoxic effect on MC3T3-E1 cells. 
 RPI-1 (0.3-3 µM) significantly decreased GDNF-stimulated viable DPC cell 
number under serum-free conditions suggesting that GDNF effect was dependent on 
signalling through the RET receptor (Figure 4.6.1A).  Addition of GDNF with RPI-1 (6 
µM) significantly decreased viable MC3T3-E1 cell numbers to levels comparable to the 
levels of the serum-free controls (Figure 4.6.1B).  The addition of 0.1 ng/ml of GDNF 
significantly increased viable glioma cell number (Figure 4). Due to the relatively high 
―sensitivity‖ of this cell line to GDNF, the inhibitor was added at higher concentrations 
within the range that showed effects on DPC and MC3T3-E1 cells, to ensure adequate 
attenuation of the receptors. [ increased sensitivity may indicate increased receptor 
numbers (Davidson et al.  2011)]. The addition of the inhibitor at 3 µM and 6 µM 
decreased the numbers of glioma viable cells (Figure 4.6.2).  This data demonstrated 
that RET inhibition reduced the GDNF stimulated increase in the number of viable 
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DPC, MC3T3-E1 and C6 glioma cells under serum-free conditions. These data 
indicated that GDNF effects were mediated by the RET receptor for all cell types tested. 
          
A    
B     
Figure 4.6.1 RPI-1 effect on A) GDNF-stimulated DPC viable cell number and B) 
GDNF-stimulated MC3T3-E1 viable cell number at 48 hours under serum-free 
conditions. GDNF was added to cultures at 100 ng/ml. Results are expressed as 
percentage controls.  (n=2, Mean ± SEM, *p =0.0001 versus serum-free + GDNF; 
*** 
p= 
versus  serum-free control (0 ng/ml GDNF unsupplemented)). 
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Figure 4.6.2 RPI-1 effect on GDNF-stimulated glioma cell number at 48 hours 
under serum-free conditions.  GDNF was added to cultures at 0.1 ng/ml. Results are 
expressed as percentage controls.  (n=7, Mean ± SD; *p= 0.0001 versus serum-free 
control (0 ng/ml GDNF unsupplemented). 
  
         
           
 
 
 
102 
 
CHAPTER 5 RESULTS 
GDNF effects on cell differentiation and in vitro mineralisation  
 
5 Short-term in vitro differentiation 
 
The stimulation of DPC, BMSC and MC3T3-E1 cell differentiation during 
disease may limit the effects of infection and repair damage by generating cells (i) to 
replace lost/damaged cells and (ii) reform the mineralised tissues of the tooth and bone. 
In this study alkaline phosphatase (ALP) was used as a marker of early differentiation of 
DPC, BMSC and MC3T3-E1 cells in response to GDNF. ALP levels can reportedly be 
used as an early indicator of differentiation ( Matsui et al.  1992; Porter et al.  2003; 
Beck et al.  1998).  
ALP activities were decreased for all cell types studied under serum-free 
compared to serum-supplemented culture conditions. Under serum-free conditions, 
GDNF (100 ng/ml) significantly decreased BMSC and MC3T3-E1 cell ALP activities 
(Figure 5B and 5C). Under serum-supplemented conditions DPC and BMSC displayed 
non-significantly reduced ALP activities in response to increasing GDNF concentration.  
However changes in MC3T3-E1 cell ALP activities under serum supplemented 
conditions were only apparent at 100 ng/ml GDNF where ALP activities were 
significantly increased (Figure 5B). This data suggested that GDNF may inhibit early 
differentiation of DPC, BMSC and MC3T3-E1cells under serum-free conditions yet 
stimulate differentiation of MC3T3-E1 cells under serum supplemented conditions at 
100ng/ml (Figure 5). 
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Figure 5 GDNF effect on (A) DPC (B) MC3T3-E1 cells and (C) BMSC ALP 
activities under serum-free and serum supplemented conditions. Results are 
expressed as percentage of control (0 ng/ml GDNF unsupplemented conditions) (Mean 
± SEM; n=4, BMSC and MC3T3-E1 cells, Mean ± SEM; n=3, *p<0.05 versus control).  
 
C 
B  
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 5.1 Long-term in vitro mineralisation  
GDNF induced proliferation of DPC and MC3T3-E1 cells at day 2 (see Chapter 
4) along with changes in ALP levels shown above (Figure 5). These data suggested that 
GDNF may be stimulating early differentiation/expansion within short term cultures 
under serum-free conditions and may therefore also affect late differentiation over the 
longer term. Notably ECM mineralisation has been reported to be preceded by 
transiently increased ALP levels (Hoemann et al.  2009; Wei et al.  2007; Lui et al.  
2007).  
Staining of mineralised ECM under osteogenic conditions [(supplementation 
with 10mM β-glycerophosphate (β-gp), 50 µg/ml ascorbic acid (AA) and 10-7 M 
dexamethasone (DEX)] demonstrates that cultures contain fully differentiated 
functionally active secretory cells, therefore Alizarin Red Staining (ARS) was used to 
visualise and semi-quantify mineralised areas of the cell cultures.  
 Preliminary mineralisation studies were performed in the absence of GDNF to 
determine the capacity of the cell cultures to produce mineralised matrix in standard 
serum supplemented cultures. MDPC-23 cells were used as a positive control to 
represent odontoblast-like cells known to produce mineralised ECM in response to 
osteogenic additives (Hanks et al.  1998; Sun et al.  1998; Pang et al.  2006).  
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Under serum-supplemented osteogenic conditions all cultures showed 
significant mineralisation compared to standard serum supplemented conditions that had 
minimal mineral deposition (Figure 5.1). MDPC-23 and MC3T3-E1 cells displayed 
relatively early mineralised ECM formation and generally stained more intensely 
compared to the DPC cultures. Staining of mineralised ECM within MDPC-23 and 
MC3T3-E1 cell cultures was evident at day 3, while DPC staining remained 
comparatively weak even after 24 days of culture (Figure 5.1). Subsequently the effect 
of GDNF was investigated under osteogenic serum-free culture conditions at 2 and 3 
week intervals compared to serum supplemented osteogenic conditions to assess GDNF 
effects on mineralisation of the cultures.    
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Figure 5.1 Effect of osteogenic culture conditions on in vitro mineralised matrix 
formation. Results are shown as percentage of control (day 3), for (A) MDPC-23 cells 
(B) DPC and (C) MC3T3-E1 cells. Corresponding images of Alizarin red staining 
(ARS) under osteogenic (OSTEO) or control (standard serum supplemented) conditions 
are shown on the right. Results are expressed as percentage of day 3 osteogenic 
absorbance value (450/630nm; Mean ± SD; n=3, *p <0.005 versus day 3 osteogenic 
conditions).  
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5.1.1 In vitro mineralisation under serum-free conditions 
 
 DPC were cultured under serum-free osteogenic supplemented conditions in 
order to study the longer term effects of GDNF.   The addition of osteogenic 
supplements and GDNF to serum-free conditions significantly increased ARS staining, 
compared to serum-free osteogenic cultures and also compared to serum-free cultures 
without osteogenic supplements (Figure 5.2). The subsequent mineralisation of the 
ECM indicated that GDNF was potentially stimulating osteo/odontogenic 
differentiation.  
                     
  
Figure 5.2 Effect of GDNF on mineralised matrix formation for DPC cultures at 7 
day. (A) Concentration of eluted Alizarin red (µM) after culture under osteogenic or 
serum-free (SF) conditions and (B) corresponding images of Alizarin red staining. 
Results are expressed as Alizarin red concentration (µM) (Mean ± SD; n=3, *p<0.001 
significantly different groups; p
… 
versus serum-free unsupplemented controls). 
A 
B 
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The effects of GDNF on in vitro mineralisation were studied using DPC and 
MC3T3-E1 cells cultured for 21 and 28 days under serum-free osteogenic conditions 
with GDNF, using serum supplemented osteogenic culture conditions as a positive 
control for mineralisation. Areas of mineralised ECM were detected within DPC and 
MC3T3-E1 cell cultures and the addition of osteogenic supplements to serum-free 
conditions increased ARS staining 28 and 21 days of culture respectively. ARS was 
significantly increased within GDNF-stimulated cultures under serum-free conditions 
(Figure 5.3).  
Interestingly when DEX was not used for supplementation the GDNF-stimulated 
serum-free DPC osteogenic cultures displayed increased ARS staining indicating that 
DEX addition decreased GDNF effects on differentiation. The highest level of staining 
was observed for serum supplemented cultures with osteogenic supplements, 
furthermore GDNF treated DPC serum-free cultures without DEX showed comparable 
staining levels to serum supplemented osteogenic conditions (Figures 5.3). 
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A similar pattern of staining was evident for MC3T3-E1 cells, albeit at day 21 
osteogenic supplements increased ARS staining under serum-free conditions compared 
to controls that contained no osteogenic supplementation. The addition of GDNF to the 
osteogenic supplements further increased the intensity of staining detected. In contrast 
to the results for DPC, the addition of DEX and GDNF to MC3T3-E1 cell cultures 
resulted in staining more intensely than all other conditions at day 21 (Figure 5.4). 
These data indicated that DEX and GDNF may act synergistically to increase MC3T3-
E1 cell differentiation. The DPC cultures again stained more weakly under all 
conditions compared with MC3T3-E1 cell cultures. At day 28, all osteogenic 
supplemented conditions for both DPC and MC3T3-E1 cultures were significantly 
increased compared to the controls (Figure 5.4).
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 A         B 
Figure 5.3 Effect of GDNF on in vitro DPC cultures mineralised matrix formation (A) Concentration of eluted Alizarin red (µM) 
after culture under osteogenic or control conditions at 21 or 28 days of culture within 48 well plates. Results are expressed as Alizarin 
red concentration (µM) (Mean ± SD; n=3, *p<0.05 versus respective control (serum-free or serum supplemented) at time point 21 
days or 28 days; 
∆
p<0.05 significantly different groups at 21 days or 28 days). Results from the 28 day group were not compared to 
21 day group (B) corresponding images of Alizarin red staining in triplicate for each condition. 
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 A        B                                                             
  Figure 5.4 Effect of GDNF on in vitro MC3T3-E1 cell culture mineralised matrix formation. (A) Concentration of eluted Alizarin 
red (µM) after culture under osteogenic or control conditions at 21 or 28 days of culture within 48 well plates.  Results are expressed as 
Alizarin red concentration (µM) (Mean ± SD; n=3, *p<0.000 versus respective control (serum-free or serum supplemented) at time point 
21 days or 28 days; 
∆
p<0.05 significantly different groups at 21 days or 28 days). Results from the 28 day group were not compared to 21 
day group. (B) Corresponding images of Alizarin red staining in triplicate for each condition. 
* 
* 
* 
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CHAPTER 6 RESULTS 
Potential role of GDNF during postnatal repair and infection 
 
6 GDNF effects on DPC and/or MC3T3-E1 cell behaviour in response 
to; 
 
6.1 Streptococcus mutans (S.mutans) 
 
DPC and MC3T3-E1 cell survival and proliferation may be limited following 
exposure to bacteria and in vivo such infections, therefore limit tissue repair and 
regeneration. S.mutans is a gram positive bacteria present within the plaque biofilm on 
teeth (Michelich et al.  1980; Marsh 2006; Verstraeten et al.  2008) and is associated 
with dental caries progression (Rosengren and Winblad 1975; Meikle et al.  1982; 
Jackson et al.  1997). S.mutans is therefore regarded as an instigator of tooth attrition 
and can contact dental pulp and periodontal bone during aggressive infections. 
However, the direct effect of S.mutans on dental pulp cells and bone cells still warrants 
further investigation (Hahn and Liewehr 2007; Law et al.  2008; Wayman et al.  1992; 
Duany et al.  1971).  
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Initially DPC and MC3T3-E1 viable cell number in response to heat inactivated 
S. mutans with and without GDNF supplementation were investigated.  DPC and 
MC3T3-E1 cells were cultured with S. mutans (at 0, 1, 10 and 100 cells per DPC or 
MC3T3-E1 cell), with and without 100 ng/ml GDNF and under serum supplemented 
conditions. The addition of S. mutans did not significantly affect the numbers of viable 
DPC or MC3T3-E1 cells (Figure 6A and B); furthermore GDNF addition had no 
significant effect on DPC or MC3T3-E1 cell viability in the presence of heat inactivated 
S.mutans (Figure 6A and B). 
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         A 
 
         B 
Figure 6 GDNF (100 ng/ml) effect on viable cell number with or without 
S. mutans addition for (A) DPC and (B) MC3T3-E1 cell cultures after 48 
under serum supplemented conditions. Bacterial cell concentrations were 0, 
1, 10 and 100 cells per DPC or MC3T3-E1 cell. Viability was determined 
by WST-1 assay. Results are expressed as percentage control (0 ng/ml 
GDNF unsupplemented conditions) (Mean ± SD; n=2). 
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6.1.1 TNFα  
 
There is potential for the use of the anti-apoptotic properties of GDNF 
(Steinkamp et al.  2003; Botchkareva et al.  2000; Dalkara et al.  2011; Ng et al.  2009) 
to aid repair of dental pulp and bone in vivo during inflammatory conditions. GDNF 
activity under in vitro conditions representative of some aspects of disease may improve 
our understanding of GDNF function during dental and bone disease.  TNFα is a pro-
inflammatory cytokine, present during infections of the dental pulp and during 
inflammatory bone and skeletal joint diseases such as rheumatoid arthritis (Kokkas et 
al.  2007; Cooper et al.  2010;   Scott and Kingsley 2006).  In this study TNFα 
supplemented cultures provided a simple in vitro model of aspects of inflammation to 
investigate the action of GDNF on cells-derived from mineralised tissue during injury 
and inflammation.   
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Under serum-free conditions no significant effects of TNFα on viable DPC cell 
numbers were detected (Figure 6.1A). The addition of GDNF (100 ng/ml) to the TNFα-
containing cultures increased viable DPC numbers to levels seen for previous 
experiments where GDNF alone was added to DPC (Chapter 4). This data indicated that 
TNFα displayed no evident interaction with GDNF-induced cell survival and 
proliferation under serum-free conditions. 
Under serum-supplemented conditions, TNFα (1-100 ng/ml) significantly 
decreased viable DPC numbers. Further supplementation with GDNF (100 ng/ml) 
abolished TNFα-induced decrease in viable DPC numbers (Figure 6.1B). Conversely, 
under both serum-free and serum supplemented conditions, MC3T3-E1 cell numbers 
were significantly increased with 10 and 100 ng/ml TNFα supplementation. Moreover 
TNFα and GDNF elicited a synergistic effect significantly increasing MC3T3-E1 viable 
cell numbers above those obtained from either TNFα or GDNF addition alone (Figure 
6.1.1). These data indicate that GDNF may negate the deleterious effects of TNFα on 
DPC, whereas for MC3T3-E1 cells GDNF enhances the effects of TNFα.  
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     A 
 
 
      B 
Figure 6.1 TNFα effect on viable DPC number with or without GDNF (100 ng/ml) 
supplementation (A) DPC cultured under serum-free conditions and (B) under serum 
supplemented conditions for 48hrs. Results are expressed as percentage of controls (0 
ng/ml GDNF unsupplemented conditions) (Mean ± SEM; n=3, *p= 0.0001 versus 
serum supplemented control; 
…
p<0.0001 significantly different groups; 
Δ
p= 0.032 
significantly different groups).                                                                                        
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A        
 
B 
Figure 6.1.1 TNFα effect on viable MC3T3-E1 cell number with or 
without GDNF (100 ng/ml) supplementation (A) MC3T3-E1 cells 
cultured under serum-free conditions and (B) under serum supplemented 
conditions for 48h. Results are expressed as percentage controls (0 ng/ml 
GDNF unsupplemented conditions) (Mean ± SEM; n=3, *p= 0.0001 versus 
serum-free control (*p= 0.023 versus serum supplemented control).             
* 
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6.1.2 NGF (nerve growth factor)  
 
The neurotrophin, NGF (nerve growth factor) may activate RET, up regulate 
GDNF expression and has been detected with GDNF during infection (Dechant et al.  
2002; Appel et al.  1997; Martinelli et al.  2006). NGF is also involved in dentine 
generation during development and reportedly present during dental pulp injury where it 
may promote dentine repair (Mitsiadis and Luukko 1995; Byers et al.  1990; Woodnutt 
et al.  2000; Shiomi et al.  2000; O’hara et al.  2009; Arany et al.  2009; Kurihara 2007; 
Mizuno 2007). NGF may also be involved in osteoblast survival and bone repair 
(Mizumo et al.  2007; Yada et al.  1994; Mogi et al.  2000; Asaumi et al.  2000; Aiga et 
al.  2006). 
 Subsequently, initial experiments were performed to assess the effect of NGF 
on DPC viability. NGF significantly reduced viable DPC number under serum-free 
conditions at all concentrations analysed and significantly increased viable DPC number 
under serum supplemented conditions (Figure 6.2). 
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Figure 6.2 NGF effect on viable DPC number under serum-free and 10% serum 
supplemented conditions as assessed by WST-1 assay. Results are expressed as 
percentage of controls (0 ng/ml NGF, unsupplemented cultures) (Mean± SD; n=6, 
*p<0.000 versus control;**p< 0.05 versus control). 
 
In addition, NGF (100 ng/ml) supplementation significantly increased DPC ALP 
levels under serum-free conditions; however, no effect was evident under serum 
supplemented conditions (Figure 6.2.1). These results indicated that NGF may stimulate 
differentiation under serum-free conditions and early differentiation/proliferation under 
serum supplemented conditions. 
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Figure 6.2.1 NGF effect on ALP activity under serum-free and 10% serum 
supplemented conditions. Results are expressed as percentage of controls (0 ng/ml 
NGF unsupplemented cultures) (Mean ± SD; n=6, *p<0.007 versus control). 
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6.2 Effect of GDNF on short term gene expression in DPC and MC3T3-E1 cells 
  This study thus far demonstrated that GDNF has effects on viability and 
proliferation in both DPC and MC3T3-E1 cell cultures. These effects may be mediated 
by several intracellular signalling cascades induced by GDNF-RET-GFRα1 binding 
(Airaksinen et al. 1999; Sariola and Saarma 2003).  To further investigate the cellular 
effects of GDNF, the expression of a panel of genes were analysed where the gene 
expression related to: (i) cell proliferation (PCNA, p27kip1), (ii) cell survival/apoptosis 
(GDNF, IL-6, p27kip1, TNFα) and (iii) differentiation (Cfbα1, BSP, IL-6). In addition, 
the expression of GDNF and associated receptors (GFRα1, RET) were investigated 
under the differing culture conditions and in response to GDNF (Figure 6.3. and 6.3.1).   
  Results from the sqRT-PCR analyses demonstrated clear differences in IL-6 
gene expression for DPC following GDNF treatment. In response to GDNF, DPC IL-6 
gene expression was increased under serum-free conditions, whereas under serum 
supplemented conditions IL-6 expression was significantly decreased. BSP expression 
in DPC was also significantly decreased under serum-free conditions compared to 
serum supplemented conditions (Figure 6.3). Cbfα1 gene expression was increased for 
DPC and MC3T3-E1 cells by GDNF (Figure 6.3 and 6.3.1). In MC3T3-E1 cells BSP 
expression exhibited a similar profile to that exhibited by DPC and with BSP decreased 
relative levels under serum-free conditions were seen compared to serum supplemented 
conditions.  
GDNF gene expression was relatively ( albeit non-significantly) increased for 
both DPC and MC3T3-E1 cells under serum-free conditions in response to GDNF 
stimulation suggesting a possible positive autocrine feedback mechanism was in effect 
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(Figure 6.3 and 6.3.1). GFRα1 expression demonstrated the same pattern of expression 
as GDNF for both DPC and MC3T3-E1 cells. Unique to DPC cells, GFRα1 appeared 
differentially regulated under serum-free compared to serum supplemented conditions 
in response to GDNF addition (Figure 6.3). For both DPC and MC3T3-E1 cells RET 
receptor expression demonstrated the same profile and was increased under serum-free 
conditions compared to serum supplemented conditions. RET gene expression further 
decreased in response to GDNF supplementation under both serum-free and serum 
supplemented conditions (Figure 6.3 and 6.3.1).  
For DPC, TNFα expression appeared increased under serum-free compared with 
serum supplemented conditions and GDNF supplementation had a minimal effect on 
TNFα expression. p27kip1 expression decreased with GDNF addition in both DPC and 
MC3T3-E1 cells under serum supplemented conditions. Under serum-free conditions 
GDNF had opposing effects on p27
kip1 
expression in DPC and MC3T3-E1 cells, 
decreasing and increasing in relative levels respectively. PCNA expression 
demonstrated a similar pattern of expression in response to GDNF although this was 
less evident for MC3T3-E1 cells, where PCNA expression was increased under serum 
supplemented conditions compared to serum-free conditions. GDNF addition decreased 
PCNA gene expression under serum conditions for both DPC and MC3T3-E1 cells. 
Under serum-free conditions relatively small increases in PCNA expression were 
detected (Figure 6.3 and 6.3.1). 
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Figure 6.3 The effect of GDNF (100 ng/ml) supplementation on relative gene expression in DPC under serum-free and serum 
supplemented (10%FBS) conditions at 48 hours. A) Graphical representation of relative gene expression levels and B) 
representative electrophoresis gel images of transcripts detected for each gene amplified. GAPDH levels were used as a normalising 
control. (Mean ± SEM; n=3, T-test *p<0.05).   
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Figure 6.3.1. The effect of GDNF (100 ng/ml) supplementation on relative gene expression of MC3T3-E1 under serum-free and 
serum (10 %FBS) supplemented conditions at 48 hours. A) Graphical representation of relative gene expression levels and B) 
representative electrophoresis gel images of transcripts detected for each gene amplified. GAPDH levels were used as a 
normalising control. (Mean ± SEM; n=2).   
 
A 
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CHAPTER 7 DISCUSSION  
7 DPC culture model characterisation 
The enzymatically-derived DPC culture model has previously been characterised 
in terms of odontoblast differentiation, effect of cryopreservation, pellet culture 
techniques, multi-potentiality and ―stemness‖ (Huang et al.  2006; Zhang et al.  2006; 
Woods et al. 2009; Yu et al.  2010; Iohara et al. 2004, 2009; Alge et al.  2010; Miura et 
al.  2003; Paino et al. 2010). Key papers produced by Gronthos and co-workers 
furthered interest in the regenerative capacity of the dental pulp by identifying putative 
stem cells within it. Gronthos et al. (2000, 2001, 2002, 2006) found that enzymatically-
derived DPCs could be expanded for up to 20-30 population doublings and were 
capable of differentiating along various cell lineages as well as forming a dentine-pulp 
complex in vivo when these cells were transplanted into immune-compromised mice. In 
these and more recent studies, DPC have been isolated by digestion using trypsin for up 
to 30 mins (Patel et al. 2009). This approach, effective for deriving many different cell 
types from the ECM, released cells from the dental pulp by cleavage of cell surface 
peptide bonds on the C-side of Arginine and Lysine residues (Gilbert et al.  2006). 
Enzymatic digestion may therefore significantly disrupt cellular membranes and affect 
viability, reducing cell yields (Kirkpatrick 1985). Indeed yield per isolation is a critical 
factor when potentially only a proportion of clonogenic DPC (possibly < 20 %) are 
capable of more than 20 doublings (Gronthos et al. 2002; Mao et al.  2006).  
 Couble et al.  (2000) applied an explant approach to obtain DPC, identifying 
differentiated odontoblast-like cells at four weeks within confluent cultures following 
addition of ascorbic acid and β-glycerophosphate to the media. This method has since 
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been used by several groups to study the interaction of these cells with bacteria, dental 
materials, pulpal innervation and ECM (Staquet et al.  2008; Farges et al. 2011; Durand 
et al.  2006; Maurin et al.  2004; Seux et al. 1991; About et al. 2000; Carrouel et al. 
2008).  
The use of bone explants to obtain human osteoblast cultures emerged in the late 
1970’s and these osteoblast-like cells have since been extensively characterised (Jones 
and Boyde 1977; Ecarot-Charrier et al.. 1983; Gallagher et al. 2003; Lian and Stein 
1992, 2003, 2004, 2006). Other techniques for isolating cells from mineralised tissues 
have also been developed (Iohara et al. 2004; Sasaki et al.  2008; Tjäderhane et al.  
1998; Téclès et al. 2008). Cao et al.  (2006) found a short period of enzymatic digestion 
followed by the explanting technique produced cells more quickly compared with the 
enzymatic culturing technique when used for isolating osteoblasts. Technically the 
explant approach comprises fewer steps, is less time consuming and requires minimal 
manipulation of the tissue compared to the enzymatic  digestion method and in the 
study presented here this approach was found to produce consistent results. Although 
enzymatic digestion approaches may result in cell damage or derivation of less robust 
cells, a more heterogeneous cell population containing DPC at different levels of 
differentiation may be obtained which may be more representative of the native pulpal 
tissue (Patel et al.. 2009; Balic and Mina 2010; Balic et al.  2010).  
In this study, explant outgrowth resulted in cells of homogenous polygonal 
morphology although this approach took several hours longer to obtain cells compared 
with the enzymatically released DPC approach (Figure 2.1). The explant approach 
proved to be more efficient, where the reuse of explants was possible thereby producing 
further DPC outgrowths (Couble et al.  2000). Therefore the explant-derived model, 
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albeit a more ―selective‖ approach, also appears an appropriate and suitable method for 
obtaining DPC. 
7.1 GDNF and GDNF receptor expression in DPC cultures  
To further characterise the explant and enzymatically-derived cells used in this 
study relative gene expression levels were compared. Data presented here demonstrate 
that explant-derived DPC displayed a different profile of GDNF, GFRα1 and RET 
mRNA expression compared with enzyme-digested DPC, however both were suitable 
models to study GDNF affects on DPC in vitro. Indeed explant-derived DPC expressed 
relatively higher expression levels of both RET and GFRα1 receptors compared with 
enzymatically derived DPC. This differential gene expression suggested that different 
cell types may have been selected according to the isolation procedure. However further 
qPCR is needed for precise quantification of transcript levels involved. Indeed 
differential gene and protein expression according to the isolation procedure used has 
previously been reported for neuronal, smooth muscle and dental pulp cell cultures 
(Iohara et al.  2004; Arthur et al. 2008; Zimmerman 2006; Kirschenlohr et al. 1995; 
Huang et al. 2006b). Zimmermann et al.  (2006) found that osteopontin levels were 
significantly increased within explanted compared to enzymatically digested smooth 
muscle cell cultures. In addition DPC gene expression level for collagen type I was 
increased while DSP levels decreased, in enzyme-digested compared with explant-
derived DPC cultures (Huang et al. 2006). Furthermore Zhang et al.  (2005) found 5 % 
of the DPC population expressed the STRO-1 antigen (a putative mesenchymal stem 
cell marker) within explanted rat cultures whereas Laino et al. (2006) found only 9.98 
% STRO-1 antigen positive cells within enzymatically isolated DPC.  
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Interestingly while RET is reported to have extremely low postnatal expression, 
in vitro expression was detectable within DPC cultures. RET expression can represent 
the degree of differentiation of some cell types, for example during neuronal 
differentiation RET expression increases as cells become more differentiated (Ibanez 
and Ernfors 2007; Hoffman et al. 2005; Hoffman 2008). It is conceivable that the 
relative difference in gene expression of GDNF and the GDNF receptors between 
explanted and enzymatically-derived cell cultures may represent the presence of cell 
populations exhibiting varying degrees of differentiation. 
7.1.1 Confirmation of the mesenchymal nature of DPC culture models 
 RT-PCR analysis indicated that the dental pulp and DPC cultures consisted of 
cells of mesenchymal nature as evidenced by the expression of the putative MSC  
markers p75
NTR
 (CD271), CD44 (hyaluronan receptor) and CD105 (endoglin is also a 
TGF-β co-receptor) (Pittenger et al.  1992, 2008; Jones et al.  2002; Bϋhring et al.  
2007; MoscatelliI et al.  2009). p75
NTR 
expression in DPC was relatively low compared 
with dental pulp tissue and this may have reflected the lack of neuronal cells present 
within these cultures. p75
NTR
 is regarded as a putative stem cell marker (Kendirci et al. 
2010; Stemple and Anderson 1992; Moscatelli et al.  2009) and its expression may also 
indicate the presence of multipotent cells within cultures (Gronthos et al.  2000). 
Notably the MSC markers (CD44, CD105 and p75NTR) have been used to isolate 
multipotent MSC from pulpal tissue using FACS and these enriched sub-populations 
can subsequently form mineralised ECM in vitro (Huang et al. .2009, Bianco et al.  
2001).   
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GFL (Glial Family Ligands) are known survival factors for neural crest and 
neural crest-derived cells (Enomoto et al. 2005; Sariola and Saarma 2003; Chalazonitis 
et al.  1998 Bunone et al. 2000; Insua et al.  2003; Hofmann et al.  2005). The dental 
papilla and hence DPC are of neural crest origin and the expression of GDNF, RET and 
GFRα1 may reflect this neural crest lineage (Saavedraa 2008; Paratcha and Ledda 
2008). GDNF gene expression as detected in this study concurs with the demonstration 
of GDNF in rat tooth by Western blot analysis (Kvinnsland et al.  2004) and GDNF 
mRNA localisation within the inner dental epithelium (IDE), enamel knots, sub-
odontoblast and odontoblast layers (Nosrat et al.  1998; 2002).  GFRα1 and RET were 
also expressed in the epithelial and mesenchymal dental papilla, respectively, during 
tooth morphogenesis (Luukko et al.  1997; Nosrat et al.  1997) suggesting a role in the 
reciprocal epithelial-mesenchymal interactions which occur during early tooth 
development. However this study now demonstrates for the first time the GDNF 
receptor expression occurring within in vitro DPC cultures. 
7.1.2 Characterisation of bone cell cultures for GDNF and GDNF receptor 
expression 
The co-expression of RET and GFRα1 in BMSC and osteoblast-like cells as 
shown here is also a novel observation. GDNF mRNA and protein expression have 
previously been detected in BMSC cultures (Ye et al.  2005; Chen et al. 2007; Garcia et 
al.  2004) and this study confirmed the expression of GDNF within MC3T3-E1 
osteoblast-like cells suggesting a role for GDNF in osteoblast regulation. GDNF 
transcript expression in BMSC was shown to be relatively weak, although 
immunocytochemical staining was clearly apparent. Differences between the level of 
gene and surface protein expression may occur and could be due to post-transcriptional 
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and post-translational modifications/processing. Indeed GDNF receptor protein 
expression is influenced by post-translational modification, as 30% of translated RET 
may misfold in the endoplasmic reticulum and subsequently be degraded (Abrescia et 
al.  2005, Kjaer and Ibàñez 2003). Further work based on these studies is now 
warranted to analyse the in situ distribution of GDNF and GDNF receptors in whole 
tooth and bone tissue. It should also be noted that the expression of the GDNF receptors 
Gfrα1 and RET does not necessarily denote responsiveness to GDNF. Indeed 
intracellular cross-talk with other growth factor receptor systems occurs whereby TGF-
β is required for RET receptor activation (Tsui-Pierchala et al. 2002; Dechant 2002; 
Airaksien 1999; Sariola and Saarma 2003). Nonetheless, the data from the studies 
presented here demonstrated that GDNF exerted direct effects mediated by Gfrα1 and 
RET on non-neuronal cell types from the dental pulp, calvarial bone and to a lesser 
extent the bone marrow (see below). 
7.1.3 In vitro culture under serum-free conditions 
Serum-free cultures facilitate the study of the direct effects on cells without 
interference from serum factors, but also present a model mimicking pathological 
conditions involving cellular insult and injury due to growth factor deprivation 
(Goyeneche et al. 2006). In this study DPC and MC3T3-E1 cell cultures displayed 
reduced cell viability when cultured under serum-free conditions in agreement with 
other reports (Onisha et al.  1999; Tarle et al.  2010; Tumber et al.  2000). Interestingly, 
BMSC cultures retained relatively good viability which corresponded with previous 
studies showing that serum-free conditions did not affect viable BMSC numbers during 
a 7 day experimental period (Sauerzweig et al. 2009; Pochampally et al.  2004). 
Interestingly Sauerzweig et al.  (2009) identified those BMSC proliferating under 
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standard serum-free conditions as differentiating towards a primitive neural lineage. It 
would therefore be interesting to investigate whether BMSC can respond to subsequent 
GDNF addition by differentiating along a neural cell lineage.  
Serum deprivation is known to arrest mitosis and serum starved cultures have 
been shown to exhibit differential gene expressions compared with serum supplemented 
cell cultures (Raff et al.  1992; Ye and Lotan 2008). Interestingly Onisha et al.  (1999) 
have previously reported that canine DPC could not be cultured under serum-free 
conditions without additional supplements. Reportedly cell-cell and cell-ECM 
interactions are likely important in regulating survival under stressful conditions. Indeed 
fibronectin (FN) coating of culture surfaces decreased the number of floating, apoptotic 
SHED (Stem cells from human exfoliated deciduous teeth) under serum-free conditions 
(Tarle et al.  2010) indicating that the loss of cell attachment under these conditions 
could be rescued by cell-ECM contact. In addition, differentiated osteoblasts secrete FN 
(Stephansson 2002; Garcia and Reyes 2005; Globus et al.  1998; Moursi et al. 1996) 
and apoptosis was induced in MC3T3-E1 cells by neutralising FN binding (Globus et 
al. 1998). BMSC also synthesise FN constitutively in vitro and FN is important in 
BMSC cell-cell adhesion in vivo; however, additional FN coating of BMSC culture 
surfaces had no effect on BMSC adherence (Jo et al.  2011; Lerat et al.  1993; Van der 
Velde-Zimmermann et al. 1997). Combined this may suggest that variations in 
endogenously secreted ECM such as FN may be responsible for differences in cell 
viability of DPC and BMSCs under serum-free culture conditions. 
In future, investigations utilising sub-optimal conditions for BMSC culture may 
be useful to study the positive effects of mitogens or survival factors such as GDNF on 
BMSC. Sub-optimal conditions may be established by reducing seeding density or 
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perhaps blocking FN adherence using antibodies against integrin β1 binding sites in 
serum-free culture conditions. Data presented here indicated that although DPC and 
MC3T3-E1 cell viability was reduced at day 1 and 2 sufficient cell numbers remained 
after 10 days of culture, indicating that serum-free conditions can be used to support 
long-term studies. 
7.2. Short term effect of GDNF on cell proliferation under serum-free conditions 
This study demonstrated that GDNF increased DPC and MC3T3-E1 viable cell 
numbers and cell proliferation under serum-free conditions. The increase in DPC viable 
cell numbers by GDNF corresponded with a decrease in p27
kip1
 expression confirming 
that cell replication/cycle progression was evident and GDNF regulation of p27
kip1
 
expression was in line with other reports (Kalechman et al. 2003; Baldassarre et al.  
2002). GDNF did not however affect p27
kip1
 expression in the osteoblast-like cells 
suggesting that this may represent a cell type-specific effect. PCNA (proliferating cell 
nuclear factor) is also a marker and regulator of cell cycle progression and cell 
proliferation (Maga and Hubscher et al.  2003; Coltrera and Gown 1991; Sasaki et al.  
1992; Golberg et al.  2008). In this study PCNA transcript expression was detected as 
being both up- and down-regulated in accordance with increasing and decreasing 
proliferation as assessed by BrdU incorporation, thus confirming the GDNF-induced 
changes in proliferation under serum-free conditions. 
7.2.1 GDNF and cell survival  
GDNF is a well characterised cell survival factor (Enomoto et al. 2005; Sariola 
and Saarma 2003; Chalazonitis et al. 1998 Bunone et al.  2000; Insua et al.  2003; 
Hofmann et al.  2005). It is known that the cellular repertoire involved in cell-cycle 
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control and hence proliferation is closely associated with pro-survival signalling 
(Maddika et al. 2007). To assess whether the increased viable cell numbers evident in 
response to GDNF were also due to increased survival of DPC and MC3T3-E1 cells, 
live/dead, LDH and caspase assays were performed to assess the levels of cell death and 
apoptosis within all cultures. GDNF decreased numbers of dead DPC that were 
observed under serum-free conditions. Moreover, caspase levels indicated that apoptosis 
occurred within serum-free DPC cultures and that this was reduced in response to 
GDNF addition. This finding is in agreement with other studies demonstrating that 
serum withdrawal induces cell death in neuronal cell cultures and this is abrogated by 
GDNF supplementation (Kobori et al.  2006). Further work is needed to confirm and 
visualise apoptosis, e.g. using the TUNEL assay. In addition, the anti-apoptotic effect 
elicited by GDNF remains to be confirmed for the MC3T3-E1 cell cultures. 
Interestingly, up-regulation of NTGF receptors under serum-free conditions in the 
absence of ligand resulted in apoptosis in several cell types (Ahn et al. 2005; Fauchais 
et al.  2008; Yuan and Yanker 2000). Within this study RET and GFRα1 expression 
were detected under all culture conditions tested and the inhibitor studies indicated that 
the functional effects were mediated by GDNF receptor binding.  
7.2.2 Osteogenic differentiation and in vitro mineralisation 
Cbfα1/runx2 gene expression in DPC and MC3T3-E1 cells was up-regulated by 
GDNF under serum-free conditions; moreover relative expression levels of Cbfα1 were 
increased in DPCs under serum-free compared with serum-supplemented conditions. 
Cbfα1 is considered a pivotal osteoblast transcription factor, although it may not be 
essential for odontoblast differentiation (Narayanan et al.  2001; Fen et al.  2002; Qin et 
al.  2007). Cbfα1 is used as a marker of the osteoblast lineage and may reflect the 
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osteogenic potentiality of cells in culture (Galindo et al.  2005; Wang et al.  1999). 
Moreover, ALP activities in the DPC, BMSC and MC3T3-E1 cell cultures were 
decreased by GDNF supplementation under serum-free conditions, suggesting an 
inverse relationship between cell proliferation and differentiation (Yokose et al. 2000; 
Hoemann et al. 2009; Maddika et al. 2007).  
An in vitro mineralisation assay was conducted as a measure of functional 
osteogenic differentiation. Cultures were grown for up to 28 days under in vitro osteo-
inductive conditions and stained with alizarin red (ARS) to detect mineralised ECM 
under serum-free conditions. Initial experiments indicated that mineralisation occurred 
at a later time point for DPC compared to MC3T3-E1 cells suggesting that DPC 
cultures were less differentiated or less inductive under these study conditions compared 
with the osteoblast-like cell line. The relatively long-term mineralisation experiments 
indicated that GDNF stimulated osteogenic differentiation of both DPC and MC3T3-E1 
cell cultures. It may be possible that cell death occurring under serum-free conditions 
related to the formation of mineralised ECM. Lynch et al.  (1998) found apoptosis was 
co-regulated with osteoblast differentiation and Fratzl-Zelman et al.  (1998) found rapid 
mineralisation occurred within cultures containing dead cells. However, other studies 
have reported mineralisation within osteoblast and BMSC cultures under serum-free 
conditions (Gronowicz et al. 1989; Sakamoto et al.  1989; Huffman et al.  2007; 
Solmesky et al. 2010). In this study the mineralisation observed under serum-free 
conditions with osteogenic induction became significant only after 28 days; thus it is 
improbable that this calcification was associated with dead cells which normally occurs 
relatively rapidly within the early stages of culture (Fratzl-Zelman et al.  1998). 
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The level of ARS under serum-free osteogenic conditions was changed with the 
addition of GDNF and/or removal of DEX. GDNF without DEX supplementation in 
MC3T3-E1 cell cultures decreased ARS staining, whereas ARS staining was increased 
in DPC cultures, indicating cell specific effects of DEX in combination with GDNF. 
The mechanism of action for GDNF increased ECM calcification remains unclear. 
GDNF may stimulate early osteogenic/odontogenic differentiation of mesenchymal 
cells and/or expansion of existing progenitor cells; moreover, GDNF may exert late 
effects on the synthesis of ECM proteins (Del Rio et al.  2011; Lin al.  2001). GDNF 
may also have promoted endogenous production of growth factors such as BMPs that 
subsequently enhanced cell differentiation during the in vitro mineralisation 
experiments. Indeed GDNF may act synergistically with BMP-4 and -7 during neuronal 
development and proliferation (Chalazonitis et al. 2004; Harvey et al.  2005).   
7.3 Short-term effect of GDNF on cell proliferation and differentiation under 
serum-supplemented conditions 
GDNF decreased viable MC3T3-E1 cell number by inhibiting proliferation 
under serum supplemented conditions as confirmed using a BrdU assay. This study also 
demonstrated that relative gene expression of the osteogenic-associated transcription 
factor Cbfα1 was up-regulated in MC3T3-E1 cell cultures under serum supplemented 
conditions by GDNF. GDNF is known to induce differentiation not only for neuronal 
cell types, but also for cells of the testes and kidney (Peterson et al. 2004; Toshifumi et 
al.  2005; Baldassarre et al.  2002; Meng et al. 2000; Insua et al. 2003; Park et al. 
2005). In this study relative gene expression of BSP in the osteoblast cultures was 
enhanced under serum supplemented conditions. Furthermore the decrease in 
proliferation in GDNF supplemented cultures may also be indicative of 
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cytodifferentiation (Aubin and Heersche 2000; Blagosklonny 2003). Interestingly, 
GDNF/RET signaling has been shown to be responsible for decreased proliferation of 
an embryonic neural precursor carcinoma cell line (Baldassarre et al.  2002). This 
effect, mediated by p27
kip1
, was suggested to be a mechanism by which GDNF regulates 
cell growth to initiate terminal differentiation (Baldassarre et al. 2002). Moreover the 
short-term experiments performed in this study demonstrated that ALP levels were 
increased concomitantly with decreasing proliferation. Further long-term studies will be 
required to investigate in detail the role of GDNF in osteogenic proliferation, 
differentiation and bone formation. 
7.4 In vitro culture under “challenging” conditions that reflect some aspects of 
infection and inflammation 
In vivo bacterial infection or injury to bone and dentine can lead to the 
proteolysis of the ECM and elicit an inflammatory reaction by the host immune system. 
Enhanced levels of GDNF found in gingival crevicular fluid from patients with chronic 
periodontitis emphasize the potential involvement of GDNF in the pathophysiology of 
dental tissues (Sakai et al. 2006). Previous studies have demonstrated that LPS 
(lipopolysaccharide) and NFĸB (a TNFα regulated transcription factor) signalling up-
regulated NGF expression during dental inflammation (Freund-Michel and Fossard 
2008; Heese et al. 1998; Magloire et al.  2001). The cytokine TNFα is well known for 
its ability to stimulate recruitment and activation of immune cells to the sites of 
infection (Zganiacz et al. 2004; Abe et al.  2010; Stashenko et al.  1991; Stashenko et 
al. 1987; Li and Stashenko 1992), however it is also reportedly able to stimulate 
osteogenic migration, proliferation and differentiation (Gowen et al.  1988; Frost et al. 
1997; Glass et al. 2011; Lencel et al.  2011; Modrowski et al. 1995). TNFα also directs 
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the differentiation of osteoclasts that resorb bone, although the exact mechanisms by 
which this occurs are not yet fully ascertained (Robinson et al. 2007; Nanes 2003). 
Given GDNF effects on osteoblast-like and odontoblast-like cell differentiation and 
survival under serum-starved conditions, the effect of GDNF under challenged 
conditions recapitulating some aspects of infection and inflammation were investigated. 
7.4.1 Streptococcus mutans (S.mutans) exposure 
S.mutans is a gram positive bacterium associated with dental caries and 
Rosengren and Winblad (1975) demonstrated that S.mutans infections are also involved 
in deeper destruction of bone during dental infections. However, the effects of S.mutans 
on the viability of the dental pulp or osteoblasts are not elucidated. Meikle et al. (1982) 
found S.mutans antigens contributed to inhibition of MC3T3-E1 cell protein synthesis 
and that this may contribute to bone loss. In accordance, bacterial wall components of 
S.mutans and LTAs (Lipoteichoic acid) have been found to induce bone resorption 
(Nair et al. 1996).  
Elson et al.  (2007) studied the direct effect of heat inactivated gram positive and 
negative bacteria compared with purified LPS on TLR activation and concluded that 
heat inactivation was a valid method for studying TLR responses of the innate immune 
system. Previously, Paterson et al. (1982, 1987) have indicated that live S.mutans 
decreased dental pulp cell numbers in vivo; however decreasing cell viability was 
evident from day 7 only suggesting that this was not a direct cytotoxic effect of the 
bacteria. More recently Abe et al. (2010) reported heat inactivated S.mutans stimulated 
DPC osteogenic and dentinogenic differentiation. Interestingly the literature suggests 
that GFL expression during bacterial infection may increase cell survival, whereby 
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infecting gram positive bacteria express outer protein structures that mimic NTGF 
structure and subsequent exposure to the host cells has been reported to increase 
neuronal cell differentiation and survival during bacterial infection (Lu and 
PereiraPerrin 2008). Moreover, Durand et al. (2006) found that LTA exposed 
odontoblasts up-regulated mRNA for hypoxia-inducible factor 1α (HIF1α), a 
transcription factor regulating GDNF expression (Foti et al. 2010). Within this study no 
effect of heat inactivated S.mutans on viable DPC or MC3T3-E1 cell number was 
evident. Likewise S.mutans had no evident effect on GDNF stimulated DPC and 
MC3T3-E1 viable cell number. Further work is needed to assess S.mutans effect in 
isolation from serum factors and to determine whether bacterial components modulate 
GDNF effects under these conditions. 
7.4.2 GDNF interaction with TNFα  
Interestingly the NFĸB transcription factor has a binding site on the human 
GDNF promoter, suggesting a potential regulatory feedback loop involving GDNF in 
response to inflammatory signalling (Appel et al. 1997; Woodbury et al.  1998). Under 
serum-free conditions TNFα exerted no effect on viable DPC numbers and GDNF 
addition increased viable cell numbers to levels previously seen without TNFα addition. 
Thus in vitro experiments were conducted using serum to mimic the multitude of 
proteins present under physiological conditions. This study demonstrated that under 
serum supplemented conditions, TNFα decreased DPC viable cell numbers, and this 
effect was abated by GDNF addition. These data suggested that GDNF may protect 
DPC against TNFα induced apoptosis/necrosis in agreement with previous reports 
(Talley et al. 1995; Yang et al. 2002; Sheng et al. 2005; Peralta-Solter et al.  1996).  
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Interestingly, TNFα promoted osteoblast proliferation which was further 
enhanced in the presence of GDNF. The mechanisms by which GDNF interacted with 
TNFα to stimulate osteoblast proliferation are as yet unknown, but plausibly the effect 
may have been due to the stimulation of converging pathways that may include CREB 
(cAMP response element), IKK and NFĸB signalling (Ono et al. 2004; Kalechman et 
al. 2003; Encinas et al. 2008). Furthermore TNFα also is proposed to regulate GDNF 
expression and secretion. (Tanaka et al. 2000; Woodbury et al. 1998; Kim et al.  2009; 
Simon et al.  2007; Esseghir et al.  2007; Kuno et al.. 2006; Appel et al. 1997). Thus, it 
is possible that increased GDNF synthesis by TNFα could lead to autocrine positive 
feedback mechanisms. 
7.4.3 Cell specific effects of GDNF 
This study demonstrated that whilst GDNF had direct effects on DPC and 
MC3T3-E1 cell viability, GDNF only decreased ALP levels in BMSC cultures under 
serum supplemented conditions but had no obvious comparable effect on BMSC 
proliferation or viability. These data corresponds with previous findings by Kramer et 
al. (2006). These apparent cell-specific effects of GDNF may reflect cell-specific 
receptor expression and intracellular signalling (Encinas et al.  2008; Tsui-Pierchala et 
al.  2002; Encinas et al.  2001; Focke et al.  2001; Mason et al.  2006) and/or may be 
due to the differential expression of tissue specific genes such as PAX and SOX genes 
in long bones as opposed to neural crest derived tissues (Fernandas et al. 2004; Betters 
et al.  2010; Dezawa et al.  2005; Otto et al . 2009; Basch et al.  2006; Wang et al . 
2009). Indeed DPC and MC3T3-E1 cells displayed similar proliferative responses to 
GDNF. Furthermore it should be noted that MC3T3-E1 cells are of foetal origin 
whereas BMSC are postnatally derived cells. Gattei et al. (1997) hypothesised that 
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GDNF has a role within the bone marrow, activating signalling between BMSC 
expressing GFRα1 and RET expressing hematopoietic cells to stimulate monocytes 
differentiation.  
This study highlighted another novel action of GDNF, that the neurotrophic 
factor modified cytokine IL-6 gene expression in DPC and MC3T3-E1 cell cultures. 
These findings are consistent with previous studies indicating a role for IL-6 in late 
stage differentiation and survival of osteoblasts and fracture healing (Jüttler et al.  2002; 
Li et al. 2010; Jilka et al. 1998; Iwasaki et al . 2008; Tsiridis and Giannoudis 2006). IL-
6 is also a known neurokine able to sustain neuronal cell survival (Hirano et al. 2000; 
Bromberg and Wang 2009) and it may therefore be speculated that IL-6 may play a role 
downstream of GDNF as described in the current study.  
7.4.4  NGF stimulation of DPC 
It was previously proposed that the neurotrophin, NGF, may be involved in 
odontoblast differentiation and dentine formation during tertiary dentinogenesis (Arany 
et al.  2009; Kurihara 2007; Woodnutt et al.  2000; Shiomi et al.  2000; O’hara et al.  
2009). Neurotrophins have been detected during fracture repair and NGF may also be 
involved in the repair of bone (Asaumi et al. 2000; Aiga et al. 2006). NGF was reported 
to stimulate differentiation and survival of osteoblasts (Mizumo et al.  2007; Yada et al. 
1994; Mogi et al. 2000). NGF can also up-regulate GDNF expression (Appel et al.1997) 
and may modulate its action in vivo during infection and inflammation (Martinelli et al. 
2006). This study demonstrated NGF increased DPC viable cell numbers under serum 
supplemented conditions. Conversely, NGF decreased viable DPC numbers and 
increased ALP activity under serum-free conditions suggesting NGF stimulated cell 
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differentiation. Further studies are required to investigate the inter-relationship between 
GDNF and NGF in the regulation of DPC and osteoblast activity.   
7.5. Summary  
In summary, this PhD study demonstrated that BMSC and MC3T3-E1 cells 
which are well characterised models for osteoblast differentiation expressed both GDNF 
receptors (GFRα1 and RET). Dental pulp and dental pulp-derived cell cultures also 
express the GDNF receptors. Furthermore, direct cell-specific, receptor-mediated 
effects of GDNF were demonstrated on the proliferation and cell survival of DPC 
cultures. However, GDNF did not affect BMSC proliferation or viability nor did GDNF 
influence MC3T3-E1 cell survival under serum-starved conditions. GDNF effects on 
DPC and osteoblast cell proliferation were inversely related to ALP levels. Nonetheless, 
GDNF stimulated in vitro mineralisation in long-term DPC and MC3T3-E1 cultures. 
Further work is warranted to investigate the precise effects of GDNF on osteoblast and 
odontoblast differentiation, the mechanisms involved in GDNF signalling in these 
mesenchymal/NCC-derived cells and whether GDNF may be used as a bioactive 
therapeutic agent in bone or dental repair.  
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CHAPTER 8 CONCLUSION 
 
In conclusion the findings from this research demonstrate that GDNF is able to 
directly stimulate odontoblast and osteoblast-like cell proliferation and differentiation. 
From these findings, it is proposed that GDNF may play an important role in the 
regulation of dental pulp homeostasis and bone metabolism. Moreover GDNF promoted 
DPC survival under ―challenged conditions‖ indicating that GDNF may be involved in 
the survival and differentiation of DPC and possibly odontoblasts during the repair of 
mineralised tissues.  
8.1 Clinical and therapeutic applications 
The putative role for GDNF during development and homeostasis, regulating 
cell differentiation, survival and proliferation may be exploited for clinical regenerative 
or therapeutic applications. 
8.1.2. GDNF as a bioactive in tissue repair and regeneration 
GDNF has already been used within clinical trials for neuronal diseases and 
GDNF regulation may be involved in rare disease such as Waardenburg-Hirschsprung 
diseases (Pelet et al. 1998; Angrist et al.  1996; Chan et al.  2003). GDNF receptor 
signalling may be also involved in neuro-endocrine cancers, breast cancers, leukaemias 
and drug dependence (Morandi et al.  2011; Plaza-Menacho et al. 2010; Lanzi et al.  
2003, 2009; Gattei et al. 1999; Niwa et al.  2007; Petrangolini et al. 2006). Indeed RPI-
1 and other indoline blockers that inhibit RET have been proposed as clinical treatments 
for such diseases (Morandi et al.  2011; Phay and Shah 2010).  
144 
 
Non-steroidal anti-inflammatory drugs (NSAIDS) are commonly used to treat 
bone diseases such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and 
osteomyelitis, however their effects are limited (Donnelly and Hawkley 1997; Harder 
and An 2003). Anti-TNFα therapy is a promising new treatment however this has many 
reported serious side effects (Bongartz et al.  2006; Williams et al.  1992; Vaz et al.  
2009). GDNF appears to modify TNFα effects and may represent a target for inhibition 
in cases where anti-TNFα treatment is used. However for this application GDNF 
regulation and signalling requires further elucidation. Moreover GDNF interactions 
with TNFα, highlight a GDNF/TNFα synergy in stimulating osteoblast differentiation 
which could possibly be harnessed to promote bone formation. MSC have previously 
been genetically engineered and used to deliver growth factors as a part of gene therapy 
and similar investigations regarding the dental pulp have been proposed to stimulate 
natural reparative events in situ (Moutsatsos et al.  2001; Nakashima et al. 2002, 
Kimelman et al. 2007). BMSC and DPSC have also gained much interest for use in 
neuronal regeneration due to DPC release of NTGF and DPC have been implanted in 
vivo to deliver NTGF or differentiate along neuronal lineages (Bolliet et al.  2008; 
Huang et al.  2009; Nosrat et al.  2001; Lillesaar et al.  2001, 2003; Apel et al. 2009). 
There is now scope within the field of dentistry for the addition of bioactives such as 
GDNF. Bioactives may be used within scaffolds, dental sealants/fillings and via 
implantation of bioactive secreting MSC to encourage regeneration of the pulp by 
increasing adherence (to biomaterials such as implants/scaffolds), survival, 
proliferation, differentiation and migration of dental pulp cells along with promoting 
angiogenesis (Brydone et al. 2010; Hing 2004; Zuk et al.  2008; Sun et al.  2010). This 
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study raises the possibility that GDNF may play a role in MSC survival, recruitment and 
proliferation during dentine repair (Shi et al. 2008). 
8.1.3 Role of GDNF in tooth inflammation and analgesia 
GDNF may protect against TNFα induced cytotoxicity during painful pulpal 
inflammation where high levels of TNFα occur such as during irreversible pulpitis 
(Kokkas et al. 2007; Donaldson 2006). Current treatment for pain relief during 
irreversible pulpitis involves tooth extraction or pulp removal (pulpectomy/extirpation) 
(Komabayashi and Zhu 2010). GDNF has recently been reported to have analgesic 
effects on pain induced by damaged nerves (Takasu et al. 2011; Adler et al. 2009). 
Therefore novel dental pulp clinical therapies using GDNF can be envisaged which 
maintain and promote tooth vitality (Komabayashi and Zhu 2010; Wang et al. 2010, 
2011). 
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Glial Cell Line-Derived Neurotrophic Factor Promotes Survival and 
Proliferation of Dental Pulp Cells 
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ABSTRACT 
 
 
This study investigated the effects of glial cell line-derived neurotrophic factor (GDNF) 
on dental pulp stromal cells (DPCs). Cultures of DPCs expressed GDNF as well as its 
receptors, GFR1 and RET. Addition of recombinant GDNF to cultures in serum-
containing medium did not significantly affect DPC growth; however, GNDF dose-
dependently increased viable cell number under serum-free culture conditions. 
Live/dead, lactate dehydrogenase (LDH) and caspase -3,-7 assays demonstrated that cell 
death occurred under serum-free conditions, and that GDNF significantly reduced the 
number of dead cells by inhibiting apoptotic cell death. GDNF also stimulated cell 
proliferation in serum-free conditions, as assessed by the BrdU incorporation assay. The 
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effect of GDNF was abolished in the presence of specific inhibitors to GFR1 and RET 
suggesting receptor-mediated events. This study also demonstrated that GDNF 
counteracted TNF-induced DPC cytotoxicity, suggesting that GDNF may be 
cytoptotective under disease conditions. In conclusion, our findings indicate that GDNF 
promotes cell survival and proliferation of DPC and suggest that GDNF may play a 
multi-functional role in the regulation of dental pulp homeostasis.    
Key words: pulp biology, neurotrophic factors, GDNF, TNF alpha, cell survival, cell 
proliferation. 
 
INTRODUCTION 
 
Neurotrophic factors have been implicated in the development and regulation of dental 
tissues ( Luukko et al., 1997; Nosrat et al., 1998, 2002; Woodnutt et al., Magloire et al., 
2001). The glial cell line-derived neurotrophic factor (GDNF) is part of GDNF family 
of ligands (GFLs) which include neurturin (NRTN), artemin (ARTN) and persephin 
(PSPN). GFLs are considered to belong to the TGFβ superfamily sharing partial amino-
acid sequence homology and structural confirmation (see for review Airaksinen and 
Saarma, 2002). GDNF is a soluble signaling molecule that binds to a specific membrane 
receptor, the GDNF family receptor  (GFR1) which forms complexes with the 
tyrosine kinase receptor RET or alternative co-receptors such as NICAM eliciting 
intracellular signals for cell growth and differentiation (Sariola and Saarma, 2003).  
 
GDNF was originally characterized as a potent trophic factor promoting the survival 
and differentiation of neurons (Airaksinen and Saarma, 2002).  GDNF was subsequently 
shown to be expressed in various tissues outside the nervous system and an important 
functional role has been recognized in urogenital tissues, in particular relating to kidney 
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development and spermatogenesis (Sariola and Saarma, 2003). The expression of 
neurotrophic factors within the adult dental pulp highlighted that GDNF may be 
involved in neuronal innervations, axon growth and function (Nosrat et al., 1997; Fried 
et al., 2000; Lillesaar et al., 2001; Luukko et al., 1997)). During tooth development, 
GDNF and its receptors GFR1 and RET are transiently localized in dental organ 
epithelium and pulpal mesenchyme suggesting a role for GDNF in epithelial-
mesenchymal interactions  (Hellmich et al., 1996; Luukko et al., 1997; Nosrat et al., 
1998)). Interestingly, ultrastructural analysis of molar tooth germs from GDNF-
knockout mice revealed that ameloblast and odontoblast differentiation was disrupted 
suggesting a role for GDNF  during  tooth cytodifferentiation ((de Vicente et al., 2002)). 
We postulated that GDNF may be involved in the regulation and maintenance of the 
postnatal dentin-pulp complex. The aim of this study was to investigate the direct 
effects of GDNF on dental pulp cells (DPC).   
 
MATERIALS & METHODS 
 
Dental pulp cell (DPC) cultures  
DPC cultures were established from rat dental pulp explants as described previously ( 
e.g., Couble et al., 2000; Huang et al., 2006).  In brief, dental pulp was extracted from 
incisors of 4-6 week-old male Wistar rats and dissected into small (~5mm
3
 ) samples 
and cultured in tissue culture flasks containing αMEM supplemented with 20% Fetal 
Bovine Serum (FBS), 1% penicillin/streptomycin  and 2.5 μg/ ml Amphotericin B 
(Sigma Aldrich, UK) in a humidified 5% CO2 incubator at 37 
O
C. DPC proliferated 
from the explants, showing a polygonal stromal/fibroblast-like morphology which 
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became more cuboidal when reaching confluency. Subconfluent cell cultures were 
trypsinized with Trypsin/EDTA (Invitrogen/Gibco, UK) and subcultured. DPC at 
passage 2 to 4 were used for the experiments.  DPC were seeded into 96-multiwell 
plates in MEM/10% FBS at 5,000 cells/well.  After 24 hours, the cultures were 
replenished with either serum (10% FBS) or serum-free MEM supplemented with 
0.1% bovine serum albumin (BSA). Recombinant human GDNF (rhGDNF, Amgen, 
Thousand Oaks, USA) was added to the cultures for a further two days. Additional 
experiments included recombinant human tumour necrosis factor-α (TNFα; Peprotech, 
UK) which was co-incubated with 100 ng/ml GDNF in αMEM/10%FBS for 2 days 
before analysis. For the receptor inhibitor experiments, DPC cultures were treated for 1 
hour with different concentrations of phosphoinositide phopsholipase C (PI-PLC; 
Sigma) which blocks signalling via GFRα1 (Krieglstein et al., 1998) , or RPI-1 
(Merck/Calbiochem), a specific RET receptor tyrosine kinase inhibitor (Cuccuru et al., 
2004) followed by further culture with the respective inhibitors in media with or without 
GDNF.    
 
Cell number and viability assays 
We used the WST1 assay (Roche Applied Biosciences) to assess the number of viable 
cells (Scheven et al., 2009); the absorbance of the reduced compound was measured at a 
wavelength of 450 with a reference filter at 630nm using a Biotek plate reader. To 
distinguish between the number of viable and dead cells in the cultures, we performed  a 
―live/dead‖ assay using acridine orange (4µM) (stains nuclei of live cells) and ethidium 
bromide (4µM) (labels nuclei of dead cells). The numbers of live and dead cells per 
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microscopic field was counted under a Nikon Eclipse fluorescent microscope using 
480nm and 520nm filters, respectively.   
 
Cell death and apoptosis assays  
The level of cell death in the cultures was determined biochemically using a lactate 
dehydrogenase (LDH) cytotoxicity assay (Roche, UK). Cell culture supernatants were 
analysed after a 2-day culture for the presence of LDH. Absorbance was determined at 
490/630nm using the Biotek plate reader. To determine the level of cellular apoptosis, 
we used the Caspase-Glo-3/-7 to determine the enzymatic activities of caspsase-3/-7 
(Promega); the cleaved luminescent product was measured with a Berthold microplate 
luminometer. 
 
 
BrdU cell proliferation assay 
 
Cell proliferation was assessed with the use of a 5-Bromo-2-deoxy-uridine (BrdU) 
labelling and detection kit (Roche Applied Sciences). In brief, cells were labelled with 
10 µM BrdU for the final hour of the 48-hour culture followed by fixation and 
immunostaining for BrdU incorporation using a specific anti-BrdU antibody. Cells were 
counterstained with hematoxylin and the total number of labelled and non-labelled 
nuclei were counted in 50 independent microscope fields. 
 
Semi-quantitative RT-PCR (sqRT-PCR) analysis: DPC cultures as well as dental 
pulp and brain extracted from 4-week-old rats underwent lysis in RLT buffer  
containing β-mercaptoethanol followed by RNA isolation using the RNeasy minikit 
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(Qiagen, UK). Subsequently, 1-2 μg of DNase-digested total RNA was used for 
oligo(dT) (Ambion, UK) reverse transcription to generate single-stranded cDNA using 
the Omniscript kit (Qiagen,UK). Centrifugal filters (Microcon) were used to purify and 
concentrate resultant cDNA.  Both RNA and cDNA concentrations were determined 
from absorbance values at a wavelength of 260 nm using a BioPhotometer (Eppendorf, 
UK). sqRT-PCR assays were performed using the RedTaq PCR system (Sigma, UK) 
and the Mastercycler gradient thermal cycler (Eppendorf, UK). Primers were designed 
from NCBI mRNA sequences using Primer-3 design software (Table 1).   
 
Immunocytochemistry 
DPC were seeded onto multispot microscope slides and incubated for 24h at 37 
0
C in a 
humidified 5% CO2 incubator (20,000 cells/well). Rat glioma C6 cells known to express 
GDNF as well as GFRα1 and RET (Song and Moon, 2006) were used as positive 
controls. The adherent cells were fixed with ice-cold acetone for 5 min, then rinsed in 
phosphate-buffered saline (PBS) containing 1%BSA. Following incubation in 3% H2O2 
for 30 min (to block endogenous peroxidase) the slides were washed in PBS/1%BSA 
and incubated in 20% normal goat serum followed by incubation with 2 µg/ml primary 
polygonal rabbit antibody against  GFRα1 (sc10716, SantaCruz) or against RET (sc167; 
SantaCruz) overnight at 4 
0
C.  The GFRα1 antibody (sc10716, Santa Cruz, USA) 
specifically binds to the 58-kDa protein, as determined by immunoblotting, while the 
RET antibody (sc167; Santa Cruz) recognizes the 150- to 179-kDa protein (Pierchala et 
al., 2006); both antibodies have been validated for use in immunocytochemical staining 
of cell membrane receptors (Alladi et al., 2010; see also manufacturer’s datasheets at 
http://www.scbt.com/datasheet-10716-gfralpha-1-h-70-antibody.html; 
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http://www.scbt.com/datasheet-167-ret-c-19-antibody.html). For controls, the primary 
antibody was substituted normal rabbit serum. The slides were rinsed in PBS/1%BSA 
and labelled and stained with biotin-streptavidin-HRP using a Biogenex detection kit 
(LP000-UL). The slides were counterstained with haematoxylin before examination 
using a Zeiss microscope.  
 
Data and statistical analysis 
Data obtained from the WST-1, LDH and caspase-3/7 assays were corrected for 
background values and expressed as percentage of controls. Data were analysed by 
ANOVA with Tukey post hoc test. 
 
RESULTS 
 
 
DPC culture model 
RT-PCR analysis showed that GDNF and its receptors GFRα1 and RET transcripts 
were present in postnatal dental pulp and DPC cultures (Fig. 1A). Immunocytochemical 
staining of DPC using specific antibodies against GFRα1 and RET suggested the 
presence of these GDNF receptors (Fig. 1B). These data indicated that the cultures 
provided a suitable model for study of the direct effects of GDNF on DPC.  
 
GDNF stimulates DPSC survival and proliferation 
We performed initial experiments to determine the effects of GDNF on cell growth 
using serum-containing or serum-free cultures. GDNF did not elicit significant changes 
in the number of viable DPCs over a 2-day culture in medium supplemented with FBS; 
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however, addition of GDNF to serum-free cultures resulted in a dose-dependent 
increase in viable DPC numbers (Fig. 2A).  We performed experiments to evaluate 
whether the GDNF-induced increase in cell numbers was due to increased cell survival 
and/or cell proliferation.  
 
The live-dead assay demonstrated that significant cell death occurred in the control, 
serum-free DPC cultures as compared to serum-supplemented cultures (Fig 2B). The 
presence of GDNF significantly increased total cell number, coinciding with a 
significant decrease in the number of dead cells in serum-free cultures, indicating that 
GDNF promoted cell survival under these conditions. (Fig. 2B). 
 
To further characterise the effect of GDNF on cell survival, we performed a 
biochemical cytotoxicity assay to measure LDH release from damaged and dying cells. 
The results show that GDNF significantly reduced LDH secretion in these cultures (Fig. 
2C). To determine if the protective effects of GDNF were due to prevention of cellular 
apoptosis, we determined cellular levels of caspase-3/7. Results demonstrate that 
caspases-3/7 levels were significantly reduced in GDNF-treated cultures compared with 
control cultures, indicating GDNF prevented DPC apoptosis (Fig. 2C). 
 
Next, cell proliferation was determined using by the BrdU-incorporation assay. The 
results showed that GDNF significantly increased the number of BrdU-labeled DPC in 
serum-free cultures, demonstrating that, along with  a pro-survival action, GDNF 
stimulated cell replication (Fig. 2D).  
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Receptor-mediated effects of GDNF   
To determine whether the GDNF effects described above were mediated via its 
canonical receptors, we treated cultures with PI-PLC, which cleaves the receptor 
subunits from their glycosylphosphatidylinositol (GPI)-anchored membrane proteins. 
Analysis of the data presented in Fig. 3 demonstrated that PI-PLC abolished GDNF 
effects on viable cell numbers in serum-free cultures, suggesting an essential role for 
GFRα1 in the GDNF effects on DPC viability (Fig. 3A). Moreover, RPI-1, a 
competitive ATP-dependent RET kinase inhibitor, dose dependently blocked GDNF 
action, underscoring GDNF dependency on the RET co-receptor (Fig. 3B). 
 
GDNF counteracts TNFα-induced reduction in DPSC number 
Finally, this study investigated whether GDNF may have cell- protective effects under 
conditions that better reflected the pathological environment. For this purpose, DPCs 
were cultured in serum-containing medium (to obtain an optimal physiological milieu) 
which was supplemented with TNFα, a pro-inflammatory cytotoxic cytokine up-
regulated in pulpitis (McLachlan et al., 2004). The results demonstrated that TNFα 
dose-dependently decreased DPC numbers; however, cultures supplemented with 
GDNF showed significantly increased DPC viability as compared with TNFα controls, 
indicating that GDNF counteracted TNFα-induced cytotoxicity (Fig. 4). 
   
DISCUSSION 
 
The notion that neurotrophic factors are implicated in tooth development and dentin-
pulp biology is not surprising due to the cranial neural crest cell origin of dental pulp 
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mesenchymal stem cells and odontoblasts and the close association of these cells with 
the pulp neuronal network (Fried et al., 2000; Tziafas et al., 2000). Dental pulp is 
increasingly gaining attention as a therapeutic tool in nerve repair and regeneration, due 
to its neurogenic potential and endogenous expression of neurotrophic factors (Nosrat et 
al., 2001; Lillesaar et al., 2001; Apel et al., 2009). The neurotrophic factor GDNF was 
shown to be expressed in both ecto-mesenchymal dental papilla as well as inner dental 
epithelial cells. GDNF is therefore implicated as an important factor controlling 
epithelial-mesenchymal interactions during tooth development, and in 
GDNF-knockout mice, ameloblasts and odontoblasts fail to differentiate fully (Hellmich 
et al., 1996; de Vicente et al., 2002). GDNF and its canonical receptors GFRα1 and 
RET are also expressed in dental pulp and (sub) odontoblasts in postnatal teeth, 
suggesting a role in odontoblast function (Nosrat et al., 1997, 1998; Luukko et al., 
1997). This study reports the expression of GDNF and its specific receptors, GFRα1 
and RET in dental pulp and DPC cultures and provides evidence that GDNF is a pro-
survival growth factor for DPC via interaction with the GFRα1/RET receptor complex, 
suggesting that GDNF may have a functional role in the regulation of dental pulp cells.   
 
Our results corroborate the well established role of GDNF as a cell survival factor and 
regulatory signaling factor for neuronal and non-neuronal cells (Airaksinen and Saarma, 
2002; Sariola and Saarma 2003). Serum-free cultures facilitate the study of direct 
effects on cells without interference of serum factors, but also present a model 
mimicking pathological conditions involving cellular insult and injury due to trophic 
factor deprivation (Goyeneche et al., 2006). Serum withdrawal induces toxicity in 
neuronal cell cultures which is abated by GDNF (Kobori et al.,2006). 
210 
 
In this study, GDNF was shown to inhibit DPC death induced by serum deprivation, 
suggesting that GDNF may play a cytoprotective role in dental pulp homeostasis during 
stress conditions and pulpal necrosis. Furthermore, the current paper offers the first 
evidence that GDNF is able to block cytotoxic effects on DPC by the pro-inflammatory 
cytokine TNFα, highlighting a possible protective role of this neurotrophic factor in 
pulpitis. TNFα is able to elicit various cellular responses, depending on cell types and 
conditions; in particular, TNFα’s cytotoxic effects are widely documented as involving 
apoptosis-related pathways mediated by its main TNF receptor TNFR1 (Shen and 
Pervaiz, 2006). The cytotoxic effects of TNFα found in our DPC cultures may involve 
induction of cell death combined with an inhibitory effect on cell proliferation. This 
finding corresponds with a previous study describing the cytoprotective effects of 
GDNF in an adrenal cell line undergoing TRAIL (TNFα-related apoptosis-inducing 
ligand)-induced cell death (Murata et al., 2006). Interestingly, TNFα induced production 
of GDNF by astrocytes and glioma cells possibly via the NFkβ binding present on the 
human GDNF gene promoter, suggesting a regulatory ―protective‖ feedback loop 
involving GDNF in response to inflammation (Appel et al., 1997; Woodbury et al., 
1998). The enhanced levels of GDNF found in gingival crevicular fluid from patients 
with chronic periodontitis emphasize the potential involvement of GDNF in the 
pathophysiology of dental tissues (Sakai et al., 2006).   
 
Apart from its effect on cell survival, GDNF was shown here to be a mitogen for DPCs. 
This is not a very surprising finding as it is well known that the cellular repertoire 
involved in pro-survival signaling is closely associated with cell cycle control processes 
(Maddika et al., 2007). Our results raise the possibility that GDNF may a role in MSC 
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recruitment and proliferation during dentine repair (Shi et al., 2008). GDNF is able to 
bind extracellular proteoglycan heparin sulphate chains (Rider, 2006), indicating the 
likelihood that GDNF produced by odontoblasts is sequestered within dentin (Nosrat et 
al., 1997, 1998). Indeed, preliminary findings from our laboratory using an antibody 
array technology have demonstrated that GDNF was detected within human dentine 
matrix extracts (Thompson et al., unpublished observations).  
This suggests that odontoblast-secreted GDNF can be sequestered within the dentin 
could be released from the matrix upon injury or disease. It is noteworthy that some of 
the neurotrophic effects of GDNF require the presence of TGF which induces the 
translocation of GFR1 to the plasma membrane (Krieglstein et al., 1998; Peterziel et 
al., 2002). However, a limitation of the current study is that it is not possible to 
conclude which particular dental pulp cell type(s) responded to GDNF. The DPC 
cultures cannot be considered homogenous, although, due to the nature of the culture 
method (explant-outgrowth of cells), the DPCs generally displayed a morphologically 
similar polygonal fibroblast/stromal-like cell appearance. Previously, DPCs have been 
shown to express several mesenchymal stem cell features and the capability to 
differentiate along different mesenchymal lineages, including osteogenic and 
odontogenic lines (see also Couble et al., 2000; Huang et al., 2006). Considering that 
GDNF and its receptors are expressed in postnatal dental pulp as well as 
(sub)odontoblasts (Luukko et al., 1997; Nosrat et al., 1997; this study), it is plausible to 
speculate that GDNF acts upon cells of mesenchymal origin, including those of the 
odontoblast lineage, and that GDNF in concert with other local signaling factors such as 
TGFβ1 may control cell viability and recruitment during reparative processes within the 
dentin-pulp (Tziafas et al., 2000; Woodnutt et al., 2000; Magloire et al., 2001). 
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In conclusion, this study demonstrates that GDNF promoted cell survival and 
proliferation of DPC under serum-starved or pro-inflammatory conditions. We propose 
that GDNF may have mutli-functionality within the dentin-pulp complex, acting as both 
survival factor and mitogen during tooth injury and repair. Further studies are warranted 
to evaluate the role of GDNF in dental pulp homeostasis and its potential in novel 
therapeutic strategies for dental pulp repair and tissue regeneration.  
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Tables and Figures 
 
 
Gene Primer sequence Accession no. Product Tm 
GAPDH F-CCCATCACCATCTTCCAGGAGC  
R-CCAGTGAGCTTCCCGTTCAGC 
NM017008 450bp 60 
GDNF F-AGAGGAATCGGCAGGCTGCAGCTG  
R-AGATACATCCACATCGTTTAGCGG 
NM019139 337bp 60 
RET  
 
F-TCAGGCATTTTGCAGCTATG 
R-TGCAAAGGATGTGAAAGCAG 
NM001110099 393bp 62.5 
GFRα1 F-AATGCAATTCAAGCCTTTGG  
R-TGTGTGCTACCCGACACATT 
U59486 218bp 60 
 
Table 1.  PCR primer sequences and annealing temperatures (Tm) 
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Figure 1: A. RT-PCR gel images showing transcripts of GDNF and its receptors 
GFRα1 and RET in dental pulp mesenchymal cells (DPCs), dental pulp and brain. B. 
Immunocytochemical staining of DPSC for GFRα1 and RET. Non-immune rabbit 
serum without specific primary antibody was used as control.   
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Figure 2.  A. Effect of GDNF on viable cell number in serum-supplemented or serum-
free cultures as assessed by WST-1. Results are expressed as percentage of controls 
(mean + SD; n=4). B. Effect of GDNF on the number of dead cells as determined by the 
live/dead assay. Results show percentage of dead cells (mean + SD; n=3) C. Relative 
LDH and caspase-3/-7 levels after 2-days culture in serum-free medium cultures 
supplemented with 100 ng/ml GDNF (mean + SD; n=3). GDNF-treated DPC cultures 
showed significantly reduced LDH and caspase-3/7 levels indicating GDNF-induced 
cell survival effects involves at least in part an anti-apoptotic effect by GDNF D. BrdU 
incorporation after 2-day DPC culture in serum-free medium. The proportion of cells 
labeled positively for BrdU (labeling index) was significantly increased in GDNF-
supplemented cultures indicating stimulation of replication by GDNF.  Statistical 
differences versus serum-free controls: * p < 0.05, **P<0.01, *** p<0.001.  
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Figure 3: Effects of GDNF receptor inhibitors on GDNF-stimulated DPC cultures. A. 
Effect of phosphatidylinositol-specific phospholipase C (PI-PLC) on viable cell number 
as assessed by WST-1 in cultures supplemented with 100 ng/ml GDNF. B.  Effects of 
the RET kinase inhibitor, RPI-1, on viable cell number in 2-day GDNF-treated DPC 
cultures. Results are percentage of control values as determined by the WST1 assay 
(mean + SD; n=6-8).  * p < 0.05, **P<0.01 versus GDNF cultures.   
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Figure 4: Effects of 100 ng/ml GDNF on 2-day DPC cultures in the presence of 
increasing concentrations of TNFα. Results are percentage of control values determined 
by the WST1 assay (mean + SD; n=5-6).  *P< 0.05, **P<0.01 versus corresponding 
TNFα cultures.   
 
 
 
 
 
 
 
 
 
 
220 
 
PAPER 2 
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ABSTRACT 
 
Little is known about the role of neurotrophic growth factors in bone metabolism. This 
study investigated the short-term effects of glial cell line-derived neurotrophic factor 
(GDNF) on calvarial-derived MC3T3-E1 osteoblasts. MC3T3-E1 expressed GDNF as 
well as its canonical receptors, GFR1 and RET. Addition of recombinant GDNF to 
cultures in serum-containing medium modestly inhibited cell growth at high 
concentrations; however, under serum-free culture conditions GDNF dose-dependently 
increased cell proliferation. GDNF effects on cell growth were inversely correlated with 
its effect on alkaline phosphatase (ALP) activity showing a significant dose-dependent 
inhibition of relative ALP activity with increasing concentrations of GDNF in serum-
free culture medium. Live/dead and lactate dehydrogenase assays demonstrated GDNF 
did not significantly affect cell death or survival under serum-containing and serum-free 
conditions. The effect of GDNF on cell growth was abolished in the presence of 
inhibitors to GFR1 and RET indicating that GDNF stimulated calvarial osteoblasts via 
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its canonical receptors. Finally, this study found that GDNF synergistically increased 
tumor necrosis factor-α (TNF-α)-stimulated MC3T3-E1 cell growth suggesting that 
GDNF interacted with TNF-α-induced signaling in osteoblastic cells. In conclusion, this 
study provides evidence for a direct, receptor-mediated effect of GDNF on osteoblasts 
highlighting a novel role for GDNF in bone physiology.    
 
 
 
Key words: GDNF, neurotrophic factor, TNF-alpha, osteoblast, bone, calvarial, cell 
proliferation 
 
 
 
1. Introduction 
 
Glial cell line-derived neurotrophic factor (GDNF) is a pleiotropic signaling molecule 
playing a pivotal role in the development and regulation of the nervous system (1-2). 
GDNF has been recognized as a potent survival factor for neuronal cells in addition to 
its essential roles in neural migration and differentiation (1-3).  GDNF is also widely 
expressed outside neuronal tissues and has been suggested to be involved in epithelial-
mesenchymal interactions during development of urogenital and dental tissues (1, 4-6). 
GDNF is able to elicit various intracellular signalling cascades via multiple receptor 
systems, primarily through the glycosyl-phosphatidylinositol-anchored, GDNF family 
receptor  (GFR1) and the tyrosine kinase transmembrane co-receptor RET (2-3).  
 
Neurotrophic growth factors and cytokines including GDNF have been shown to be 
expressed in bone marrow stromal cells prompting an emerging interest in therapeutic 
regenerative application of bone marrow-derived mesenchymal stem cells in 
neurological disorders (7-11). Interestingly, whilst GFR1 expression was detected 
222 
 
along with GDNF in bone marrow stromal cells, RET proved to be absent in these cells 
(12-13). However, GDNF/GFR1 complexes cleaved from the stromal cells were 
shown to elicit functional signaling through RET expressed on hematopoietic and 
leukemic cells suggesting a signaling pathway involving cell-cell interactions within the 
bone marrow environment  (13-14). In this study we addressed the question whether 
GDNF may be involved in bone metabolism. In particular, this study focused on the 
short term effects of GDNF on the proliferation and survival of osteoblastic cells using 
a non-transformed calvarial-derived cell line as model system for osteoblasts. In 
addition, the research investigated a possible interaction between GDNF and the 
multifunctional, pro-inflammatory cytokine, tumor necrosis factor-α (TNF-α). 
 
2. Materials and methods 
 
2.1 Cell cultures  
 
The MC3T3-E1 cell line is a non-transformed, clonal osteoblast-like cell line 
established from mouse calvaria and has extensively been used as a physiologically 
relevant in vitro model for calvarial osteoblasts, osteogenic differentiation and bone 
formation (15).  MC3T3-E1 were acquired from the European Collection of Cell 
Cultures (ECACC) and were cultured in αMEM containing 10% Fetal Bovine Serum 
(FBS), 1% penicillin/streptomycin, 200 mM glutamine and 2.5 μg/ ml Amphotericin B 
(Sigma Aldrich, UK) in a humidified 5% CO2 incubator at 37
o 
C. Subconfluent cell 
cultures were trypsinised using Trypsin/EDTA (Gibco, UK) and plated into 96-
multiwell plates in MEM/10% FBS at 5,000 cells/well.  After 24 hours, the cultures 
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were replenished with either serum (10% FBS) or serum-free MEM supplemented 
with 0.1% bovine serum albumin (BSA). Recombinant human GDNF (rhGDNF, 
provided by Amgen, Thousand Oaks, USA) or TNF-α (PeproTech, UK) was added to 
the cultures for a further two days. For the receptor inhibitor experiments, cultures were 
treated for 1 hour with different concentrations of phosphoinositide phopsholipase C 
(PI-PLC; Sigma) which blocks signalling via GFRα1 (16), or RPI-1 
(Merck/Calbiochem), a specific RET receptor tyrosine kinase inhibitor (17), followed 
by further culture with the respective inhibitors in media with or without GDNF. 
 
2.2 Cell number and viability assays 
 
The WST1 assay (Roche Applied Biosciences) was used to assess the number of viable 
cells (18); the absorbance of the reduced compound was measured at a wavelength of 
450 with a reference filter at 630nm using a Biotek plate reader. The ―live/dead‖ assay 
used 4µM acridine orange to stain nuclei of live cells and 4µM ethidium bromide to 
label nuclei of dead cells. The number of live and dead cells per microscopic field was 
counted under a Nikon Eclipse fluorescent microscope using 480 and 520nm filters, 
respectively.  The level of cell death in the cultures was determined biochemically using 
a lactate dehydrogenase (LDH) cytotoxicity assay (Roche, UK). Cell culture 
supernatants were analysed after a 2-days’ culture for the presence of LDH. Absorbance 
was determined at 490/630nm using the Biotek plate reader.  
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2.3 BrdU cell proliferation assay 
Cell proliferation was assessed using a 5-bromo-2-deoxy-uridine (BrdU) labeling and 
detection kit (Roche Applied Sciences). In brief, cells were labeled with 10 μM BrdU 
for the final hour of the 48 hours’ culture followed by fixation and immunostaining for 
BrdU incorporation using a specific anti-BrdU antibody. Cells were counterstained with 
hematoxylin and the total number of labeled and non-labeled nuclei were counted in 50 
independent microscope fields. 
2.4 Biochemical alkaline phosphate (AlP) assay 
Cells were lysed in 0.1% Triton X-100 and incubated for 10 min in 1 M diethanolamine 
buffer (pH 9.8) containing 1mg/ml  p-nitrophenyl phosphate (pNPP)  at 37° C. 
Production of PNP (p-nitrophenol) was quantified spectrophotometrically at an 
absorbance of 405 nm using an automatic plate reader.  
 
2.5 Semi-quantitative RT-PCR (sqRT-PCR) analysis  
Cells were lysed in RLT buffer containing β-mercaptoethanol followed by RNA 
isolation using the RNeasy minikit (Qiagen, UK). Subsequently, 1μg of DNase-digested 
total RNA was used for oligo(dT) (Ambion, UK) reverse transcription to generate 
single-stranded cDNA using the Omniscript kit (Qiagen, UK). Centrifugal filters 
(Microcon) were used to purify and concentrate resultant cDNA.  Both RNA and cDNA 
concentrations were determined from absorbance values at a wavelength of 260 nm 
using a BioPhotometer (Eppendorf, UK). sqRT-PCR assays were performed using the 
RedTaq PCR system (Sigma, UK) and the Mastercycler gradient thermal cycler 
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(Eppendorf, UK). Primers were designed from NCBI mRNA sequences using Primer-3 
design software (Table 1).   
 
2.6 Immunocytochemistry 
 
MC3T3-E1 were seeded onto multispot microscope slides and incubated for 24h at 37 
0
C in a humidified 5% CO2 incubator (15,000 cells/well). The adherent cells were fixed 
with ice-cold acetone for 5 min followed by rinsing in phosphate-buffered saline (PBS) 
containing 1% BSA. Following incubation in 3% H2O2 for 30 min (to block endogenous 
peroxidase), the slides were washed in PBS and incubated in 20% normal goat serum 
followed by incubation with 2 µg/ml primary polygonal rabbit antibody against  GFRα1 
(sc10716, SantaCruz) or against RET (sc167; SantaCruz) overnight at 4
o 
C. Both 
antibodies have been shown to specifically recognise the respective protein receptors as 
determined by immunoblotting, and have been validated for use in 
immunocytochemical staining of cell membrane receptors (see manufacturer’s 
datasheets). To demonstrate that the immunocytochemical staining was specific for the 
primary antibody, the primary antibody was substituted with 20% normal rabbit serum. 
The slides were rinsed in PBS/1% BSA and labeled and stained with biotin-
streptavidin-HRP using a Biogenex detection kit (LP000-UL). The slides were 
counterstained with haematoxylin before examination under a Zeiss microscope.  
2.7 Data and statistical analysis 
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Data obtained from the WST-1, LDH and ALP assays were corrected for background 
values and expressed as percentage of controls. Data were analysed using ANOVA with 
Tukey’s posthoc test.    
 
 
3. Results 
 
 
3.1 Expression of GDNF, GFRα1 and RET in calvarial osteoblasts 
 
sqRT-PCR analysis revealed that GDNF and its receptors GFRα1 and RET were 
expressed in the osteoblast cell line MC3T3-E1 (Fig. 1A). No obvious changes in gene 
expression were evident in serum-free cultures as compared to cultures maintained in 
serum supplemented media (Fig. 1A). This observation was supported by gel image 
analysis (unpublished observations). Immunocytochemical staining of MC3T3-E1 using 
specific antibodies against GFRα1 and RET confirmed the presence of these GDNF 
receptors (Fig. 1B).  
 
3.2 GDNF stimulates MC3T3-E1 cell proliferation 
 
Addition of GDNF to the osteoblast-like cells did not elicit major changes in the 
number of viable cells over a 2-day culture period in medium supplemented with FBS; 
however, at 100 ng/ml GDNF a significant, albeit modest decrease in cell number was 
evident (82.9% of controls). Conversely, GDNF dose-dependently increased viable 
MC3T3-E1 numbers in serum-free cultures (Fig. 2A).    
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Biochemical analysis of alkaline phosphate (ALP), a non-specific marker for early 
osteoblast differentiation (19-20) demonstrated that GDNF had no significant effect on 
overall ALP activity (data not shown), but following correction for cell numbers a dose-
dependent decrease in ALP levels at increasing GDNF concentrations in serum-free 
cultures was evident (Fig. 2B). These data indicated that the reduced relative ALP 
activity in GDNF-treated serum-free cultures corresponded with increased cell growth.  
 
To corroborate the WST-1 data, cell proliferation was further analyzed using the BrdU-
incorporation assay. The BrdU data demonstrated that the mitotic activity in serum-free 
cultures was greatly reduced compared to the serum-supplemented cultures (Fig. 3). 
GDNF had a modest, albeit non-significant, effect on BrdU labeling in serum-
containing cultures (23% reduction compared to controls). However, GDNF 
significantly increased the number of BrdU-labeled cells in serum-free cultures by 
103.7% (i.e. two-fold increase) demonstrating that GDNF stimulated cell replication 
under these conditions (Fig. 3).  
 
3.3 GDNF does not affect osteoblast cell survival 
 
To further investigate whether GDNF influenced cell survival, the live-dead assay was 
applied. Results demonstrated that significant cell death occurred in control, serum-free 
cultures as compared to serum-supplemented cultures (Fig. 4A). GDNF did not 
significantly affect the number of dead cells in either serum-containing or serum-free 
cultures suggesting that GDNF did not affect cell death or survival under either 
condition (Fig. 4A).  
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These data were corroborated by the biochemical cytotoxicity LDH assay demonstrating 
that GDNF did not influence the level of cell death under serum-free conditions (Fig. 
4B).  
 
3.4 Receptor-mediated effects of GDNF   
 
To determine whether GDNF affected the cells through its canonical receptors GFRα1 
and RET, cultures were treated with specific compounds known to block GDNF 
signalling. PI-PLC which hydrolyses the GFRα1 subunits from their 
glycosylphosphatidylinositol (GPI)-anchored membrane proteins thereby negating 
GDNF signalling via this receptor, abrogated GDNF effects on viable cell numbers in 
serum-free cultures (Fig. 5).  These data underline an essential role for GFRα1 in the 
GDNF effects on osteoblast viability. RPI-1, a competitive ATP-dependent RET kinase 
inhibitor, dose-dependently blocked GDNF action indicating that activation of the RET 
co-receptor was necessary to elicit GDNF signalling in these cells (Fig. 5).  
 
3.4 Interaction of GDNF with TNFα 
 
Finally this study investigated the effects of GDNF in the presence of the pro-
inflammatory cytokine TNF-α, which is known to have profound effects on bone cells 
including MC3T3-E1 osteoblastic cells (21-23). TNF-α dose-dependently increased 
viable cell numbers in both serum-containing and serum-free MC3T3-E1 cultures (Fig. 
6). Addition of GDNF to the cultures supplemented with TNF-α further promoted 
osteoblastic cell growth in these cultures: The stimulating effects of GDNF appeared 
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relatively modest and non-significant in the 10% FBS cultures (Fig. 6A); however, 
GDNF synergistically increased cell numbers in the presence of TNF-α in serum-free 
cultures (Fig. 6B).  
 
4 Discussion  
 
The current study provides evidence of a direct effect of GDNF on calvarial-derived 
osteoblasts suggesting a potential role for this neurotrophic factor in the regulation of 
craniofacial bone metabolism. GDNF as well as both of its canonical receptors GFRα1 
and RET were shown to be expressed in MC3T3-E1 osteoblastic cells and signaling 
through both receptors was needed for GDNF effects on osteoblast cell growth. This is a 
novel and interesting finding, as previous studies reported that only GDNF and 
GFRα1were present in two human osteosarcoma cell lines (Saos-2, MG63) and primary 
bone marrow stromal cells, but not RET (12). Thus this latter work had led to the 
conclusion that GDNF signaling in the bone marrow environment involved interaction 
with RET-expressing hematopoietic cells (13-14). Previous studies have suggested that 
isolated cells from calvarial bones may behave differently than osteoblasts derived from 
long bones ((21-23)), which may reflect the mechanistically different processes by 
which the different structures in the skeleton develop (i.e. flat bones via 
intramembranous bone formation, whereas long bones through the process of 
endochondral bone formation; (27)). Moreover, it is worth noting that a significant part 
of the craniofacial skeleton originates from neuronal crest ―ecto-mesenchymal‖ 
progenitor cells and therefore the calvarial osteoblasts may therefore exhibit a different 
molecular repertoire and cell behavior than mesodermal/mesenchymal-derived bone-
forming cells present in long bones (24-26). RET is considered important for 
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development and differentiation of neural crest-derived tissues, including cranial tissues 
(28-30). GDNF was shown to be co-expressed with GFRα1/2 and RET in dental 
epithelial and mesenchymal cells during tooth development (31,32). Our recent studies 
indicated that mesenchymal/stromal cell cultures derived from dental pulp also 
displayed co-expression of GDNF and GFRα1/RET (33). RT-PCR analysis suggested 
that the calvarial osteoblasts expressed GDNF and the receptors GFRα1 and RET in 
serum-free cultures to a similar degree as cells maintained in serum-supplemented 
media.Previous studies demonstrated gene expression of both GDNF receptor 
components GFRα1 and RET in adrenal medullary cells and glial cells cultured in 
serum-free medium (34, 35).Interestingly, addition of serum upregulated the 
transcription levels of GFRα1 and RET in these cells (34, 35). Further quantitative RT-
PCR is recommended to evaluate and substantiate the effects of culture conditions on 
gene expression in osteoblasts; notwithstanding our observations indicate that the 
calvarial osteoblastic cell line expressing the primary GDNF receptors represents a 
suitable model to investigate GDNF signaling in either serum-containing or serum-free 
culture media.  
This study demonstrates that GDNF stimulated MC3T3-E1 cell proliferation in 
serum-free conditions, which corresponded with a concomitant inhibitory effect on 
relative ALP activity, a marker of early osteogenic differentiation. Moreover, our data 
indicate that GDNF at high concentrations exerted a cell growth curbing effect on 
osteoblasts maintained in serum-supplemented culture medium; an effect that appeared 
to be associated with a slight increase in ALP activity (Fig. 2). It is well established that 
cell differentiation is often inversely related with mitotic activity and our observations 
indicate that GDNF effect on calvarial osteoblasts mainly involves an action on cellular 
231 
 
proliferation with a concomitant inverse effect on immediate differentiation. 
Interestingly, GDNF/RET signaling has been shown to be responsible for the anti-
mitotic action in an embryonic neural precursor carcinoma cell line (36). This effect 
mediated by p27
kip1
 was suggested to be a mechanism by which GDNF regulates cell 
growth to initiate terminal differentiation (36). Long-term culture experiments will be 
required to investigate in further detail the role of GDNF in osteogenic proliferation, 
differentiation and bone formation.  
 
The mitotic and cell survival actions of GDNF through GFRα1/RET signaling 
are well documented in the literature underscoring the multifunctional role of GDNF in 
tissue maintenance, repair and regeneration (1-3). Shi et al (37) described that GDNF 
promoted mesenchymal stem cell migration and survival; a mechanism by which GDNF 
may deliver renoprotection and kidney repair. The physiological implications of our 
findings that GDNF stimulated calvarial osteoblast proliferation under serum-deprived 
conditions are as yet unclear, but may allude to a novel role of this neurotrophic factor 
in bone remodeling and repair. GDNF is considered a member of the TGFβ superfamily 
as it has a partial amino-acid sequence homology and similar structural confirmation to 
TGF (38), which comprise growth factors including bone morphogenetic proteins 
pivotal in regulation of bone development, metabolism and repair. TGF1 can have 
diverse and multiple effects in different cell systems; notably this signaling molecule 
has been ascribed a central role in bone cell recruitment, proliferation and 
differentiation (39). Interestingly, TGF1 induces translocation of GFR1 to the plasma 
membrane thereby enabling GDNF signaling through this receptor (40). It is also worth 
noting that GDNF is a potent inducer of the nuclear transcription factor, murine GDNF 
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inducible factor (mGIF) which is homologous to the human TGFβ inducible early gene 
(TIEG) (41). TIEG expression which has been suggested to play a pivotal role  in the 
regulation of osteoblast differentiation (42) is highly induced in human osteosarcoma 
cells as well as immortalized human fetal osteoblasts following treatment with TGFβ 
(43).  It would be fascinating to explore whether GDNF signaling in calvarial 
osteoblasts is related to induction of TIEG/mGIF. 
Considering that GDNF is produced by bone marrow stromal cells as well as 
osteoblasts (9, 44, 45), it is tempting to speculate that GDNF in conjunction with other 
auto- and paracrine factors may be involved in the regulation of osteoblast recruitment 
in bone growth and remodelling. Indeed, this study demonstrated that GDNF cooperated 
with the cytokine TNF-α to stimulate osteoblastic cell growth suggesting an interaction 
between GDNF and TNF-α signalling pathways in osteoblasts. TNF-α has been ascribed 
a multifunctional role in bone metabolism (22); TNF-α effects may involve a pro-
resorptive (osteoclastic bone degradation) action during inflammatory conditions (21), 
but TNF-α has also been recognised as an anabolic cytokine stimulating osteogenic 
migration, proliferation and differentiation  (46-50). Interestingly, TNF-α has been 
shown to have neuroprotective capabilities which in part may be dependent on 
induction of cytoprotective neutrotrophic growth factors such as GDNF (51-53).  
Moreover TNF-α was reported to induce GDNF in chondrocytes underscoring a 
potential role for GDNF in skeletal cells under pro-inflammatory conditions (54). 
Further research is warranted to explore the precise role and mechanistic interaction of 
these pleiotrophic signaling molecules in bone remodeling and their potential 
therapeutic use in bone regeneration and repair.       
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In conclusion, this is the first study to report that the neurotrophic factor GDNF 
is able to influence the proliferation of calvarial osteoblasts via its canonical receptors 
GFRα/RET expressed on these cells highlighting a novel regulatory pathway in 
craniofacial bone physiology.  
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Tables and figures 
 
 
Table 1.  PCR primer sequences and annealing temperature (Tm) 
 
Gene 
symbol 
Primer sequence (5’ to 3’) Genbank 
Accession no. 
Product 
size 
Tm 
GAPDH F-CCCATCACCATCTTCCAGGAGC  
R-CCAGTGAGCTTCCCGTTCAGC 
NM017008 450bp 60 
GDNF F-AGAGGAATCGGCAGGCTGCAGCTG  
R-AGATACATCCACATCGTTTAGCGG 
NM019139 337bp 60 
RET  
 
F-TCAGGCATTTTGCAGCTATG 
R-TGCAAAGGATGTGAAAGCAG 
NM001110099 393bp 62.5 
GFRα1 F-AATGCAATTCAAGCCTTTGG  
R-TGTGTGCTACCCGACACATT 
U59486 218bp 60 
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Fig. 1. (A) Representative RT-PCR gel images demonstrating the presence of 
transcripts for GDNF and its receptors GFRa1 and RET in MC3T3-E1 calvarial 
osteoblasts cultured 
in serum-supplemented (10% FBS) or serum-free culture medium for 2 days. C6 glioma 
cells were used as positive control, and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) as control, housekeeping gene. Respective cycle number used for GDNF, 
GFRa1, RET and GAPDH were 35, 45, 45 and 25. (B) Immunocytochemical staining of 
MC3T3-E1 for GFRa1 and RET. Positive staining (brown) for both receptors was 
clearly evident in the MC3T3-E1 cells, whilst immunostaining was absent in controls 
(specific 
primary antibody was substituted with non-immune rabbit serum). (For interpretation of 
the references to colour in this figure legend, the reader is referred to the web 
version of this article.)       
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Fig. 2. (A) Effect of GDNF on viable MC3T3-E1 cell number in 2-day serum 
supplemented 
(10% FBS) or serum-free (0.1% BSA) cultures as assessed by WST-1. 
Results are expressed as percentage of controls (mean ± SD; n = 4). (B) Effect of 
GDNF on alkaline phosphatase (AlP) activity in osteoblast cultures after 2 days of 
culture. Results represent relative AlP activity corrected for cell number (percentage 
of controls; mean ± SD; n = 4). ⁄P < 0.05, ⁄⁄P < 0.01 versus control values. 
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Fig. 3. BrdU incorporation in 2-day MC3T3-E1 cultures in serum-supplemented 
(10% FBS) or serum-free (0.1% BSA) cultures. The results show the proportion of 
cells labeled positively for BrdU (Li: labeling index). Significantly different from 
controls: ⁄P < 0.05. 
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Fig. 4. Effects of GDNF on cell death in MC3T3-E1 cultures. (A) The number of dead 
cells as determined by the live/dead assay in cultures treated with 100 ng/ml GDNF. 
Results show percentage of dead cells in 1- and 2-day cultures (mean ± SD; n = 3). 
(B) Relative LDH levels after 2-days culture in serum-containing or serum-free 
medium cultures supplemented with 100 ng/ml GDNF (mean ± SD; n = 3). Results 
are mean ± SD (n = 3–4). 
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Fig. 5. Effects of GDNF receptor inhibitors on GDNF-stimulated MC3T3-E1 cultures. 
(A) Effect of phosphatidylinositol-specific phospholipase C (PLC) on viable cell 
number in cultures supplemented with 100 ng/ml GDNF. (B) Effects of the RET 
kinase inhibitor, RPI-1, on viable cell number in 2-day GDNF-treated cell cultures. 
Results are percentage of control values as determined by the WST1 assay 
(mean} SD of 6.8 replicates). Data from GDNF control cultures (without inhibitor) 
were significantly different from controls without GDNF (P < 0.01). ..P < 0.01 versus 
GDNF cultures. 
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Fig. 6. Osteoblastic MC3T3-E1 cell numbers after 2-days’ culture in the presence of 
increasing concentrations of TNF-a with or without 100 ng/ml GDNF in media 
supplemented with 10% serum (A) or in serum-free cultures (B).Viable cell numbers 
were assessed using the WST-1 assay; results are expressed as percentage of 
controls (mean ± SEM; n = 3). ⁄P < 0.05, ⁄⁄⁄P < 0.001 GDNF-supplemented cultures 
versus corresponding TNF-a controls. 
 
 
